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CHAPTER 1
General Introduction
10
General IntroductIon
Timely identification of people with intellectual disabilities (ID) in need of palliative 
care is important for discussing their needs and preferences also timely in the course 
towards the end of life. In people with ID, identification of those in need of palliative 
care is not a common or conscious practice and has not yet been addressed in research. 
This calls for a tool that aids healthcare professionals in timely identification of people 
with ID who might benefit from palliative care. Because of the specific challenges of care 
in this population, we anticipated that existing tools for the general population might 
not be applicable to people with ID. Therefore, the aim of this thesis was to develop and 
evaluate an applicable, feasible and valid tool for timely identifying people with ID in 
need of palliative care.
Intellectual disabilities
The definition of ID, provided by the American Association on Intellectual and 
Developmental Disabilities in 2011,(1) states that people with ID are “characterized by 
significant limitations in both intellectual functioning and in adaptive behaviour, which 
covers many everyday social and practical skills. This disability originates before the age of 
18”. People may differ in the level of intellectual functioning. The classification based on 
IQ test results or tests for adaptive functioning differentiates mild ID (IQ 55-70), moderate 
ID (IQ 40-55), severe ID (IQ 25-40) and profound ID (IQ < 25). On estimation, about 0.7% of 
the Dutch population have ID.(2) This percentage is similar to other developed countries(3) 
and may be higher when people with borderline ID (IQ 70-85) are included. Intellectual 
disabilities are often accompanied with co morbid conditions, e.g., sensory problems, 
mobility problems, seizures and/or psychiatric or behavioural problems, which makes 
the population at risk for vulnerable ageing.(4-6)
In 2013, at the start of the study described in this thesis, 160,740 people in the 
Netherlands had an indication for long-term support, care and/or treatment based on 
their intellectual disabilities.(7) For 90,460 people of this group the indication included 
residential stay. Usually, this support, care and/or treatment is primarily provided by 
care organizations for people with ID and may include residential settings, community-
based homes, supported living and day activity centres. Although in the ‘90s the Dutch 
Government’s policy was to stimulate de-institutionalization (i.e. moving from the central 
residential settings (‘institutions’) to supported accommodation in the community), 
a relatively large group of people with ID in the Netherlands still lives in these central 
residential settings today.(8, 9)
The everyday care for people with ID is usually provided by daily care professionals 
(DCPs), with either an educational background in social work (the majority) or nursing.
(10) Dependent on the needs, this care varies from a small number of hours a week for 
independently living people with ID to 24-hours a day for people with more severe ID 
and a high level of care dependency. Either a general practitioner (GP) or a specialized 
physician for people with intellectual disabilities (ID-physician) is the principal physician 
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and responsible for the medical care. Since February 2000, the medical specialism 
Intellectual Disability Medicine has been acknowledged in the Netherlands. Physicians 
who complete the 3-year advanced training are registered as ID-physicians. For some 
patients the GP is the principal physician and the ID-physician provides only care on 
GPs request or care for specific disability-related problems (e.g., behavioural problems or 
epilepsy). In addition to DCPs and physicians, other disciplines, such as physiotherapists, 
speech therapists and psychologists or remedial educationalists, provide care for persons 
with ID.
 
Palliative care and intellectual disabilities
Throughout the last twenty years, there has been a growing attention for palliative care 
for people with ID, in research(11, 12) as well as in practice.(13, 14) Palliative care is defined 
by World Health Organization in 2002 as ‘‘an approach that improves the quality of life 
of patients and their families facing the problems associated with life-threatening illness, 
through the prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and spiritual’’ 
.(15) Bottom line of the growing attention is an increasing awareness of the importance of 
improving care at the end of life for people with ID.
Several studies and reports have shown that professionals caring for people with 
ID are not sufficiently equipped to provide palliative care and are in need of training.(13, 
16, 17) These professionals lack expertise in palliative care, while specialized palliative care 
services (palliative care units, hospices) often are unfamiliar with the specific needs of 
people with ID regarding this topic. Furthermore, the problems people with ID face at 
the end of life and their specific needs often are recognized only late in the process of 
an serious illness or not recognized at all.(6, 17) Another problem is that it is often found 
difficult to communicate with people with ID about their illness and to involve them in 
end-of-life decisions.(18, 19)
Recognition of the need for palliative care
In order to improve the provision of palliative care, healthcare professionals should be 
able to answer the question “when is palliative care for this person needed?”. Improvements 
in palliative care are most useful when it is sufficiently clear that for a person the palliative 
care phase has started. Ideally, this knowledge is the result of a timely discussion among 
all people involved. Timely identification of people with ID who are in need of palliative 
care facilitates the discussion of the people’s needs and preferences timely in the course 
towards the end of life.(20-22) Additionally, it provides the people involved with time to 
anticipate on important end-of-life decisions, such as treatment options (e.g. curative, 
life prolonging or palliative), a Do Not Resuscitate (DNR) order, usefulness of hospital 
admissions, preferred place of palliative care provision and preferred place of dying. 
However, up to now it seems that timely identifying people with ID who are in need of 
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palliative care is not a common or conscious practice. This calls for a tool that supports 
healthcare professionals in timely identifying people with ID who may benefit from 
palliative care. 
For the general population (without ID), several tools have been developed for this 
purpose, such as the Prognostic Indicator Guide of the Gold Standard Framework,(23) the 
Supportive and Palliative Care Indicators Tool (SPICT),(24) or the Radboud Indicators for 
Palliative Care Needs (RADPAC).(25) Such a tool is not specifically available for people with 
ID and we anticipated that the existing tools may not be applicable to the care for people 
with ID. Caring for people with ID entails specific challenges when it comes to identifying 
needs, such as reciprocal communicational challenges between professional and person 
with ID, presentation of problems in ways that cannot be interpreted unambiguously, 
reliance on proxies, and delays in and uncertainties about the diagnosis of underlying 
diseases.(6, 17, 26, 27)
PALLI study
In order to support proactive palliative care for people with ID, we started the PALLI 
study: PALliative care: Learning to Identify in people with ID. With our study, we aimed 
to develop and evaluate an applicable, feasible and valid tool (PALLI) that supports 
healthcare professionals in identifying people with ID in need of palliative care. PALLI 
was primarily aimed at physicians – either a GP or ID-physician – and DCPs, although 
more professionals are often involved. In the care for people with ID, DCPs are important 
information sources about changes in health and wellbeing, because of their day-to-day 
working experience with the person with ID. These changes may be signals that indicate 
the need for palliative care.(28) In return, DCPs often need others, such as physicians, 
to interpret meaning and cause of their reported changes (or ‘gut feelings’ regarding 
possible changes) and to place these changes in an end-of-life perspective and start the 
discussion about providing palliative care.
Because identification of people in need of palliative care has not yet been addressed 
in ID-related research, we developed PALLI based on the knowledge and experiences 
of healthcare professionals we derived from different methods (retrospective survey, 
individual interviews and focus groups). In addition, we tested PALLI on applicability, 
feasibility and validity in a prospective follow-up study.
Aim and research questions
The aim of this thesis was to develop and evaluate an applicable, feasible and valid tool 
(PALLI) for timely identifying people with ID in need of palliative care.
To generate relevant items for a draft version of PALLI the following research questions 
were studied:
1. When and how do physicians recognize death in the foreseeable future in 
 people with ID? 
13
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2. Which symptoms are present at the moment physicians recognize death in the 
 foreseeable future and which interventions are provided between the moment 
 of foreseeing death and patient’s actual death? 
3. When and how do physicians recognize the need for palliative care in people 
 with ID?
After development of PALLI, we had the following research questions regarding its 
application in practice:
4. Is PALLI an applicable tool, i.e. are items in PALLI relevant and clear, and do they 
 encourage to reflect on the person with ID?
5. Is PALLI a feasible tool, i.e. are professionals able to complete PALLI?
6. Is PALLI a valid tool, i.e. is the construct of PALLI valid and does PALLI have 
 predictive validity?
Structure
This thesis comprises the design of the PALLI study (chapter 2), the development of PALLI 
(chapter 3-6), applicability, feasibility and validity of PALLI (chapter 6 & 7) and the general 
discussion (chapter 8).
Design PALLI study
In Chapter 2, we provide a detailed description of the design of the PALLI study as it was 
intended at the start.
Development of PALLI
To develop PALLI, we used a five-stage procedure based on knowledge and experiences 
of professionals. In the first step of the developmental process, GPs and ID-physicians 
completed a survey about their last patient with ID with a non-sudden death. Chapters 
3 and 4 deal with this survey. In Chapter 3, we describe when and how physicians did 
recognize patients’ death in the foreseeable future, and when physicians did discuss the 
start of the palliative care phase. In Chapter 4, we report on the presence of symptoms 
at the moment of physicians’ recognition of patients’ death in the foreseeable future. 
We also report on the provided interventions in the period between the moments that 
physicians foresaw death and the patients’ actual death.
In addition to this survey, we conducted in-depth structured interviews with a 
selection of the physicians who completed the survey and with DCPs, in order to answer 
the question how they recognise the need for palliative care in people with ID. In Chapter 
5, we present data from these interviews with physicians.
The survey and interviews generated relevant items for a draft version of PALLI, 
which was built in the third step. Fourth, the draft version was discussed in multiple 
focus groups with physicians, DCPs, and palliative care nurses specialized in people with 
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ID. The aim was to get a first impression of the applicability and feasibility and to get 
feedback on content and priority of items and wording, language and scoring of items. 
In the fifth step, we modified the draft version into a final version ready for testing in 
practice. We describe these steps more in detail in Chapter 6.
Applicability, feasibility and validity
We used a one-year prospective follow-up study to test PALLI on applicability, feasibility 
and validity. In Chapter 6, we report on PALLI’s applicability as reported by physicians 
and DCPs in terms of relevance and clarity of the questions and encouragement to reflect 
on the person with ID. In Chapter 7, we present data on PALLI’s feasibility as reported 
by physicians and DCPs in terms of their ability to complete PALLI. Furthermore, we 
explored PALLI’s construct validity, in terms of the association with outcomes related 
to deteriorating health and related to the need for palliative care, and PALLI’s predictive 
validity, in terms of the association with the outcomes at follow-up and with death 
within 12 months.
General discussion
In Chapter 8, we discuss the main findings and methodological considerations of the 
studies in this thesis. We also discuss recommendations for implementation of PALLI and 
recommendations for further research.
Note. This manuscript is based on separate papers published in journals. Consequently, 
the words used to refer to people with ID may differ (person, patient or client). In 
chapter 2 until chapter 5, we use the term professional caregivers instead of daily care 
professionals.
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CHAPTER 2
PALLI study: a study protocol for development 
and validation of a tool for the identification of 
people with intellectual disabilities who are in 
need of palliative care
Milou Christians
Cis Vrijmoeth
Michael Echteld
Marijke Tonino
Dederieke Festen
Henny van Schrojenstein Lantman-de Valk
Marieke Groot
Unpublished paper, available from: https://www.researchgate.net/publication/303310869_PALLI_
study_a_study_protocol_for_development_and_validation_of_a_tool_for_the_identification_of_
people_with_intellectual_disabilities_who_are_in_need_of_palliative_care
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Abstract
Background
Early identification of the need for palliative care is crucial, to prevent problems and 
relieve suffering. Professionals who care for people with intellectual disabilities (ID) 
experience barriers in the identification of those in need of palliative care, mostly due to 
communication challenges. The aims of the PALLI study are 1) to develop a tool that will 
help healthcare professionals identify people with ID who are in need of palliative care, 
and 2) to examine the validity and applicability of the tool.
Methods
A mixed method design is used to develop the tool. First, ID-physicians and general 
practitioners (GPs) complete a retrospective questionnaire about the process of palliative 
care provided to their last patient with ID with a non-sudden death. In addition, interviews 
with physicians and professional caregivers of people with ID regarding recognition of 
the need for palliative care are conducted. The survey and interviews generate items 
relevant for identification. These items are subsequently discussed and prioritized in 
focus groups.
The resulting preliminary identification tool is tested for validity and applicability 
in a prospective follow-up study. 100 adult patients with ID receiving care from GPs 
and 100 adult patients with ID receiving care from ID-physicians are included. Patients 
are followed during a 10-month period, with data collection at 0, 5 and 10 months. 
Data include information on burden of illness, symptoms, activities of daily living, and 
mobility. For those patients who die during the period of data collection, information 
about the quality of death and dying is collected.
Conclusion
This in-depth study ends up in a validated screening tool that will help healthcare 
professionals to identify people with ID who are in need of palliative care. The tool is 
likely to contribute to timely and patient-centred provision of palliative care.
19
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background
Background
There is a growing awareness that early identification of the need for palliative care is 
crucial for symptom relief and the prevention of problems in patients in the palliative 
care phase. Negative consequences for those in need of palliative care, but not identified 
in a timely fashion, are untreated pain and other symptoms, emergency admissions, 
unaddressed advance care planning, and an absence of an individualized, well-
considered plan of action.(29-32) Early identification enables all persons involved to discuss 
patient’s values, preferences and care goals early in the course of an illness and to make 
better informed decisions about the planning and provision of palliative care.(33-35)
Despite the importance of early identification, little is known about this topic in 
people with intellectual disabilities (ID; see box 1). Due to related challenges, such as 
difficulties and delays in diagnosis, referral or treatment(36) and patient-professional 
communicational challenges,(27) early identification of people with ID who are in need of 
palliative care may be complex. People with ID may not communicate symptoms or care 
needs, or communicate these in a different way.(37, 38) For example, physical problems 
can manifest themselves as changes in characteristic behaviour. Because of these 
nonspecific expressions, signs indicating a need for palliative care can easily be missed 
or misinterpreted and healthcare professionals have to work with assumptions, rather 
than clear diagnoses.
The lack of research data and these challenges emphasize the need for support 
in identifying the need for palliative care in people with ID. Several tools to support 
professionals identifying the need for palliative care have been developed and tested in 
the general population,(39) such as the Radboud Indicators for Palliative Care Needs(25) or 
the Supportive and Palliative Care Indicators Tool.(24, 40) As far as we are aware, these tools 
are not tested in the ID population and tools specific for the ID population are not yet 
developed. The existing tools are unlikely to be applicable in the ID population due to 
the above-mentioned population characteristics.
In order to address this knowledge gap, we initiated the PALLI study: PALliative care: 
Learning to Identify in people with intellectual disabilities. The aims of the PALLI study are 1) 
to develop a tool that will help healthcare professionals identify people with ID who are 
in need of palliative care, and 2) to examine the validity and applicability of the tool. In 
this paper, we present the PALLI study design and methodological approach.
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Box 1. People with ID
“People with intellectual disabilities have significant limitations in both intellectual functioning and in 
adaptive behavior, which covers many everyday social and practical skills. This disability originates before 
the age of 18. Intellectual functioning - also called intelligence - refers to general mental capacity, such as 
learning, reasoning, problem solving, and so on. Adaptive behavior is the collection of conceptional, social, 
and practical skills that are learned and performed by people in their everyday lives.” (AAIDD; American 
Association on Intellectual and Developmental Disabilities)(1
Methods
The development of the tool consists of two parts. First, the tool is constructed and then 
it is tested for validity and applicability.
Part 1: construction of the tool
We use a four step procedure to construct the PALLI-tool.
Step 1: Retrospective survey
We ask ID-physicians (see Box 2) and GPs to complete a retrospective survey. This survey is 
based on a survey used by Claessen et al.(41) in a nation-wide study among Dutch GPs about 
their last patient with ID who did not die suddenly. The survey includes questions regarding 
immediate and underlying causes of death; moment of recognition of patient’s death in 
the foreseeable future; signals that led to this recognition, presence of symptoms on the 
moment of recognition; moment of discussion of the start of the palliative care phase and 
its implications for care; treatment aims and interventions after the moment of recognition; 
and barriers and facilitators of identifying the need for palliative care in patients. We add 
questions considered relevant for people with ID and we modify some existing questions 
to make them more suitable. The survey is pilot-tested among ID-physicians and GPs for 
applicability, relevance and consistency.
ID-physicians are recruited via the Netherlands´ Society of Physicians for People with 
Intellectual Disabilities (NVAVG) and GPs via the primary care network around Radboudumc 
Nijmegen, the Netherlands, and via the authors’ network. Permission to use the mailing list 
is obtained from the chair of the network. Physicians are provided with information about 
the study and receive a request for participation by email. Participating physicians are asked 
if they had provided palliative care for a patient with ID. If they answer negative, we ask 
them to only complete questions on physician characteristics, such as type of physician, 
gender, age, years of experience as physician, and training in palliative care. Physicians who 
have provided palliative care for a patient are requested to complete the entire survey.
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Step 2: Telephone interviews
We then interview a purposive selection of ID-physicians and GPs who completed the 
retrospective survey. Ten ID-physicians and ten GPs are selected in such a way that 
balanced distributions of physicians’ work-experience and patients’ cause of death 
(cancer vs. non-cancer) and levels of ID are obtained. In addition, we perform interviews 
with a convenience sample of 15 professional caregivers of people with ID (see Box 2). 
The interview comprises questions regarding experiences with the process of identifying 
the need for palliative care and related signals. Professional caregivers are recruited via 
the authors’ network and via an online announcement on the website of Agora, a Dutch 
centre for support and information on palliative care (www.agora.nl).
Box 2. Care for people with ID in the Netherlands
In the Netherlands, approximately 230 organizations provide care to a broad spectrum of people 
with ID (www.zorgkaartnederland.nl), varying in level of ID, mobility and co morbid conditions (e.g. 
visual, auditory or behavioural problems). The organizations include different care settings: central 
residential settings, community-based homes, supported living and day activity centres. In the 
central residential settings, people with ID live together in homes on a campus. Professional caregivers 
(social workers and nurses) deliver care on a daily (24-hours) basis. A general practitioner (GP) or an 
ID-physician is the principal physician and responsible for the medical care. Since February 2000, 
the medical specialism Intellectual Disability Medicine has been acknowledged in the Netherlands. 
Physicians who completed the 3-year educational training are registered as Physicians for People with 
Intellectual Disabilities (ID-physicians). For some patients the GP is the principal physician and the 
ID-physician provides only care on GPs request or care for specific disability-related problems (e.g., 
behavioural problems or epilepsy). Since the 1990s, the Dutch Government’s policy is to stimulate 
people with ID to move from residential settings (‘institutions’) to supported accommodation in the 
community. These accommodations include community-based homes and homes where people live 
independently. The amount of care provided varies from a small number of hours a week to 24-hours 
a day. For medical care, these people primarily rely on a GP.
Step 3: Focus groups
We extract signals related to the need for palliative care and barriers and facilitators of 
identifying the need for palliative care from the data collected in step 1 and step 2. Based 
on these items a preliminary tool is built which is discussed and prioritized in focus 
groups. We organize five meetings with different professionals involved in the palliative 
care process: two with professional caregivers from two different care organizations for 
people with ID, one with ID-physicians, one with GPs and one with palliative care nurses 
specialized in care of patients with ID. In each group, six to ten participants are recruited 
via the authors’ network and via an online announcement on the website of Agora.
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Step 4: Development of the tool
After the preliminary tool is discussed in the focus groups, we modify the tool based 
on the participants’ comments and supplements. This version of the tool is tested for 
validity and applicability in part 2 of the study.
Part 2: study of the validity and applicability of the PALLI-tool
The validity and applicability of the PALLI-tool is examined in a prospective follow-up 
study.
Study population and setting
Participants are 100 patients for whom a GP is the principal physician and 100 patients 
for whom an ID-physician is the principal physician. Inclusion criteria are: people with 
ID (borderline to profound ID, IQ < 85); aged 18 years or older; and a negative response 
on the ‘Surprise Question’ of the Gold Standards Framework(23) “Would you be surprised if 
this patient died in the next year?” either by the ID-physician or the team of professional 
caregivers. Patients who do not meet the criteria are excluded. Participants are recruited 
from organizations that provide care to people with ID in the Netherlands (see Box 2).
Instruments for outcome variables
In addition to the tool we develop, instruments used in the prospective follow-up study 
are selected on applicability in people with ID, applicability in palliative care populations, 
and psychometric properties, if information is available.
Illness burden 
To examine the patients’ illness burden physicians complete the Cumulative Illness Rating 
Scale (CIRS).(42, 43) The CIRS consists of thirteen items in seven body systems categories: 
cardiac/vascular/respiratory; eyes-ears-nose-throat; gastrointestinal; urogenital; 
musculoskeletal/integuments; neurological/psychiatric; endocrine/metabolic. For each 
item physicians rate the illness burden on a 5-point Likert scale, i.e./ranging from no 
problem (0) to extremely severe problem (4). The CIRS has been used in other palliative 
care populations(44, 45) and has proven to be reliable and valid in a family practice context 
(46), but was not previously used in patients with ID.
Activities of daily living (ADL)
To examine the patients’ ADL-dependency, professional caregivers complete a Dutch 
translation of the Barthel-Index (BI).(47) The BI consists of ten items: bowels, bladder, toilet 
use, bathing, grooming, dressing, feeding, transfers (bed to chair and back), mobility 
on level surfaces, and mobility on stairs. For each activity professional caregivers rate 
the dependency on a two, three or four point scale. The total ADL score ranges from 0 
(completely dependent) to 20 (completely independent). The BI has been used in people 
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with with ID with good results.(48, 49) The BI also has proven to be a useful tool in people 
with life threatening illnesses.(50)
Symptoms
To examine the patients’ symptoms, professional caregivers complete the Utrecht 
Symptom Diary (USD), a modified and extended Dutch version of the Edmonton 
Symptom Assessment System (ESAS).(51) The USD consists of pain, sleeping problems, 
dry mouth, dysphagia, appetite, defecation, nausea, shortness of breath, tiredness, 
confusion, anxiety, depression and wellbeing. For each symptom professional caregivers 
rate the symptom burden using an 11-point numeric rating scale, ranging from 0 (no 
symptom burden) to 10 (highest symptom burden). The USD is part of a program to 
stimulate palliative care, funded by the Dutch government, and is therefore widely used 
in palliative care settings in the Netherlands.(52) In addition to the USD items, we add 
the degree to which patients suffer at the moment from fever, drowsiness, restlessness, 
seizures, and the degree to which patients had shown weight loss or an overall decline 
in health in the past months. Furthermore, we add questions from the Brief Hospice 
Inventory (BHI)(53) regarding the degree to which symptoms were controlled, the degree 
to which patients were comfortable in the past days, and the degree of patient’s quality 
of life at that moment.
Mobility
To examine the patients’ mobility, professional caregivers complete five questions 
regarding the ability to walk in different settings based on the Hauser Ambulation Index 
(HAI)(54) and characteristics of the Gross Motor Function Classification System (GMFCS).
(55) The settings include: at home, work/school, less than 50 m in a safe environment, over 
50 m in a safe environment, outside the safe environment. For each setting professional 
caregivers rate the mobility on an eight point scale: (1) no help, (2) using furniture or 
railing, (3) using cane or crutch, (4) using walker, (5) using wheelchair, but able to move 
using his/her feet, (6) using wheelchair, but able to move using his/her arms, (7) pushed in 
a wheelchair, (8) using electric wheelchair, (9) bedridden. The total mobility score ranges 
between 0 (walking independent in each setting) and 40 (bedridden). This assessment 
of mobility is previously used in studies with people with ID.(56, 57)
Quality of death and dying
To explore the patient’s quality of death and dying we interview the professional 
caregiver using the format of the Dutch version of the Quality of Death and Dying 
(QODD).(58, 59) This version of the QODD consists of 17 items that contribute to the 
persons’ quality of end-of-life: pain under control, control of event, control of bladder 
and bowels, breathing comfort; at peace with dying, unafraid of dying, ability to laugh 
and smile, untroubled about strain on loved ones, maintained dignity and self-respect, 
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time with family/friends\other residents, physical expressions of affection, health care 
costs covered, say goodbye, visit of religious or spiritual advisor, means to hasten death, 
dialysis or artificial ventilation, and funeral arrangements in order. For each question the 
professional caregiver rates the occurrence on a six point scale (never to always) or yes/
no for the last seven questions, and then evaluates the occurrence on 11-point numeric 
rating scale, ranging from 0 (terrible experience) to 10 (almost perfect experience). The 
QODD has been used in other palliative care populations,(59) but was not previously used 
in patients with ID. We adjust the QODD to make it more suitable for use in the care of 
people with ID.
Patients’ perception of their own quality of life and health
To explore the patients’ subjective quality of life we interview eligible patients using the 
format of the Schedule for the Evaluation of Individual Quality of Life (SEIQoL-DW).(60) The 
SEIQoL-DW is administered by means of a semi-structured interview. Adjustments are 
made to make the SEIQoL-DW suitable for use in people with ID. First, the patients name 
three to five areas that they find important for their quality of life. Each area is reflected 
in a related visual cue, a pictograph, presented by the researcher. This pictograph is used 
during the rest of the interview when the area referred to is discussed. Second, patients 
determine the level of satisfaction or functioning in each area, using a visual traffic light 
(green = as good as possible and red = as bad as possible) or using a visual scale of 
five images of faces (very happy face = as good as possible to very sad face = as bad as 
possible). Third, the interviewer asks the patient to rank the areas in importance, after 
which weight points are assigned to the areas based on the ranking order. The SEIQoL-
DW has been used in other palliative care populations,(61, 62) but not previously used in 
patients with ID.
In addition to the SEIQoL-DW, we use a semi-structured interview to ask patients 
questions regarding their perception of their own health. First, we ask patients how 
healthy they think they are using the visual traffic light or the visual scale of five faces. 
Second, patients are asked if they suffer from any symptom or pain. In case of somatic 
symptoms, we ask patients to show where it is located in their body using the picture of 
a person from the ESAS.(51) Third, we ask patients what they would change of their body 
if they had the ability to change it.
The interview protocol and the visual aids are tested and discussed with a research 
assistant with ID and adjustments are made based on her comments.
Procedures
An announcement of the study is published on the website of Agora and sent by email 
to GPs and care organizations for people with ID in the authors’ network. Organizations 
are invited to participate in the study. Interested care organizations are visited by the 
authors to present the study and provide information on what participation entails. 
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After informal agreement to participate, written formal permission for the study to take 
place within the care organization is asked from the representative advisory board and 
the board of directors. Then care organizations are visited by the authors to discuss the 
procedure of informing all people involved – i.e. local managers, professional caregivers, 
physicians, patients and/or legal representatives – and of obtaining informed consent. 
This information procedure differs for each care organization.
Eligible patients are selected by ID-physicians or the team of professional caregivers. 
Before the selection, the physicians and professional caregivers receive information about 
the study, including an explanation of the use of the ‘Surprise Question’. The aim is to 
include patients with different characteristics, e.g. level of intellectual disability, medical 
history, and co morbid conditions. Selected patients and/or their legal representatives 
receive information about the PALLI study via the care organization.
Patients are included by the research team after written informed consent is 
obtained from the patients themselves or the legal representative. We ask the principal 
physician or psychologist whether patients are mentally competent to provide 
informed consent themselves. The patients receive information, with adjusted texts and 
pictograms, for a better understanding.
Patients are followed over a ten-month-period. For each patient a physician (ID-
physician or GP) and a professional caregiver complete a coded online survey at baseline 
(T1), follow-up after five months (T2) and follow-up after ten months (T3). The survey 
includes questions of the developed tool. In addition, the survey for physicians includes 
questions about illness burden (CIRS) and for professional caregivers question regarding 
activities of daily living (BI), symptoms (USD) and mobility. A randomly selected 
subsample of fifty percent of the physicians and professional caregivers complete 
questions with regard to applicability of the tool at T1; i.e. relevance of questions, 
completeness of questions, comprehensibility of questions and duration of completing 
the tool. After the study period, the research team extracts data concerning medical 
consumption – contacts with professionals, treatments, and use of medication – and 
co morbid conditions from the patients’ medical files. If a patient dies during the study 
period, the research team contacts the professional caregiver to offer condolences and 
to ask if they are willing to participate in a telephone interview in which information 
about the quality of death and dying (QODD) of the patient is collected.
We conduct interviews with a selection of included patients with borderline to 
moderate intellectual disabilities. In the first step of the selection, we ask the contact 
persons of each organization (mostly physicians) to screen included patients for 
participation in an interview based on two questions. First, “Is it advisable for the patient 
to participate?”. Related sub questions are “Whether or not is it advisable with regard to 
the patients’ health and the patients’ co morbid conditions (e.g. visual, auditory and speech 
problems), “Would the patient be willing to participate?”, and “Would the patient enjoy 
participating in an interview?”. Second, “Is the patient cognitively and physically able to 
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understand the questions from the interview and answer them?”. Related sub questions are 
“Is the patient able to understand and answer simple and tangible questions?” and “Is the 
patient able to reflect on and talk about his/her quality of life (what he/she likes or dislikes, 
what he/she finds important)?”. In the case the contact person is not able to answer the 
questions we ask the patients’ physician or professional caregiver. In the second step, we 
ask professional caregivers of patients selected in the first step to answer the same two 
questions. After a positive answer on both questions, we ask professional caregivers to 
approach the patient and his or her legal representative (if required). When a patient is 
willing to participate, informed consent (for this part of the study) is obtained and the 
interview is planned. The interview takes place at a venue preferred by the patient and, 
if desired, in the presence of a relative or professional caregiver.
Sample size
The sample size is based on the ability of the checklist to make an independent small 
distinction between time points with respect to the different determinants (ADL, mobility, 
symptom, medical consumption and illness change) scores. We used a linear multiple 
regression model to test whether one variable (the checklist) can cause a small change 
(effect size=.2) controlling for four other factors (yet to be determined). Power was set 
to .9, and the alpha error probability to .05. Using G*Power 3.1,(63) we determined the 
sample size to be 89. These analyses are planned in the GP and ID-physician populations 
separately, making 2*89=178 respondents necessary. Taking possible patient dropout 
into account, we increased this number to 200.
Data analyses
The definition of the psychometric properties to be determined and their associated 
analyses are derived from the Consensus‐based Standards for the selection of health 
Measurement Instruments (COSMIN).(64) In this study, content validity, construct validity, 
responsiveness and interpretability of the checklist are tested. Content validity is studied 
by triangulating the views obtained from a retrospective survey, the literature and 
experts. Construct validity is studied by examining associations between the tool on the 
one hand and illness burden, ADL, mobility, symptoms, medical consumption and co 
morbid conditions on the other hand. The independent association between the checklist 
and these variables is assessed using multiple linear and logistic regression analysis. In 
addition, sensitivity and specificity of the checklist in predicting survival is assessed; 95% 
confidence intervals are provided. Responsiveness is assessed by associating baseline 
checklist data with follow-up ADL, mobility, symptom, medical consumption and illness 
change scores, controlling for baseline outcome data. Generalized linear models with 
random effects will be used for these analyses. Statistical analyses will be performed 
using SPSS 21.
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Ethics
The Ethical Review Committee of Radboudumc has concluded that the study does not 
fall within the remit of the Dutch Act on Human Research and for this reason, full ethical 
review by a Dutch ethical review committee was not necessary (reference number: 
2014/074).
An advisory committee including ID-physicians and specialists in palliative care 
and/or people with ID is related to the study and the research team. Patients, legal 
representatives and others involved are offered the possibility to consult an ID-physician 
for independent judgment or advice.
Discussion
Strengths
To the best our knowledge, the PALLI study is the first to address early identification of 
people with ID who are in need of palliative care. The primary outcome is a practical 
screening tool that will help healthcare professionals to identify these patients. We 
expect the tool to provide a starting point for all persons involved, i.e. professionals, 
relatives and patients, to discuss a patient’s health status and his need of palliative 
care in a multidisciplinary setting. Early identification with the tool is likely to benefit 
the patient’s quality of life in the palliative care phase, because it enables to anticipate 
problems and needs and to make end-of-life decisions in a timely fashion.
The combination of a retrospective and a prospective design allows to explore 
the process of palliative care in depth and to provide secondary outcomes. With the 
retrospective survey and interviews, we gain insight into the barriers professionals 
face when shifting towards a palliative care approach. The prospective follow-up study 
provides longitudinal data on changes in health, symptoms, care dependence, medical 
consumption and quality of death and dying. Because we used online questionnaires for 
physicians and professional caregivers, it is possible to follow a large cohort of patients 
with ID for a significant period. A cohort study allows distinguishing palliative care 
trajectories in people with ID, which will allow further progress in anticipatory care.
The study is not burdensome for the patient and does not interfere with the 
provided care. The prospective study contributes to practice, by providing data for 
education of health care professionals working with people with ID. Further research can 
enrich our data by including the perspective of patients and relatives (parents, siblings). 
Challenges
Because palliative care for people with ID is still a relatively small field of research, most 
instruments that are well adapted for use in palliative care are not validated for use 
in this population. This challenges us to critically monitor the use of the instruments 
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throughout the study and to adjust the contents when questions are not applicable to 
people with ID or when questions are in need of modification. On the other hand, it also 
provides useful information about the applicability and usefulness of the instruments.
In the development and validation of the screening tool, we are aware of the 
need to consider the interpretation of the outcomes. It is possible that the results of 
the tool identify a patient as in need of palliative care, when in fact another problem is 
the underlying cause. For example, problems attributable to a reversible and treatable 
condition, serious life events (e.g. death or illness of a relative) or significant changes 
in the proximal environment of the patient. We think the screening tool can support in 
identifying those patients that may benefit from a palliative care approach, but careful 
weighing of the outcomes by the treatment team involved is needed to decide on 
starting palliative care and what the actual palliative care needs are.
Conclusions
This in-depth study results in a valid screening tool that will help healthcare professionals 
to identify people with ID who are in need of palliative care. In addition, we explore 
valuable data on the process of providing palliative care and on patients’ health status 
during the palliative care phase. The resulting tool is likely to contribute to timely 
provision of palliative care in line with the needs of the patient.
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Abstract
Background
Physicians are increasingly confronted with people with intellectual disabilities (ID) who 
are facing life-threatening diseases. We aimed to explore when and based on which 
information sources and signals physicians recognized that a patient with ID would die 
in the foreseeable future. Insights may help in identifying patients in need of palliative 
care.
Method
In this study, 81 physicians for people with ID and 16 general practitioners completed a 
retrospective survey about their last case of a patient with ID with a non-sudden death.
Results
More than 20% of all physicians foresaw death not until the last week of life. In 30% of 
all patients, the physician did not discuss the start of the palliative care phase until the 
last week. The most reported information sources based on which physicians foresaw 
death were the physicians themselves and professional caregivers. We found 40 different 
signals that lead to physicians’ foreseeing death. These were not only medical signals, 
but also behavioural and physical signals.
Conclusions
Results indicate that the physicians’ ability to foresee death is a result of a process of 
growing awareness in which multiple signals from different information sources 
converge. This demands continuous multidisciplinary communication because people 
involved have their own unique interactions with the patient and can therefore 
contribute to a growing and timely awareness of patients’ death in the future.
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Introduction
There is a growing consensus on the importance of a timely start of palliative care in 
people who are facing life-threatening conditions.(20) Due to an increased longevity,(65) 
more people with intellectual disabilities (ID) are facing life-threatening conditions 
and are in need of palliative care. The World Health Organization(15) defines palliative 
care as “an approach that improves the quality of life of patients and their families facing 
the problem associated with life-threatening illness, through the prevention and relief of 
suffering by means of early identification and impeccable assessment and treatment of pain 
and other problems, physical, psychosocial and spiritual”.
An important aspect within this definition is identification of those patients who 
are in need of receiving palliative care. Ideally, patients ought to be identified early in 
their disease trajectory so the highest quality of life and –dying can be achieved by 
advance care planning. Since identification is difficult, palliative care often starts when 
healthcare professionals realise themselves that patients might die in the foreseeable 
future. Insights in when and how death in the foreseeable future is recognized may 
provide useful information that helps in the identification of patients in need of palliative 
care. However, these insights are not yet available for people with ID. In this retrospective 
after-death study, we therefore present data on the moment of physicians’ recognition 
of death in the foreseeable future.
Recognizing when a patient will die, as a component of prognostication, is 
a core skill of physicians working in palliative care, but is often found difficult.(66) In a 
retrospective after-death study in a general population, general practitioners (GPs) did 
not recognize death in the near future in one out of three patients.(32) A related factor is 
the condition leading to death. In a study by Claessen et al. in 2013(41), GPs recognized 
death in the foreseeable future only in the last week of life for only 6% of patients with 
cancer, while this percentage was four times higher in patients with other diseases.
Foreseeing death may even be more difficult for physicians working with people 
with ID. Healthcare professionals can easily miss or misinterpret signals that indicate that 
patients are nearing end of life, because of difficulties and delays in diagnosis, referral or 
treatment, the lack of knowledge among professional caregivers regarding diseases, care 
avoiding behaviour among patients with mild ID and patient-healthcare professional 
communicational challenges.(13, 27, 36) Patients may not communicate their problems or 
changed care needs, or communicate these in a different way.(6, 37, 67) This is especially true 
for patients with profound intellectual and multiple disabilities.(68) Somatic problems 
may manifest themselves as changes in characteristic behaviour or functional decline, 
but are difficult to identify as somatic problems.
In this descriptive paper, our aims were to explore when physicians recognize 
patients’ death in the foreseeable future; to explore when physicians discuss the start 
of the palliative care phase and the implications for the care provision with patients, 
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relatives and/or other healthcare professionals; to explore the information (signals) 
and the sources of information on which the physicians based their recognition of 
death in the foreseeable future; and to examine which physician characteristics, patient 
characteristics, conditions leading to death and signals are related to the moment of 
physician’s recognition.
Method
Sample and Procedure
Between September and November 2013, we requested General Practitioners (GPs) and 
physicians for people with ID to complete an online retrospective survey about their 
last patient with ID who did not die suddenly. We approached 255 physicians who were 
registered members of the Netherlands’ Society of Physicians for People with Intellectual 
Disabilities (NVAVG) in 2013. In addition, we approached 83 GPs, most of who were 
connected to the primary care network around Radboud University Medical Centre in 
2013. Since registered members of the NVAVG are not only ID-physicians (see Box 1) 
we divided the type of physician in this study into physicians for people with ID, i.e. ID-
physicians, ID-physicians in training and other physicians primarily working with people 
with ID, and GPs.
Box 1.  Care of people with ID in the Netherlands
In the Netherlands, 240 organizations provide care to a broad spectrum of people with ID (www.
zorgkaartnederland.nl), varying in level of ID, mobility and comorbid conditions (e.g. behavioural, 
physical or sensory problems). The organizations include different care settings: central residential 
settings, community-based homes, supported living and day activity centres. In the central residential 
settings, people with ID live together in homes on one location. Professional caregivers (mostly with 
a social work education) and nurses deliver care on a daily (24-hours) basis. A GP or an ID-physician is 
the principal physician and responsible for the medical care. For some patients the GP is the principal 
physician and the ID-physician only provides care on GPs request or care for disability-related problems 
(e.g., behavioural problems or epilepsy). Since 2000, the medical specialism Intellectual Disability 
Medicine has been acknowledged in the Netherlands. Physicians who completed the 3-year educational 
training are called Physicians for People with Intellectual Disabilities (ID-physicians). In addition, other 
disciplines, such as physiotherapists, speech therapists and behavioural experts, are available on location. 
Since the 1990s, the Dutch Government’s policy is to stimulate people with ID to move from residential 
settings to supported accommodation in the community. These accommodations include community-
based homes and homes where people live independently. The amount of care provided varies from a 
number of hours a week to 24-hours a day. For medical care, these people primarily rely on a GP.
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Measures
We based the retrospective survey on the survey used by Claessen et al. (2013)(41) which 
originally consisted of 44 semi-structured questions regarding end-of-life care provided 
by Dutch GPs to patients in a general population with a non-sudden death. We added 
questions considered relevant for people with ID and we modified existing questions to 
make them more suitable. The survey was pilot-tested among seven ID-physicians and 
two GPs for applicability, relevance and consistency. The final survey consisted, among 
others, of questions regarding physician characteristics, patient characteristics, causes of 
death, the moment of physicians’ recognition of death in the foreseeable future and signals 
that led to the recognition of death in the foreseeable future. In the survey, physicians 
were asked if they had provided care for a patient with ID with a non-sudden death. 
We asked physicians with a negative response to only complete questions on physician 
characteristics. Physicians with a positive answer completed the entire survey using the 
patient’s medical record.
Physicians who completed the entire survey were asked when it became clear to 
them that the patient would die in the foreseeable future. Additionally, we asked the 
physicians when they discussed the start of the palliative care phase and the implications 
for the care provision with patients, relatives and/or other healthcare professionals. 
Physicians answered both questions in ‘time before death’: more than one year, six 
to twelve months, four to six months, one to four months, two to four weeks, one to two 
weeks, less than one week, one to four days and less than one day. Physicians named the 
source of information based on which they foresaw death: patient, family, professional 
caregivers, medical specialists, and the physician themselves or other persons. Physicians 
could fill in more than one answer. Signals that led to the physicians’ recognition 
of death in the foreseeable future were asked using a predefined list of nine themes 
consisting of changes in symptoms, physical functioning, behaviour, appearance, well-
being, care needs, mood, daily routines and day/night rhythm. A physician with experience 
in working with people with ID checked and supplemented the themes. For each theme, 
physicians described the signals they noticed in their own words. Physicians were given 
the option to add signals not covered by the themes. Conditions leading to death were 
noted using a predefined list and categorized later into cancer, overall decline in health, 
neurodegenerative diseases and other diseases. Physicians described the immediate 
cause of death in their own words. We present the questions used for answering our 
aims in Appendix 1.
Data analyses
We coded and categorized all signals using the following procedure. In the first step, 
CV, together with a physician with experience in working with people with ID, and 
MC independently coded the signals. In the second step, CV and MC exchanged and 
discussed the coded signals until consensus was reached. In the third step, an ID-
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physician checked and approved the coded signals. In the fourth step, CV, MC and MG 
categorized the coded signals and discussed the final categories. In order to present the 
prevalence of these categories, we counted the coded signals in each category for each 
patient. We dichotomized the prevalence of each category into the number of patients 
with at least one reported signal of that category versus the number of patients with no 
reported signals of that category.
We checked data for normality using skewness, kurtosis and Kolmogorov-Smirnov 
tests. A Chi Square test was used for the number of physicians who followed some form 
of training in palliative care. Mann-Whitney U-tests were performed for the differences 
in number of patients with ID between physicians for people with ID and GPs and the 
differences in number of comorbid conditions reported by physicians for people with 
ID and GPs. We performed a t-test for the difference in number of signals reported by 
physicians for people with ID and GPs. Univariate and multivariate hierarchical linear 
regressions were used to examine independent correlates of the moment of recognition. 
We performed univariate regression analyses to determine which factors would enter 
the multivariate analysis. A p-value of 0.10 was the threshold for entry. In the multivariate 
regression analysis, we entered patient characteristics in the first step and conditions 
leading to death and signals in the second and third step. Data analyses were performed 
using SPSS 21.
Ethics
The Ethical Review Committee of Radboudumc has concluded that the study does not 
fall within the remit of the Dutch Act on Human Research and for this reason did not 
have to go through a Dutch ethical review committee (reference number: 2014/074).
Results
Physician and patient characteristics
Physicians
A total of 169 physicians filled in the survey of which 134 were physicians for people 
with ID (52.5% response) and 35 were GPs (42.2% response). Of the 169 physicians 57.4% 
(n = 97) had provided palliative care to a deceased patient with ID and 43.6% (n = 72) 
had not. These groups did not differ with respect to type of physician, sex, age and 
experience as physician, only with respect to their training in palliative care (X
2 = 8.5, p < 
.01). Significantly more physicians who provided palliative care to a patient with ID had 
followed some form of training in palliative care (84.5%), ranging from a single course 
or peer group in palliative care to a training programme leading to an accreditation as 
palliative care physician.
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Of the physicians who had provided palliative care, 83.5% was a physician for 
people with ID (n = 81) and 16.5% was a general practitioner (n = 16). The median period 
between the survey and death of the patient was six months (IQR = 2-11.75 months). 
The median age of the physicians was 48 years (IQR = 35-56 years), 35.1% was male 
and 79.1% had more than ten years of experience as a physician. Physicians for people 
with ID were the principal physician for more patients with ID than were GPs (median 
= 150 patients [IQR = 100-200] versus 27.5 patients [IQR = 17.25-50]; U = 313, p = .00). 
The median number of deaths of patients with ID in the previous twelve months was 
also higher for physicians for people with ID (3 deaths; IQR = 2-5) than for GPs (1 death; 
IQR = 0-1.75; U = 404.5, p < .001). Most physicians for people with ID worked in a care 
organization for people with ID (97.5%). Three GPs worked in a private practice, seven 
GPs in a duo practice, and eight GPs in a group practice or medical centre.
Patients with ID
In Table 1, we present the characteristics of the patients with ID. The mean age at death 
of all patients was 57.4 years (SD = 16.2; range = 16-90). Nearly a quarter was younger 
than 50 years at the time of death. The main immediate causes of death reported by 
physicians were diseases of the respiratory system (40.2%; e.g., pneumonia) and cachexia 
or dehydration (24.7%).
Additionally, Table 1 presents the differences between patients of physicians for 
people with ID and GPs. A higher percentage of GPs provided palliative care to a patient 
with borderline to moderate ID, whereas a higher percentage of physicians for people 
with ID provided palliative care to a patient with a lower level of intellectual functioning 
(severe – profound ID). Patients of GPs died relatively more often from cancer opposed 
to other diseases compared with patients of physicians for people with ID. Physicians for 
people with ID reported a higher median number of comorbid conditions than GPs (3.0 
conditions [IQR = 1-4 conditions] versus 1.5 conditions [IQR = 1-2 conditions]; U = 391, 
p = .01).
Recognition of death in the foreseeable future
Moment of recognition
The moment of physicians’ recognition of death in the foreseeable future is shown in 
Table 2. Of all physicians, 22.6% foresaw death not until the last week of life, whereas 
42.3% foresaw death before the last month of life. Physicians did not know the moment 
of recognition in two cases.
Moment of discussion of the start of the palliative care phase
Table 2 also shows the moment the physicians discussed the start of the palliative care 
phase. One physician for people with ID and four GPs did not explicitly discuss the start
of the palliative care phase. Of all physicians, 30.4% discussed the start of the palliative
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Table 1. Patient characteristics
Total
(n = 97)
Physicians for 
people with ID
(n = 81)
GPs
(n = 16)
Sex n % n % n %
Male 61 62.9% 52 64.2% 9 56.3%
Female 36 37.1% 29 35.8% 7 43.7%
Level of intellectual disabilities 
Borderline to mild 17 17.5% 11 13.6% 6 37.5%
Moderate 29 29.9% 22 27.2% 7 43.7%
Severe 23 23.7% 21 25.9% 2 12.5%
Profound 28 28.9% 27 33.3% 1 6.3%
Cause of intellectual disability
Down syndrome 22 22.7% 19 23.5% 3 18.8%
Place of death 
Community based home / Home 
in central residential setting
86 88.7% 73 90.1% 13 81.2%
Other (family, hospital, hospice) 11 11.3% 8 9.9% 3 18.8%
Condition leading to death
Cancer 27 27.8% 19 23.4% 8 50.0%
Neurodegenerative diseases (incl. 
dementia)
20 20.6% 18 22.2% 2 12.5%
Overall decline in health 25 25.8% 22 27.2% 3 18.8%
Other diseases (e.g., diseases of 
the respiratory system, circulatory 
system, digestive system, skin, 
genitourinary system, and blood)
25 25.8% 22 27.2% 3 18.8%
care phase not until the last week of life, whereas 35.9% discussed the start of the 
palliative care phase before the last month of life. None of the GPs discussed the start of 
the palliative care phase before the last three months of life.
Moment of recognition versus moment of discussion
In 30.9% of all cases, the moment the physician discussed the start of the palliative care 
phase was at the same moment the physician recognized death in the foreseeable future; 
in 34.0% of all cases, after the moment the physicians recognized death in the foreseeable 
future; and in 26.8% of all cases prior to the moment the physicians recognized death in 
the foreseeable future.
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Table 2. Percentages of physicians’ recognition of death in the foreseeable future and physicians’ discussion of 
the start of the palliative care phase (in time before death)
Recognition of patients’ death 
in the foreseeable future
Discussion of the start of the 
palliative care phase
Total 
(n = 97)
Physicians 
for people 
with ID
(n = 81)
GPs
(n = 16)
Total
(n = 92)
Physicians 
for people 
with ID
(n = 80)
GPs
(n = 12)
n (%) n (%) n (%) n (%) n (%) n (%)
More than one year 9 (9.3) 8 (9.9) 1 (6.3) 5 (5.4) 5 (6.3) -
Six to twelve months 7 (7.2) 7 (8.6) - 7 (7.6) 8 (10.0) -
Four to six months 10 (10.3) 9 (11.1) 1 (6.3) 10 (10.9) 15 (18.8) -
One to three months 15 (15.5) 12 (14.8) 3 (18.8) 11 (12) 16 (20.0) 2 (16.7)
Two to four weeks 12 (12.4) 10 (12.3) 2 (12.5) 11 (12) 6 (7.5) 5 (41.7)
One to two weeks 20 (20.6) 14 (17.3) 6 (37.5) 18 (19.5) 10 (12.3) 1 (8.3)
Less than one week 8 (8.2) 8 (9.9) - 15 (16.3) 8 (10.0) 2 (16.7)
One to four days 11 (11.3) 10 (12.3) 1 (6.3) 8 (8.7) 6 (7.5) 1 (8.3)
Less than one day 3 (3.1) 2 (2.5) 1 (6.3) 5 (5.4) 4 (5.0) 1 (8.3)
Not known 2 (2.1) 1 (1.3) 1 (6.3) 2 (2.2) 2 (2.5) -
Sources of information
The sources of information based on which the physician recognized death in the 
foreseeable future are displayed in Figure 1. The most reported sources were physicians 
themselves and professional caregivers. GPs relied more on professional caregivers as 
source of information than physicians for people with ID, whereas physicians for people 
with ID relied more on information of themselves, medical specialists, relatives and 
patients.
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Information from the patient itself
Information from medical specialist
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Physicians' signalled problems or symptoms
Percentage of physicians (%)
GPs Physicians for people with ID Total
Figure 1. Percentages of the sources of information based on which the physician recognized death in the 
foreseeable future (more than one answer possible)
Signals that led to recognition of death in the foreseeable future
Physicians described a mean number of 4.8 signals per patient (SD = 2.8). The mean 
number of signals per patient was higher for physicians for people with ID than for GPs 
(5.0 [SD = 2.8] versus 3.4 [SD = 2.0]; t = 2.16, p < .05). After coding the signals, we had a 
list of forty different coded signals. We then categorized these coded signals (Table 3). 
With each category, we present examples of related coded signals and the percentage of 
physicians who reported at least one signal of that category. Physicians for people with 
ID reported more signals of each category than GPs, except for signals of a functional 
decline.
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Table 3. Categories of signals with examples of coded signals and percentage of physicians who reported at 
least one signal of that category
Category Examples of signals Total
(n = 97)
Physicians 
for people 
with ID
(n = 81)
GPs
(n = 16)
Changes in 
symptoms
Increasing fatigue, respiratory 
problems, problems with the 
digestive system, pain, fever
74.2% 76.5% 62.5%
Functional decline Decline in functioning, decline 
in mobility, increasing need 
of care, decline in activities of 
daily living
60.8% 60.5% 62.5%
Changes in 
characteristic 
behaviour or mood
Increasing resistance, 
withdrawal, anxiety, loss of 
contact, more affectionate, 
more biddable, decreasing 
opposite behaviour
53.6% 56.8% 37.5%
Decreased intake 
and weight loss
Less intake of food and fluids, 
weight loss, emaciation
46.4% 48.1% 37.5%
Signs of discomfort 
or illness
Agitation, locomotive unrest, 
moaning, facial signs of 
suffering
34.0% 34.6% 31.3%
Development or 
aggravation of a 
disease
Metastasis, development 
of decubitus, development 
of pneumonia, increasing 
seizures
28.9% 30.9% 18.8%
Not responding 
to a treatment or 
insufficient recovery
- 27.8% 29.6% 18.8%
Correlates of recognition of death in the foreseeable future
Table 4 shows the outcomes of the univariate regression analyses of correlates of 
recognition of death in the foreseeable future. No physician characteristics were 
related to the moment of physicians’ recognition in the univariate analysis. Of the 
patient characteristics, age and level of intellectual disabilities were not related to the 
moment of physicians’ recognition, opposed to sex and Down syndrome. Cancer and 
neurodegenerative diseases were significantly related to the moment of physicians’ 
recognition as well as functional decline and changes in characteristic behaviour and 
mood. In addition, we present the results of the final model of the hierarchical multivariate 
regression analysis in Table 4. Only patients’ sex, cancer as condition leading to death 
and changes in characteristic behaviour and mood remained significantly associated to 
the moment of physicians’ recognition of death in the foreseeable future.
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Table 4. Univariate and multivariate linear regression of correlates of the moment of physicians’ recognition of 
death in the foreseeable future (n = 95)
Univariate analysis Multivariate analysis
F B SE B β ΔF B SE B β
Physician characteristics
Sex 0.03 0.09 0.48 .02 - - -
Age 1.03 0.02 0.02 .10 - - -
Type of physician1 0.53 -0.45 0.62 -.08 - - -
Experience2 0.83 -0.46 0.50 -.09 - - -
Training in palliative care3 0.73 0.53 0.63 .09 - - -
Patient characteristics 7.08**
Sex 8.36 1.31 0.45 .29** 0.91 0.43 .20*
Age 0.27 -0.01 0.02 -.06 - - -
Down syndrome4 6.51 -1.33 0.52 -.26* -0.47 0.55 -.09
Level of intellectual disabilities
Borderline to mild 0.26 -0.31 0.61 -.05 - - -
Moderate 0.02 0.06 0.50 .01 - - -
Severe 0.52 0.38 0.53 .07 - - -
Profound 0.15 -0.19 0.50 -.04 - - -
Condition leading to death 2.75**
Cancer 6.38 1.24 0.49 .25* 1.18 0.58 .24*
Neurodegenerative diseases 4.51 -1.16 0.55 -.21* 0.20 0.62 .04
Overall decline in health 2.69 0.85 0.52 .17 1.12 0.59 .22
Signals 3.28**
Changes in characteristic 
behaviour or mood
12.73 1.52 0.43 .35** 1.13 0.42 .26*
Signs of discomfort or illness 1.02 0.49 0.48 .10 - - -
Functional decline 6.10 1.11 0.45 .25* 0.34 0.46 .08
Decreased intake and weight 
loss
3.90 0.89 0.45 .20 0.23 0.43 .05
Development or aggravation of 
a disease
1.50 0.61 0.50 .13 - - -
Not responding to a treatment 
or insufficient recovery
1.09 -0.53 0.50 -.11 - - -
Changes in symptoms 0.20 -0.24 0.52 -.05 - - -
Note. Final model multivariate analysis: R2 = .29; * p < .05; ** p < .01; 1type of physician = physician for people with ID 
vs. GP; 2experience = ≤ 10 years vs. > 10 years; 3training in palliative care = yes vs. no; 4Down syndrome = yes vs. no.
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Discussion
We studied when and how physicians recognize death in the foreseeable future in 
patients with ID. More than 20% of the physicians foresaw death not until the last week of 
life, whereas only 42% foresaw death before the last month of life. In 30% of the patients, 
the physician did not discuss the start of the palliative care phase before the last week 
of life. Four of the GPs did not explicitly discuss the start at all. Physicians’ discussion 
of the start of the palliative care phase was in 30% at the same time, in 26% after and 
in 34% prior to the moment of physicians’ recognition. The most reported sources of 
information based on which physicians foresaw death were the physicians themselves 
and professional caregivers. Physicians described an average of five different signals per 
patient that led to the recognition of death in the foreseeable future, however physicians 
for people with ID described significantly more signals than did GPs. Overall, physicians 
recognized death in the foreseeable future earlier in female patients, patients who died 
from cancer and patients who showed changes in characteristic behaviour or mood.
The percentage of physicians in our study who only foresaw death in the last week 
of life is comparable to the 26% noted by Claessen et al. (2013)(41) in a Dutch general 
population of patients with other diseases than cancer and almost four times higher 
than the 6% noted by Claessen et al. in patients with cancer. However, when interpreting 
this comparison we must note that processes that lead to recognition may be different 
in both populations due to patients’ communicational abilities, ID-related comorbid 
conditions and differences in the social network around the patient. Still, our findings 
suggest that physicians’ recognition of death in the foreseeable future is also a challenge 
in patients with ID. This may be related to the large proportions of patients who died 
from an overall decline in health, e.g. frail patients with a general decline towards 
death, patients with no clear diagnosis, and patients who died from neurodegenerative 
diseases. Recognizing impending death can be difficult, because these vulnerable 
patients are prone to die from relatively minor conditions (e.g. pneumonia), but are 
also known to outlive recurrent infection episodes. In contrast, a diagnosis of cancer is 
often found related to earlier recognition,(32, 41) because cancer is a clear diagnosis with a 
more predictable disease course.(69) In addition, a clear diagnosis is likely to improve the 
palliative care phase, because it allows physicians to anticipate comorbid conditions. The 
comparison between the moment of recognition and discussion may suggest that the 
majority of physicians discuss palliative care only when death is foreseeable, rather than 
earlier on in the course of an illness or when noting a decline in health or functioning. 
This may also indicate that the term ‘palliative care’ still connotes dying and the terminal 
care phase.
Our findings show that the combination of physician and professional caregivers 
is important in noticing signals that lead to the recognition of death in the foreseeable 
future. This is emphasized by the result that physicians foresaw death earlier in patients 
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who showed changes in characteristic behaviour or mood. Professional caregivers are 
often the first to notice changes in patients’ behaviour or mood. However, they need others 
like physicians to support them and corroborate meaning and cause. Patients are least 
mentioned as an information source, which is probably due to challenges in reciprocal 
communication. Patients with ID may lack the ability to communicate health problems 
verbally, which in turn may lead to physicians’ difficulties with involving the patient with 
ID, therefore resulting in a tendency to rely more on proxies. Medical specialists were less 
often mentioned as a source of information than in Claessen et al. (2013).(41) This may be 
due to the tendency of healthcare professionals who take care of people with ID to be 
reticent regarding hospital admission or diagnosis and treatment by a medical specialist. 
Patients with ID are often vulnerable and visiting a medical specialist is often viewed as 
discordant with views on quality of life. Physicians for people with ID were more likely 
to state themselves, relatives and patients as sources of information, whereas GPs more 
often noted professional caregivers as source of information. Although professional 
caregivers are an important source of information, it is noteworthy that in 2013 40% 
of Dutch GPs reported a need for improvement in the collaboration with professional 
caregivers regarding the care for people with ID.(70)
The results highlight the diversity in signals that lead to physicians’ recognition of 
death in the foreseeable future. The finding that physicians for people with ID reported 
more signals than GPs is in line with the care approach of both physicians. Dutch GPs are 
known for their reactive approach, expecting patients to take the initiative and present 
problems,(71) whereas physicians for people with ID mostly work in care organizations 
where the patient’s health and wellbeing is periodically and multidisciplinary evaluated. 
Physicians for people with ID are therefore likely to be more acquainted with the health 
status and signals that lead to recognition. These differences may partly be mediated 
by differences in patient populations: physicians for people with ID usually see patients 
with more severe levels of ID than GPs. This may also explain that patients of GPs died 
relatively more often from cancer. Overall, the results indicate that the physicians’ 
recognition of death in the foreseeable future is a process of growing awareness in 
which multiple signals from different information sources converge.
Strengths and limitations
To our knowledge, this is the first empirical study on physicians’ recognition of death in 
the foreseeable future in people with ID. Because of the explorative nature of the study, 
physicians could describe signals in their own words. This enabled us to obtain detailed 
data on the subjective experiences of physicians. Our study used a retrospective after-
death survey, which can be a limitation as physicians may not have been able to recall 
all experiences and data. Due to this design, physicians may also have reported signals 
in retrospect with the knowledge that the patient eventually died. On the other hand, 
it might have enabled the physician to reflect back on the process and subsequently 
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report signals that would not have been reported while still in the process.
In interpreting the results, the relatively large group of physicians for people with 
ID and patients with a low level of intellectual functioning should be taken into account. 
The results may reflect a patient population in Dutch care organizations for people with 
ID, because in a normal population of people with ID the proportion of borderline to 
moderate ID is higher.(72) Furthermore, significantly more physicians who completed the 
whole survey had followed some form of training in palliative care. Therefore, the results 
may reflect the experiences of physicians interested in palliative care, rather than the 
average physician.
Implications for practice and research
The results show that recognition of death in the foreseeable future and discussion of 
the start of the palliative care phase occurs late in many patients, which emphasizes 
the need for support of timely recognition and discussion. This may enable healthcare 
professionals to provide proactive palliative care led by the patients’ changing needs. 
Systematic assessment of palliative care needs and prognosis is therefore necessary. 
Further research can assist in developing a tool for identification or modify existing tools 
such as the Gold Standards Framework Prognostic Indicator Guidance,(23) the Radboud 
Indicators for Palliative Care Needs(25) or the Supportive and Palliative Care Indicators 
Tool.(24) Because our study was only aimed at physicians, further research can enrich our 
findings by including perspectives of others, especially of patients, patients’ relatives and 
professional caregivers.
Although end of life care is often seen as a medical process, the psychosocial and 
behavioural signals emphasize the need for physicians to look beyond somatic and 
medical problems (e.g. pain) in palliative care. This asks for continuous multidisciplinary 
communication since each person involved has his or her own unique interactions with 
the patient and can therefore contribute to a growing and timely awareness of death 
in the future. Physicians have the medical knowledge, but are dependent on others for 
information about daily functioning.
Conclusions
Although physicians’ recognition of death in the foreseeable future is a challenge in 
patients with ID, it should improve. This is especially true for those who die from other 
causes than cancer and for those where changes in characteristic behaviour are absent 
or missed by healthcare professionals. The tandem of physician – professional caregivers 
is important in noticing and interpreting signals, as these are not only medical, but 
also include characteristic changes in behaviour, mood or daily functioning. Physicians’ 
ability to foresee death is a result of a process of growing awareness in which multiple 
signals from different information sources converge.
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Appendix 1. The questions used for answering the aims of 
this paper
How long before patients’ death did it become clear to you that the patient would 
die in the foreseeable future? (only one answer possible)
̆̆ More than one year ̆̆ One to two weeks
̆̆ Six to twelve months ̆̆ Less than one week
̆̆ Four to six months ̆̆ One to four days 
̆̆ One to three months ̆̆ Less than one day
̆̆ Two to four weeks ̆̆ Not known
How did it become clear to you that the patient would die in the foreseeable future? 
(multiple answers possible)
Due to problems or symptoms that I signalled (as a physician)
Due to problems or symptoms that the patient signalled and expressed itself
Due to problems or symptoms signalled by professional caregivers
Due to problems or symptoms signalled by family
Due to problems or symptoms signalled by a medical specialist
Other, ...
Through which of the following signals did it become clear to you that the patient 
would die in the foreseeable future? (multiple answers possible; specify in own words)
̆̆ (Changes in) symptoms, for 
example ..
̆̆ (Changes in) care needs, 
for example ..
̆̆ (Changes in) physical functioning, for 
example ..
̆̆ (Changes in) mood, for 
example ..
̆̆ (Changes in) behaviour, for 
example ..
̆̆ (Changes in) daily 
routines, for example ..
̆̆ (Changes in) appearance, for 
example ..
̆̆ (Changes in) day/night 
rythm, for example ..
̆̆ (Changes in) well-being, for 
example ..
̆̆ Other, for example ..
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Is the start of the palliative care phase and the implications for the care provision 
discussed with patients, relatives and/or other professional caregivers?
̆̆ Yes
̆̆ No
How long was the period between discussing the start of the palliative care phase 
and patients’ death? (only one answer possible)
̆̆ More than one year ̆̆ One to two weeks
̆̆ Six to twelve months ̆̆ Less than one week
̆̆ Four to six months ̆̆ One to four days 
̆̆ One to three months ̆̆ Less than one day
̆̆ Two to four weeks ̆̆ Not known
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Abstract
Background
Insights into symptoms and interventions at the end of life are needed for providing 
adequate palliative care, but are largely lacking for people with intellectual disabilities 
(ID).
Objectives
We aimed at determining the prevalence rates of physician-reported symptoms from 
the Edmonton Symptom Assessment System (ESAS) at the moment that physicians 
recognized patient’s death in the foreseeable future. In addition, we aimed at exploring 
provided interventions as reported by physicians in the period between physicians’ 
recognition of death in the foreseeable future and patients’ death.
Measurements
In this study, 81 physicians for people with ID (ID-physicians) completed a retrospective 
survey about their last patient with ID with a non-sudden death.
Results
On average, patients suffered from three out of the eight ESAS symptoms. Fatigue 
(83%), drowsiness (65%) and decreasing intake (57%) were most reported. ID-physicians 
reported a median number of four interventions. Interventions were mostly aimed at 
somatic problems, such as pain and shortness of breath. Burdensome interventions 
such as surgery or artificial respiration were least or not reported. Palliative sedation was 
provided in a third of all cases.
Conclusion
Although ID-physicians reported a variety of their patients’ symptoms and of provided 
interventions at the end of life, using adequate symptom assessment tools suitable 
for people with ID and continuous multidisciplinary collaboration in palliative care are 
essential to capture symptoms as fully as possible.
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Introduction
Due to an increased life expectancy(65, 73) more people with intellectual disabilities (ID) are 
experiencing a prolonged period of ill health and are therefore in need of end-of-life care. 
One of the important determinants of good end-of-life care, as mentioned by patients, 
family and clinicians, is effective symptom management.(74, 75) In general, symptoms 
such as pain, fatigue, respiratory problems or anxiety often lead to restrictions in daily 
activities and reduced quality of life. These symptoms are common during the end-of-
life phase of cancer and other chronic diseases(76, 77) and their occurrence increases in the 
last months of life.(78) Early assessment and management of symptoms is therefore an 
important aspect of palliative care, but is one of the main challenges in palliative care for 
people with intellectual disabilities (ID).(17, 79) People with ID have ‘significant limitations 
in both intellectual functioning and adaptive behavior, which covers many everyday social 
and practical skills, originating before the age of 18’, ranging from mild to severe and 
profound limitations(1). Because of these limitations, people with ID may communicate 
symptoms in a different way, e.g. expressed via changes in characteristic behaviour, 
such as withdrawal or agitation.(37, 67) Consequently, healthcare professionals may easily 
miss or misinterpret symptoms that in turn may hinder adequate management of these 
symptoms.
Insights into symptom prevalence and interventions are therefore needed for the 
organization of symptom assessment and management, but are largely unknown in 
people with ID approaching the end of life. Research into symptoms in adults with ID 
has mainly focused on mental health and on pain. For example, Hermans et al.(80) showed 
that depressive and anxiety symptoms were present in 16% of Dutch older people with 
ID (age >50) and Boerlage et al.(81) showed that 18% of institutionalized Dutch people 
with ID suffered from pain. However, none of these studies included people with ID 
approaching the end of life.
In this retrospective after-death study, we therefore present physician-reported 
data on symptom prevalence and provided interventions. In a recent study, we explored 
when and based on which information sources and signals physicians recognized death 
in the foreseeable future in people with ID. Palliative care often starts when healthcare 
professionals realise themselves that patients might die in the foreseeable future.(82) In 
the present study, we aimed at determining the prevalence rates of symptoms at this 
moment of physicians’ recognition. Additionally, we aimed to explore the interventions 
provided between the moments of physicians foreseeing death and patients’ actual 
death.
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Method
Sample and Procedure
Between September and November 2013, we asked physicians to complete an online 
retrospective survey about their last patient with ID who did not die suddenly. We 
approached 255 physicians who were registered members of the Netherlands’ Society of 
Physicians for People with Intellectual Disabilities (NVAVG) in 2013. These are physicians 
primarily working with people with ID, to whom we refer in this paper as ID-physicians 
(see also Box 1). ID-physicians completed the 3-year educational training Intellectual 
Disability Medicine, a medical specialism acknowledged in the Netherlands since 2000.
Box 1. Care for people with ID in the Netherlands
In the Netherlands, 240 organizations provide care to a broad spectrum of people with ID (www.
zorgkaartnederland.nl), varying in level of ID, mobility and co morbid conditions (e.g. behavioural, 
physical or sensory problems). The organizations include different care settings: central residential 
settings, community-based homes, supported living and day activity centres. In the central residential 
settings, people with ID live together in homes on one location. Professional caregivers (mostly with a 
social work education) and nurses deliver care on a daily (24-hours) basis. A General Practitioner (GP) 
or an ID-physician is the principal physician and responsible for the medical care. For some patients 
the GP is the principal physician and the ID-physician only provides care on GPs request or care for 
disability-related problems (e.g., behavioural problems or epilepsy). In addition, other disciplines, 
such as physiotherapists, speech therapists and behavioural experts, are available on location. Since 
the 1990s, the Dutch Government’s policy is to stimulate people with ID to move from residential 
settings (‘institutions’) to supported accommodation in the community. These accommodations include 
community-based homes and homes where people live independently. The amount of care provided 
varies from a number of hours a week to 24-hours a day. For medical care, these people primarily rely 
on a GP.
Measures
We based the retrospective survey on a survey used by Claessen et al.(41), which originally 
consisted of 44 semi-structured questions regarding end-of-life care provided by Dutch 
General Practitioners (GPs) to patients with a non-sudden death. We added questions 
considered relevant for people with ID and we modified existing questions to make them 
more suitable. The survey was pilot-tested among seven ID-physicians and two GPs for 
applicability, relevance and consistency. The final survey consisted, among other things, 
of questions regarding causes of death, the moment of physicians’ recognition of death in 
the foreseeable future, symptoms at the moment of recognition, and provided interventions. 
In the survey, ID-physicians were asked if they had provided care for a patient with ID 
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with a non-sudden death. Physicians with a negative response only completed questions 
on physician characteristics, whereas physicians with a positive answer completed the 
entire survey using the patient’s medical record.
ID-physicians were asked when it became clear to them that the patient would 
die in the foreseeable future. Physicians answered this question in ‘time before death’: 
more than one year, six to twelve months, four to six months, one to four months, two to four 
weeks, one to two weeks, less than one week, one to four days and less than one day. With 
regard to symptoms, we asked the physicians to answer which of the symptoms from 
the Edmonton Symptom Assessment System (ESAS)(51) - fatigue, drowsiness, decreasing 
intake, shortness of breath, pain, anxiety, depressed mood, and nausea – were present 
at the moment of physicians’ recognition of death in the foreseeable future (yes or no).
To monitor interventions, physicians answered which of the predefined 
interventions – aimed at somatic problems, psychosocial problems or other problems 
(see Table 3) – were provided in the period between the moment of physicians 
foreseeing death and the moment of patients’ actual death. Physicians could add 
previously unmentioned interventions. Underlying conditions leading to death were 
noted using a predefined list and categorized later into cancer, overall decline in health, 
neurodegenerative diseases and other diseases. Physicians described the immediate 
cause of death in their own words.
Analyses
We used Chi Square tests to examine differences in sex, experience as physician and 
training in palliative care between physicians who had provided palliative care for 
a deceased patient with ID and physicians who had not. A Mann-Whitney U-test was 
performed for the differences in age between both groups. For the comparison of 
symptoms across underlying conditions leading to death, we calculated 95% confidence 
intervals (CI). Data analyses were performed using SPSS 21.
Results
Physician and patient characteristics
Physicians
A total of 134 ID-physicians filled in the survey (52.5% response) of which 60.4% (n = 
81) had provided palliative care for a deceased patient with ID and 39.6% (n = 53) had 
not. These groups did not differ with respect to sex, age and experience as physician, 
only with respect to their training in palliative care (X
2 = 9.3, p < .01). Significantly more 
physicians who provided palliative care to a patient with ID had followed some form of 
training in palliative care (84.5%), ranging from a single course in palliative care to an 
extensive and accredited training programme.
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The median period between the survey and death of the patient was 5 months 
(interquartile range [IQR] = 2-9). The mean age of the 81 physicians was 44.6 years (SD = 
11.9; range 26-65), 74.1% was female and 66.7% had more than 10 years of experience as 
a physician. Most ID-physicians worked in a care organization for people with ID (97.5%). 
Patients with ID
In Table 1, we present the characteristics of the patients with ID. The mean age at death 
of all patients was 56.3 years (SD = 16.2; range = 16-90) and 23.5% had Down syndrome. 
The most frequent immediate causes of death were diseases of the respiratory system 
(44.4%; e.g., pneumonia) and cachexia or dehydration (23.5%). Patients had a median 
number of 3 co morbid conditions (IQR = 1-4), for example motor impairments (42%), 
epilepsy (33.3%) and visual impairments (24.7%).
Table 1. Patient characteristics 
Total (n = 81)
Sex n %
Male 52 64.2%
Female 29 35.8%
Level of intellectual disabilities 
Borderline to mild 11 13.6%
Moderate 22 27.2%
Severe 21 25.9%
Profound 27 33.3%
Underlying condition leading to death
Cancer 19 23.5%
Neurodegenerative diseases (e.g., dementia) 18 22.2%
Overall decline in health 22 27.2%
Other diseases (e.g., diseases of the respiratory system, 
circulatory system, digestive system, skin, genitourinary 
system and of the blood)
22 27.2%
Recognition of death in the foreseeable future
The moment of physicians’ recognition of death in the foreseeable future is shown in 
Table 2. Of all physicians, 24.7% foresaw death not until the last week of life, whereas 
44.4% foresaw death before the last month of life.
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Table 2. Physicians’ recognition of death in the foreseeable future (in time before death)
Total (n = 81)
Time before death n %
More than six months 15 18.5%
One to six months 21 25.9%
One to four weeks 24 29.6%
Less than one week 20 24.7%
Not known 1 1.2%
Symptoms
Physicians reported a median number of 3 symptoms per patient (IQR = 2-4; range = 
0-8). Eight patients had five or more different symptoms. Only one patient had none of 
the ESAS symptoms. We present the reported symptom prevalence rates as columns in 
Figure 1. Fatigue, drowsiness and decreased appetite were most reported by physicians. 
Furthermore, we present the prevalence rates of symptoms across underlying conditions 
leading to death as different lines in Figure 1. In patients who died from cancer the 
prevalence rates of fatigue, pain, depressed mood and nausea were higher than the 
average rates for the whole group. So were the prevalence rates of drowsiness and 
shortness of breath for the patients who died from neurodegenerative diseases. For 
some symptoms prevalence rates varied considerably between different patient groups: 
decreased appetite (95% CI: other diseases 61.5-92.7 vs. neurodegenerative diseases 
9.0-45.2), pain (95% CI: cancer 36.3-76.9 vs. neurodegenerative diseases 1.0-25.8) and 
nausea (95% CI: cancer 15.4-54.0 vs. other diseases 0.0-14.9).
Interventions
Table 3 shows the interventions provided in the period before patients’ death. The 
median number of interventions reported by physicians was 4 (IQR = 2-5; range = 0-10). 
A total of 78 patients (96.3%) received one or more interventions aimed at somatic 
problems, 32 patients (39.5%) received one or more interventions aimed at psychosocial 
problems, and 44 patients (54.3%) received one or more other interventions. Most 
reported interventions were aimed at pain, constipation, shortness of breath and anxiety. 
The least reported interventions were surgery (2 patients), chemo- or radiotherapy 
(2 patients) and blood transfusion (1 patient). None of the patients received dialysis, 
artificial respiration or resuscitation.
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Table 3. Interventions provided between the moment of physicians’ recognition of death in the foreseeable 
future and the moment of patients’ death
Total (n = 81)
n %
Interventions aimed at somatic problems
Pain 62 76.5%
Constipation 42 51.9%
Shortness of breath 40 49.4%
Delirium 10 12.3%
Fatigue 5 6.2%
Other somatic problems (not specified) 30 37.0%
Interventions aimed at psychosocial problems
Anxiety 27 30.3%
Depressed mood 9 11.1%
Other psychosocial problems (not specified) 10 12.3%
Other interventions
Palliative sedation 28 34.6%
Wound care 17 21.0%
Antibiotics 8 9.9%
Artificial nutrition 6 7.4%
Artificial hydration 5 6.2%
Discussion
Primary findings
We studied symptom prevalence and provided interventions in people with ID approaching 
the end of life as reported by ID-physicians. Regarding symptoms, physicians reported a 
median number of three out of the eight ESAS symptoms per patient. Fatigue was the most 
reported symptom, followed by drowsiness and decreased appetite. Physicians reported a 
median number of four interventions per patient. Most reported interventions were aimed 
at somatic problems, such as pain or shortness of breath.
Compared to a study in a general population of patients receiving palliative care 
for at least three months from Dutch GPs our results regarding symptom prevalence 
somewhat differ(83). For example, for pain (30% vs. 56%) and nausea (11% vs. 25%) the 
percentage in people with ID is lower, whereas for fatigue (83% vs. 36%), and shortness of 
breath (42% vs. 27%) the percentage in people with ID is higher. For anxiety (17% vs. 13%) 
and depressed mood (16% vs. 9%) differences are smaller. However, these comparisons 
should be interpreted with caution since the study of Borgsteede et al.(83) includes people 
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with a significant higher age at death and significant more people who died from cancer. 
Furthermore, the percentages of people with ID who suffer from anxiety, a depressed mood 
or pain may be higher, because healthcare professionals are likely to underestimate these 
symptoms in this population.(6, 80, 81)
Our results show that some symptoms differed considerably across underlying 
conditions leading to death. Pain was least reported in patients who died from 
neurodegenerative diseases, which is noteworthy since pain is a common, but often 
underreported problem in people with dementia.(84) This result may be related to the relative 
high proportion of patients with Down syndrome, who are likely to suffer from Alzheimer’s 
disease at older age. Pain assessment may be even more challenging in this group, because 
there is evidence that the disease progression may alter the pain perception and hinder the 
ability to express pain.(84, 85) The results with regard to the prevalence rates of pain and the 
high frequency of interventions aimed at pain, stress the importance of using instruments 
for proxies to adequately assess pain or distress in people with ID, such as the Rotterdam 
Elderly Pain Observation Scale (REPOS)(86) or the Disability Distress Assessment Tool (DisDAT)
(87). Pain is an important cause of distress, but not all distress behaviour is caused by pain. The 
use of pain observation scales, such as the REPOS, and distress scales, such as the DisDAT, may 
help disentangle the possible causes of distress and help in providing the most adequate 
intervention.
The nature of interventions provided shows that most of the interventions reported 
by ID-physicians have a component of maintaining quality of life, whereas burdensome 
interventions aimed at cure or life-prolongation such as surgery, dialysis, artificial respiration 
or resuscitation were least or not reported. This is line with the general tendency of 
healthcare professionals who take care of people with ID to be reticent regarding diagnosis 
and treatment that may interfere with the quality of life or may cause distress to the patient, 
but rather focus on comfort. This tendency may be even more pronounced at the end of life. 
In addition to the high percentage of patients receiving at least one intervention aimed at 
somatic problems, almost four out of ten patients received at least one intervention aimed 
at psychosocial problems. While we acknowledge the capability of physicians to manage 
psychosocial problems, we suggest involvement of other disciplines, such as psychologists 
or spiritual caregivers, in order to manage these problems effectively and to prevent 
unnecessary medication use.
Regarding palliative sedation, the percentage of cases in which physicians provided 
this intervention (34,6%) is higher than percentages in a study(88) of a stratified sample of all 
deaths in the Netherlands in 2010 (12.3%) and in a study(89) among Dutch GPs providing this 
intervention in a general population between 2006 and 2011 (5.7%). This result may underline 
the difficulties of symptom assessment and management: because meaning and cause of 
symptoms are not always clear, ID-physicians may more easily provide palliative sedation. 
We must note though, that the other studies defined palliative sedation as continuous deep 
sedation. In our study, the type, dose or moment of provision of sedation was unknown.
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Strengths and limitations
To our knowledge, this is the first empirical study exploring symptoms and interventions 
in people with ID approaching the end of life. The use of a retrospective after-death survey 
enabled comparability due to a fixed endpoint for all patients. On the other hand, this 
design can be a limitation as physicians may not have been able to recall all experiences 
and data. Due to this design, physicians may also have reported symptoms in retrospect 
with the knowledge that the patient eventually died. Because we only explored whether 
eight ESAS symptoms were present, our results are limited to those symptoms and 
other important symptoms may not have been included. In interpreting the results, the 
relatively large group of patients with low levels of intellectual functioning should be 
taken into account. Our results may reflect a population of Dutch people with ID living 
in residential care facilities. This is often a vulnerable population with a higher level of 
dependency than those living in community based homes.
Furthermore, since not all ID-physicians completed the entire survey, the results 
may reflect the experiences of ID-physicians interested and trained in palliative care, 
rather than the average ID-physician. The focus on physicians may be a limitation, 
because of their reported tendency to underestimate outcomes.(90, 91) However, ID-
physicians generally work in care organizations for people with ID where the patient’s 
health is periodically evaluated by a multidisciplinary team. ID-physicians are therefore 
likely to be more acquainted with the presence of symptoms in people with ID than the 
average physician in a general population is.
Implications for practice and research
The results show that symptoms are common in people with ID approaching the 
end of life. Since adequate symptom control is an important aspect of palliative care, 
we argue for a continuous multidisciplinary approach of symptom assessment and 
management. For this purpose, proxies who know patients well, such as relatives and 
professional caregivers, are important sources of information for symptom assessment, 
but often need the medical knowledge of physicians to corroborate meaning and cause. 
Furthermore, in the care for people with ID, patients often need proxies to perform and 
to monitor the effect of an intervention set out by the physician. In order to adequately 
assess and communicate symptoms by proxies, we suggest the use of instruments such 
as the previously mentioned REPOS(86) or the ‘Signal box for nursing assistants’,(92) a Dutch 
tool developed for nursing assistants to signal palliative care needs in patients and pass 
this information on to others. The signal box is one of the best practices to improve 
palliative care throughout care settings in the Netherlands.(93)
Further research can supplement our findings by including perspectives of others, 
especially of patients, relatives and professional caregivers. Another focus of further 
research should be on a prospective follow-up of multiple symptoms, including disability- 
or syndrome-related symptoms (e.g. dysphagia). Regarding interventions, it would be 
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interesting to examine this topic in more depth by including indications. Furthermore, 
we did not ask ID-physicians whether the reported symptoms were controlled and 
whether the reported interventions sorted effect.
Conclusions
Although ID-physicians reported a variety of their patients’ symptoms and of provided 
interventions at the end of life, the use of adequate tools suitable for symptom assessment 
in people with ID is essential to capture symptoms such as pain as fully as possible. This 
will enhance the provision of the best possible symptom management and thereby 
enhance obtaining the highest level of quality of life. For this purpose, a continuous 
multidisciplinary care approach and involving relatives are crucial for physicians. The fact 
that research is scarce and the questions that remain after this study indicate a need of 
further research in symptom assessment and management in people with ID at the end 
of life.
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Abstract
Background
A growing number of people with intellectual disabilities (ID) is suffering from life-
threatening chronic illnesses and is therefore in need for palliative care.
Aims
We aimed to explore how the need for palliative care is recognized in people with ID.
Methods
We conducted a semi-structured interview study among 10 ID-physicians in the 
Netherlands.
Results
Identification of people with ID in need for palliative care mostly results from a process 
in which multiple signals from different information sources converge and lead to a 
growing awareness. As a result, ID-physicians do not expect people to return to their 
prior level of health or functioning, but rather expect an irreversible decline leading to 
death. The presence, stage and prognosis of the disease, physician-patient interaction, 
and communication with proxies who provide contextual information are factors 
influencing the process.
Conclusions
Distinctive for a population of people with ID are the frequent diagnostic uncertainty in 
people with ID, the patients’ communicational abilities and the reliance of ID-physicians 
on close proxies. We argue for a proactive attitude of physicians regarding care and 
support of people with ID with palliative care needs.
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Introduction
In people with intellectual disabilities (ID), a trend of an increased life expectancy is seen.
(65) Due to this increased life expectancy leading causes of death, such as cardiovascular 
diseases, respiratory diseases and cancer, resemble those of the general population.
(36, 73) As a result, more people with ID experience a prolonged period of ill health and 
are therefore in need of palliative care, which is ‘‘an approach that improves the quality 
of life of patients and their families facing the problems associated with life-threatening 
illness, through the prevention and relief of suffering by means of early identification and 
impeccable assessment and treatment of pain and other problems, physical, psychosocial 
and spiritual’’ (World Health Organization Definition of Palliative Care(15)).
Essential for adequate planning and early provision of palliative care is identifying 
those people who are in need of palliative care, because it enables healthcare 
professionals to anticipate their needs(21, 94) and to communicate in an early stage about 
important end-of-life decisions.(19, 95) For example, medical decisions such as a Do Not 
Resuscitate (DNR) order, not referring to hospitals or to forgo further treatments, are 
aspects that have to be discussed.
In general, there is a growing awareness of the importance of identifying the need 
for palliative care, but research on this topic is still scarce. A recent study found that the 
identification of the need for palliative care in a broader population of patients of Dutch 
General Practitioners (GPs) is a gradual process of multiple signals, such as diagnosis of 
a disease, increased care dependency, not recuperating, and social changes.(28) However, 
these results may not be generalizable to people with ID, because of the challenges 
healthcare professionals encounter when providing care for this population: for example, 
patient-professional communicational challenges, lack of medical knowledge among 
professional caregivers and delays in diagnosis, referral or treatment.(13, 27, 36)
Up to now, it seems that identifying people with ID who are in need of palliative 
care is not a common or conscious practice and, to the best of our knowledge, has not 
yet been addressed in scientific literature. Therefore, this interview-based study aimed 
to explore how physicians recognize the need for palliative care in people with ID. 
Insights in when and how the need for palliative care is recognized may provide useful 
information that helps in timely identification of people in need for palliative care.
Methods
This study builds upon an interpretative approach of qualitative research, more 
specifically that of the narrative tradition.(96)
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Participants and procedure
Between October and December 2013, we interviewed 10 ID-physicians about their 
experiences with identifying the need for palliative care in people with ID. The interviews 
are part of a larger study aimed at developing a tool that will help healthcare professionals 
to identify people with ID who are in need of palliative care. Since 2000, the medical 
specialism Intellectual Disability Medicine has been acknowledged in the Netherlands 
(www.nvavg.nl). Physicians who complete the three-year training are specialized 
in medical care for people with ID and are called ID-physicians. In the Netherlands, a 
General Practitioner (GP) or an ID-physician is the principal physician and responsible for 
the medical care for people with ID. For some people the GP is the principal physician 
and the ID-physician only provides care on GP’s request or care for disability-related or 
syndrome-related problems (e.g., behavioural problems or epilepsy).
ID-physicians were purposively recruited out of 81 ID-physicians who, as part of 
the larger study, completed a retrospective survey about the care for their last patient 
with ID with a non-sudden death.(82) In the survey, 42 physicians gave permission to be 
approached for an interview. In order to include different perspectives and experiences 
the criteria for purposive sampling were physicians’ work-experience, the underlying 
cause of death (cancer vs. non-cancer) and level of ID of the patient described in the 
retrospective survey. Based on earlier experiences with qualitative interview-based 
studies we approached a number of 10 ID-physicians; all of them agreed to participate. 
The final sample consisted of both ID-physicians and ID-physicians still in training.
Data collection
Our interview guide was based on a guide used by Claessen et al.(28) to examine how 
GPs recognize the need for palliative care in a general population. We modified existing 
questions to make them more suitable and we added questions considered relevant for 
people with ID. The final version of the interview guide consisted of a semi-structured 
part regarding the identification of the need for palliative care in people with ID in general 
and an open part regarding the physicians’ last patient with ID with a non-sudden death 
(see Appendix 1). Both parts contributed to answering our research aims. The first author 
(CV) conducted the interviews: 8 interviews by telephone and 2 interviews face-to-face. 
Each interview was digitally recorded. During and after the interviews the interviewer 
made notes of the most important findings.
Data analysis
Interviews were transcribed verbatim, read, and reread for familiarization with the data. 
Data analysis was performed using Atlas.ti.(97) The first four interviews were analyzed 
and coded by PB (second author), CV and MG (last author) independently. They then 
compared and discussed codes until consensus was reached about a preliminary 
codebook. The remaining interviews were analyzed by PB by means of ‘axial coding’ and 
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finally core concepts were selected after ‘selective coding’.(98) The results of the analysis 
were discussed and approved by PB, CV and MG. The quotations presented in the results 
were translated by CV, then checked and supplemented by MG and finally discussed 
and approved by CV and MG. We used the Consolidated criteria for reporting qualitative 
research (COREQ) checklist to examine the scientific rigour of the data collection and 
analysis.(99)
Ethics 
The Ethical Review Committee of Radboudumc has concluded that the larger study does 
not fall within the remit of the Dutch Act on Human Research and for this reason did not 
have to go through a Dutch ethical review committee (reference number: 2014/074). All 
participants were given written and verbal information about the study. ID-physicians 
gave verbal informed consent before the start of the interview.
Results
Physicians and patients
The mean duration of the interviews was 35 minutes (range = 17-53 minutes). Most 
ID-physicians were female (80%) and had more than 20 years of experience (50%). Two 
physicians were ID-physicians still in training and had less than 10 years of experience. 
The median age of the ID-physicians was 48 years (range = 28-62 years). The ID-
physicians were the principal physician for a median number of 152 patients with ID 
(interquartile range = 98-200 patients) of which a median number of 4 patients with 
ID died in the previous twelve months (interquartile range = 3-5 patients). Four of the 
patients described in the retrospective survey had mild to borderline ID, three patients 
had moderate ID and three patients severe to profound ID. The median age at death of 
the patients described was 53 years (range = 29-90 years). Underlying causes of death 
were cancer (N=1 for cervix, oesophageal, bronchus and lung), heart and circulatory 
disease (N=1 for stroke), respiratory disease (N=1 for pneumonia), disease of the digestive 
system (N=1 for volvulus) and overall decline in health (N=3).
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Process of identification
In Figure 1, we visualise the process of identification (on the right) and the factors that 
influence this process (left boxes). The moment and the way in which ID-physicians realize 
that someone is in need for palliative care are unique in each patient with ID. However, 
analysis revealed that awareness is the key in identification. This raise of awareness 
can occur suddenly or can be (more slowly) growing. In some cases, ID-physicians 
become suddenly aware of the need for palliative care, for example when someone is 
diagnosed with an irreversible advanced life-threatening disease, with poor prognosis, 
and expected death in the near future. Under these circumstances, it is evident for the 
ID-physician that the patient is in need of palliative care.
(IDP5) “It was actually very clear, also compared to the worsened condition of him at 
that moment […] severe weight loss […] and then the diagnosis came: lung cancer. 
This man already had survived another form of cancer, and then this came on top. And 
it was localised in such a way that the pulmonologist said we can’t treat this effectively 
[…] Eventually he died after three months.”
In most cases, identification is described as a process in which multiple signals from 
different sources of information converge and over time lead to a growing awareness of 
the need for palliative care. Signals which emerged from the data were new, increasing 
or recurrent somatic problems, changes in characteristic behaviour, the co-existence of 
multiple disease trajectories, a decline in daily functioning or quality of life, running out 
of treatment options, or not fully recovering after a disease (e.g., recurrent infections). In 
Table 1, we present examples of these signals, and in Table 2, we present examples of the 
people involved, named by the ID-physicians as source of information regarding those 
signals.
(IDP6) “At a certain point so many things coexist, each of which is not treatable 
anymore […] Yes, it is a feeling that you get, well, we should take a closer look at what 
we still will and won’t do.”
(IDP10) “There was an evident physical decline, mainly because of recurrent infections 
[...] where the effect of antibiotics fails to happen, so that you almost could start 
treatment after treatment.”
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Table 1. Examples of signals based on which physicians identified the need for palliative care
Examples of signals
Changes in characteristic 
behaviour or mood
Increasing resistance, social withdrawal, anxiety, angriness, 
sadness, depressed mood, more submissive, increasing or 
decreasing opposite behaviour.
Functional decline Decline in functioning, decline in mobility, falling, increasing 
dependence, decrease in communication abilities (verbal 
and nonverbal).
Decreased intake and weight loss Loss of appetite, less food and fluid intake, weight loss, 
emaciation, problems with swallowing (dysphagia).
Development or aggravation
of diseases
Cancer, heart failure, dementia, COPD, recurrent infections 
(respiratory tract, urinary tract, periods of fever without clear 
focus), increasing seizures†, delirium, diseases because of 
psycho pharmaceutical side effects‡.
Changes in symptoms Increasing fatigue, problems with the digestive system, 
changes in spasticity†, drowsiness, collapse.
Signs of discomfort or illness Pain, dyspnoea, locomotive unrest, irritable, unrest at night.
Note. These signals may not be specific to the palliative care phase, but were mentioned in retrospect with 
the knowledge that patients ultimately died; † = specifically mentioned for people with more severe ID; ‡ = 
specifically mentioned for people with borderline and mild ID
Cases of sudden awareness and growing awareness of the need for palliative 
care are not mutually exclusive. For example, it is possible that a gradual decline or 
an accumulation of problems, whether or not visible to the ID-physician or identified 
as a possible indicator to start with palliative care, has preceded a sudden awareness. 
However, in all cases awareness results in a shift in the physicians’ expectation regarding 
the patient: the ID-physician does not expect the patient with ID to return to the prior 
level of health or functioning, but rather expects a further irreversible decline that 
inevitably leads to death.
(IDP4) “(CV) At what point do you start providing palliative care? (IDP) [...] Sometimes 
this is a very clear diagnosis, someone with metastatic cancer […] But also when you 
see someone getting older and deteriorating and there is (a presumption of) dementia. 
Or people who became so frail in the last year, then you say I don’t know what is going 
on, but I do know that the course towards the end of life is clear. And I don’t know how 
fast it will go, but even then, I’ll discuss palliative care. […] Yes, that the course is moving 
towards death, that someone won’t recover, it is a downward spiral. And the period, 
even in people with dementia it can last for years [...].”
We must note that there are deviating trajectories: people with ID who remain alive 
having a stable, but ill health for a longer period than the ID-physician expected these 
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people to live; or people with ID who recuperate during the palliative care phase, some 
until a level at which there is no clear need for palliative care anymore.
(IDP10) “Situations can also change, in that someone tends to a phase of recovery, 
while we first thought of the terminal phase. We aren’t even speaking of the palliative 
phase anymore”
Table 2. Examples of information sources based on which physicians identified the need for palliative care 
Information source Example
Professional caregiver (IDP4) “(I) What information do professional caregivers pass on? (IDP) 
Particularly very vague things: it doesn’t go well, we are worried. Less 
intake of food and fluids is one that always sets alarm bells. In elderly, 
especially over a longer period of time, when there is weight loss without 
a specific cause […] Yes, the more vague the signals, the more alarms bells 
will ring.”
Medical specialist (IDP5) “At a certain point I receive a message, usually when someone has 
been to a medical specialist, well, that there is something irreversible.”
Patient (IDP7) “That patient with severe ID and the brain tumour was only able 
to speak a few words and when he pointed his finger towards his head 
it meant that he was in pain. That does not mean that he had pain in 
his head, it could also be constipation […] But that is a different way of 
presenting compared to a patient with mild ID, who is perfectly able to tell 
what (s)he feels and experiences.”
Relatives (IDP2) “There were so many complications that at one stage the parents 
said […] we don’t see the man we saw before the illness, he is not enjoying 
things anymore, he is just not that person anymore. And the parents came 
to me with the question: shouldn’t we stop, is this still desirable?”
Factors influencing the process of identification
Here, we elaborate on the factors influencing the process of identification that emerged 
from the data: diagnosis and treatment, physicians’ experience and knowledge, 
physician-patient interaction and physicians’ communication with proxies (left boxes in 
Figure 1).
Diagnosis and treatment
The disease of the patient, the stage and prognosis of the disease and the remaining 
treatment options all affect the process of identification of the need for palliative care. 
Diagnosis of a life-threatening disease with a poor prognosis and expected death in 
the near future is likely to induce a sudden awareness of the need for palliative care. 
Contrary, in people with ID with a diagnosis of a chronic disease in an early stage (e.g., 
dementia in people with Down syndrome or heart failure) or in frail people with ID with 
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an overall decline in health the process is more gradual and the moment when palliative 
care needs are experienced is more diffuse.
(IDP4) “Yes, for example COPD, cardiovascular diseases and heart failure are difficult 
I think. [...] When there is a clear diagnosis, someone has metastatic cancer and you 
can’t manage the metastases, you are pretty sure that you can’t cure the patient. In 
heart failure, the transition is more gradual, you know you won’t cure heart failure, but 
the treatment is initially aimed at keeping people as good as possible and they will also 
be admitted to the hospital […] At a certain point, you want to stop with this and shift 
the aim to comfort. That transition is very difficult [...].”
In the care for people with ID, the nature of underlying diagnoses or causes of 
problems are not always identified, possibly due to the often aspecific presentation, 
physician-patient communicational challenges and to the tendency of ID-physicians to 
be reticent to start diagnostic procedures that may interfere with the quality of life. This 
may delay physicians’ awareness of a need for palliative care.
(IDP2) “At one point, I admitted him to the hospital. Now, I question this decision. […] 
At the moment itself you want to give someone the benefit of the doubt […] you never 
know whether someone will recover […] Looking back, I decided to stop antibiotics 
after the third time, maybe I should have thought earlier about whether it was still 
meaningful. And that is also difficult because you don’t know the cause, does he have 
continuous pneumonia because he constantly chokes, because of bad resistance, or is 
there something else? […] Yes, I think that especially the diagnostic uncertainty makes 
it difficult whether you should really stop with treatment or not.”
In other situations, ID-physicians recognize the need for palliative care at moments 
of decision making concerning possible treatment options: this is especially true when 
people with ID do not respond to their treatment, when (burdensome) treatment is not 
advisable given the patient’s quality of life, or when expected progress in health fails to 
happen. These moments force ID-physicians to reflect on what is best for the patient’s 
health status and quality of life. Hence, a shift from curative or life-prolonging towards 
palliative treatment options may be induced.
(IDP 9) “(CV) How do you recognize that a patient is in need for palliative care? [...] (IDP) Well, 
at the moment the course of the illness is not as you expected it to be. For example, when you 
have a clinical picture, you start a treatment, and you notice that it doesn’t have the desired 
effect: someone doesn’t respond well to it, the treatment has no effect, the treatment doesn’t 
fit with the patient or is not possible. These are the moments of decision. And the suffering 
doesn’t necessarily have to be high, but it is an important moment, and then you enter the 
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phase and start to periodically assess what is needed.”
Physicians’ experience and knowledge
The extent in which ID-physicians are able to identify a need for palliative care also 
depends on experience and knowledge. Previous experience with patients in the last 
phase of their lives and knowledge of providing palliative care facilitates timely identifying 
people with ID in need for palliative care. In addition, knowledge about diseases and 
prognosis helps physicians to perform better differential diagnostic procedures, to 
anticipate future problems and to decide which type of care is needed. Interdisciplinary 
discussion about patients with another (more experienced) ID-physician provides other 
insights on the patients’ health status and can prevent tunnel vision.
(IDP7) “My first case was a multiple disabled boy. I thought I could still treat him, but I 
just started to work here, and my colleague who earlier was involved in the care of this 
boy said: this isn’t going well; we should call everyone involved, because he is going to 
die. Whereas I completely didn’t recognize it at that stage, my experienced colleague 
did. [...] She had been a nursing home physician before. Therefore, she had experience 
in end of life care and with patients’ death and dying. [...] She recognized something I 
had never seen before. […] (CV) Do you think it is easier now you are older and you’ve 
seen more deaths yourself? (IDP) Yes […] The first trajectories were emotionally heavy 
and now I am calmer being there. I think I am more professional now. You’ve gained 
more knowledge, you’ve seen more. I’ve also experienced deviating trajectories [...]”
Physician-patient interaction
The ability to express problems and changed care needs, verbal or non-verbal, is different 
in each person and depends on the level of ID and co morbid conditions. ID-physicians 
found it more difficult to notice and interpret signals of people with more severe ID. This 
relates to the inability of people with more severe ID to express themselves in a way that 
can be understood by the physician. Both ID-physician and patient with ID often rely on 
professional caregivers to make the translation in consultations. People with less severe 
ID are often better in verbal communication of their needs, which may help physicians 
to recognize a need for palliative care earlier.
(IDP2) “Yes, you see clear differences. Some people still really enjoy food and laughter, 
for them it is much easier to determine whether they are unlike their usual self, compared 
to someone who is always calm, only sitting in the chair and almost never reacts. Those 
are the people for whom it is difficult to determine whether there are genuine problems, 
is someone really in pain or does (s)he really suffer. In some people it is evident and in 
some people it is not.”
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(IDP8) “(CV) Is there a difference between people with severe ID and people with mild 
ID? (IDP) Yes, [...] We had one case of a woman with mild ID and cancer in her face who 
said when I cannot speak anymore [...] then I want to die, eh. With this, she showed the 
essential points for her quality of life. This frequently occurs in people with mild ID, that 
they are able to voice what is important for them in life, and in people with severe ID, 
that is not possible. They can only show it.”
However, according to one ID-physician some people with less severe ID may 
present minor problems as serious problems or minor problems with a fixed pattern, 
which may hinder the process of awareness.
(IDP3) “Well, what I said earlier, particularly minor symptoms which are interpreted by 
the patient as something serious. And when someone routinely does this, you tend to 
withhold examination. With the result, that now and then you are too late. Anyway, 
that’s all in the game, but it is very hard.”
Other barriers in communication may relate to rigid thought patterns of patients 
with ID. For example, one ID-physician mentioned a patient with an autism spectrum 
disorder who did not communicate his health problems since the medical specialist 
once had told the patient that “everything concerning his health was fine (IDP5)”. Another 
ID-physician mentioned a case in which aversion towards physicians, medication or 
hospitals impeded physician-patient communication.
(IDP1) “This woman [...] had an aversion towards physicians; therefore professional 
caregivers were better informed than I was. So I really needed her professional 
caregivers to get a view of her situation [...] I don’t think about it as personal, I believe 
that she had an aversion towards all the medical fuss.”
Another aspect between ID-physicians and patients with ID that influences the 
process of awareness of the need for palliative care is familiarity of physicians with the 
patients’ characteristic way of communicating (verbal or non-verbal), but also familiarity 
with the patients’ health status (co morbid conditions) and the patients’ medical history 
and former functioning. This knowledge is important to physicians in the process of 
making the decision to start with palliative care.
(IDP8) “Well, you have developed communication patterns with the patient, and it is 
conspicuous that in noticing differences in those patterns I often recognize dementia, 
for example in people with Down syndrome […] that behaviour can also be something 
situational, it could also be a result of sensory disorders […] but the moment that the 
contact with me clearly changes, yes, that can provide important information.”
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(IDP2) “yes, that also depends on what someone was able to do before, whether (s)
he was always independent, for example ADL independent […] I would rather think 
that we should treat that person. When someone is completely dependent on support 
and care from professional caregivers I would rather think, yes maybe we should stop 
treatment. It really depends on the case and the previous abilities of this person, what 
life looked like before.”
Physicians’ communication with proxies
How physicians value communication with proxies, such as professional caregivers 
and relatives, as providers of contextual information is an important care feature that 
may influence awareness of the need for palliative care. For example, according to 
ID-physicians, communication with professional caregivers is essential for adequate 
information exchange regarding changes in daily functioning and wellbeing, especially 
in people with more severe ID. Professional caregivers work on a regular or daily (24h) 
basis with people with ID and often know them for years. Therefore, they are often the 
first to notice changes in characteristic behaviour or functioning that might be signals 
of an irreversible decline that inevitably leads to death. That is why frequent changes in 
professional caregivers impedes continuity of care, leading to less familiarity with people 
with ID and possibly more difficulties in noticing these changes.
(IDP3) “Well, if professional caregivers work for a long time with a patient and when 
they know a patient well, then they are able to assess and manage reactions, and if 
these are different they notice that. […] And that is extremely important.”
The signals provided by professional caregivers are not always clear. Instead, they 
often provide vague signals: a gut feeling telling that something is wrong, without 
being able to make it tangible (see quote Table 2). These feelings may be signs for ID-
physicians to monitor the patient’s health status more closely. ID-physicians indicate 
that professional caregivers with a medical background or with more work-experience 
often report more relevant or more tangible information about patients’ health status, 
compared to those with a social background or with less work-experience.
(IDP9) “It is relatively well organized on the main locations, but at locations in the 
community they have difficulties in taking care of a palliative trajectory for a patient 
[…] at these locations there are often professional caregivers with less nursing 
education, who have difficulties in identification, who think it’s scary, who haven’t 
experienced such a process before, yes, these are all influencing factors.”
In addition, because of their familiarity with the patient with ID, patients’ relatives 
can contribute to the process of identification of the need for palliative care (see quote 
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Table 2). Involving relatives generates important information for the physician with 
regard to patients’ former and current functioning. This may help the ID-physician in his 
decision to start with palliative care.
Discussion 
Main findings
For most ID-physicians the identification of people with ID in need of palliative care is the 
result of a process in which multiple signals from different information sources converge 
and over time lead to a growing awareness of the need for palliative care. In other cases, 
ID-physicians become suddenly aware of the need for palliative care, for example at 
moments of diagnoses with poor prognosis and expected death in the future. The result 
is a shift in expectation with regard to the patient: the ID-physician does not expect 
the patient with ID to return to a prior level of health or functioning, but rather expects 
a further irreversible decline leading to death. The process of identification depends 
on whether or not diseases are identified, the stage of the underlying disease and its 
prognosis, and the remaining treatment options. Other factors influencing the process 
of identification are physicians’ experience and knowledge, the quality of the reciprocal 
physician-patient communication and familiarity, and physicians’ communication with 
proxies as providers of contextual information.
Our results are in line with the outcomes of Claessen et al.,(28) who found that GPs in 
a general population identify people in need of palliative care based on a combination 
of various signals: clear signals, such as diagnosis of a life-threatening disease (e.g., 
cancer), but most of the times based on more subtle signals, such as problems patients 
experience (increased care dependency, not recuperating after intercurrent diseases), 
and experiences of relatives (e.g., noticing deterioration) and social changes. The 
corresponding results suggest similarities in the way people with and without ID are 
identified as in need of palliative care. Both studies conclude that in some cases there 
is a moment when there is a clear transition from curative or life-prolonging care to 
palliative care, while in other cases this transition and the physicians’ awareness of the 
need for palliative care develops more gradually.
However, there are some important differences worth mentioning. More than in 
a general population, the nature of underlying diseases is not always known in people 
with ID, often due to the aspecific presentation, communicational challenges and the 
tendency of ID-physicians to be reticent regarding burdensome diagnosis or treatment. 
The implication is that ID-physicians have to make decisions based on presumptions 
of the best fitting diagnosis or based on other signals, when diagnoses are unknown, 
possibly inducing delays in adequate referral and treatment. Another difference 
with Claessen et al.(28) is that for GPs in a general population the patient himself is an 
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important source of information. A large proportion of people with ID has difficulties 
in verbal communication on their problems, express problems in an aberrant way 
(e.g., through behaviour) or does not communicate problems at all.(6) More than GPs 
in a general population ID-physicians rely on their own observations and on proxies as 
interpreters, especially close proxies in the professional network around the patient, in 
order to assess and manage these problems. This dissimilarity is also reflected by the care 
approach of both types of physicians. Dutch GPs often work from a reactive approach, 
expecting patients or relatives to come and present problems,(71) whereas ID-physicians 
mostly work in dedicated care organizations where the patient’s health and wellbeing 
is periodically evaluated by a multidisciplinary team with or without the patient with ID. 
This approach is more proactive.
Strengths and limitations
To our knowledge, this is the first study that explored how and when ID-physicians 
recognize the need for palliative care in people with ID. Because of the explorative nature 
of the study, we used semi-structured interviews to obtain detailed information on the 
experiences of each individual physician. By purposively including ID-physicians, we 
aimed to get data from a broad spectrum of identification processes. The estimation that 
10 interviews were required was correct. After 8 interviews we reached data saturation 
and the last 2 interviews yielded no new information. However, we did not perform a 
member check. We are aware that the results may reflect the experiences of ID-physicians 
interested in palliative care, rather than the average physician working with people with 
ID, since we used a sample of ID-physicians who completed a retrospective survey about 
the care provided to a patient with ID with a non-sudden death. Furthermore, the results 
are limited to the perspectives of ID-physicians, as we did not interview other people 
involved in the provision of palliative care for people with ID.
Implications for research and practice
Our results show that each case is unique: signals differ across patients, illness trajectories 
and the information sources involved. Because of the variability of the signals, continuous 
communication of physicians with proxies who can provide contextual information is 
essential. In the care for people with ID, professional caregivers and family are important 
information sources for physicians about changes in health and wellbeing. In return, 
they often need physicians to interpret meaning and cause of their gut feelings, to 
place all signals in an end-of-life perspective and to start the discussion about providing 
palliative care. Therefore, we argue for a proactive attitude of physicians working with 
people with ID towards their patients with chronic diseases or those patients who are 
getting older or becoming more frail and openness to the possibility of palliative care.(100) 
Timely identification of those people in need of palliative care gives the people involved 
time to discuss the current health status and to anticipate future needs, so that the 
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highest level of quality of life can be attained.
In order to be proactive, we suggest that a tool for identification of patients with 
ID in need of palliative care could support healthcare professionals, like the Supportive 
and Palliative Care Indicators Tool(24) developed for a general population. Therefore, in 
further research we are working towards such a tool specifically for people with ID. This 
tool should be implemented in daily practice to screen people with ID for palliative care 
needs and should have the potential to start the discussion about the possibility of 
providing palliative care. For example, in people with a (presumption of ) chronic disease 
in an early stage (e.g., dementia, heart failure), in frail people who show a deterioration 
in health or functioning,(101) or from an arbitrary level of age onwards (e.g., >50 years; 
we know from recent research that people with ID aged 50-59 are as frail as a general 
population aged 70-79(102)).
Because we only aimed to explore the perspective of ID-physicians, further 
research could create a broader view on identification by including significant others, for 
example professional caregivers. Furthermore, it would be interesting to learn whether 
these results are applicable to other countries, because the Netherlands are the only 
country with ID-physicians as an acknowledged medical specialism.
Conclusion
Identification of people with ID in need of palliative care is mostly the result of a process 
in which multiple signals from different information sources converge and lead to a 
growing awareness of the need for palliative care. Important factors influencing the 
process of identification are related to the diagnosis and the interaction of ID-physicians 
with the patient with ID, the team of professional caregivers and family. We argue for a 
proactive attitude of physicians with regard to (periodically) screening people with ID 
for palliative care needs. Communication of physicians with proxies who can provide 
contextual information regarding changes in health and wellbeing is essential for this 
purpose. With this study, we provide important information on signals, information 
sources and influencing factors that can be used in developing a tool for identification of 
those people with ID in need of palliative care.
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Appendix 1. Interview guide
General part
These questions are about the physician’s experience with recognizing the need for 
palliative care in people with ID in general.
Starting questions:
1. How would you define palliative care and what are its most important aspects for 
you?
2. At what point do you start providing palliative care in people with ID?
3. How do you recognize the need for palliative care in people with ID?
4. At what point do you realize that a patient with ID will die within in the foreseeable 
future?
Further questions:
1. What are the signals / symptoms / changes in … that lead to the recognition of the 
need for palliative care in people with ID?
2. What makes it easier to recognize the need for palliative care in people with ID? 
3. What makes it more difficult to recognize the need for palliative care in people 
with ID?
4. Are there differences between patients in the recognition of the need for palliative 
care? (e.g., level of intellectual disabilities, underlying disease, co morbid conditions, 
interaction with patient, interaction with other professionals, interaction with 
relatives?)
Case specific part:
The next questions are about the case of the ID-physicians’ last patient with ID with a 
non-sudden death (as described in the survey).
Starting question:
1. Can you describe the process of recognition of the need for palliative care in this 
case?
Further questions depending on the information provided by the physician in the survey.
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Abstract
Background
Timely identifying people with intellectual disabilities (ID) in need of palliative care is 
important. Therefore, we developed PALLI: a screening tool for deteriorating health, 
indicative of a limited life expectancy. Here, we aimed to describe development of PALLI 
and to explore its applicability.
Method
We used a five-stage mixed-methods procedure to develop PALLI based on knowledge 
from practice. For exploring applicability, professionals caring for people with ID 
completed PALLI for 190 people with ID and provided information on applicability after 
5-6 months.
Results
The final version of PALLI included 39 questions relevant for people with ID. Applicability 
was adequate: most professionals found PALLI relevant and reported no ambiguous 
questions. Added value of PALLI was reflecting on and becoming aware of the process 
of decline in health.
Conclusions
PALLI shows promising applicability and has potential as a tool for timely identifying 
people with ID who may benefit from palliative care.
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Introduction
There is a growing interest in timely identification of the people who may benefit from 
palliative care, in a general population, but also in people with intellectual disabilities 
(ID). This is because it facilitates healthcare professionals to discuss people’s needs and 
preferences timely in the course of a serious illness,20,21,94,103 for example by discussing 
(non-)disclosure of bad news of the life-limiting illness and death to the person with 
ID.104 Furthermore, it supports all the people involved so they have time to anticipate 
important end-of-life decisions, such as treatment options, hospital admissions, place 
of providing palliative care and place of death.95 Identification is included as one of the 
recent Delphi-based consensus norms for best practices in palliative care for people 
with ID,79 next to equity of access to palliative care services, communication needs and 
involvement of people with ID in end-of-life decision making. The authors state that 
“all health and social care providers caring for people with intellectual disabilities must be 
able to recognise when palliative care is needed [...] They must be alert to the signs and 
symptoms of serious illness, end of life and the dying phase”. Up to now, it seems that timely 
identification in people with ID is not a common or conscious practice. Therefore, in 
this study we describe the developmental process and explore applicability of a newly 
developed screening tool that was designed to help healthcare professionals identify 
people with ID in need for palliative care.
In a recent study we reported that for ID-physicians (see box 1) identification 
of the need for palliative care often is the result of process in which multiple signals 
provided by different information sources converge and lead to growing awareness.106 
These processes are individually unique and can be complex and difficult because 
of the influence of a variety of factors (i.e., whether or not underlying diseases are 
identified; stage, prognosis and remaining treatment options, quality of physician-
patient communication; familiarity with the person with ID; and how communication 
with proxies as providers of contextual information is valued. Furthermore, due to 
communicational challenges with people with ID, problems that they may present in 
aberrant ways (e.g., through behavioural changes) and their reliance on proxies to voice 
concerns about their health, underlying diseases are commonly diagnosed late or not 
known.14,27,107,108 Consequently, healthcare professionals could benefit from a specific 
tool that supports them in identifying people with ID who are in need for palliative care 
at the earliest stage possible.
Several valuable tools exist for the general population,39 like the GSF Prognostic 
Identification Guidance,109 the Supportive and Palliative Care Indicators Tool (SPICT24), 
and the Radboud Indicators for Palliative Care Needs (RADPAC 25) or the NECPAL CCOMS-
ICO Tool.110 However, we anticipate that these tools might not be applicable for people 
with ID because the included general indicators are not specific to them. Furthermore, 
these tools may not be the norm for people with ID, for example due to an early onset 
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of frailty102 and a high risk of multimorbidity.4,111 Next to this, the reliance on included 
clinical indicators of diseases such as cancer or organ failure may not be applicable as 
diseases in people with ID may be diagnosed late or not diagnosed at all.
Therefore, we developed PALLI (PALliative care: Learning to Identify in people with 
ID): a tool that can be used to screen people with ID for deteriorating health indicative 
of a limited life expectancy.112 It provides a quick overview of the current health status 
compared to a previous period of three to six months. With this tool, healthcare 
professionals should be able to identify people with ID in need of palliative care 
provision. In a recent paper PALLI has shown promising feasibility and validity.113 In this 
paper, we aimed to describe the development of PALLI and to explore its applicability 
as reported by healthcare professionals in terms of relevance and clarity of items and 
encouragement to reflect on the person with ID.
Box 1. Overview of the care structure for people with ID in the Netherlands
¨  Organizations provide care to a broad spectrum of people with ID – varying in level of ID, mobility 
and co morbid conditions – and include central residential settings, community-based homes, 
supported living and day activity centres.
¨  A General Practitioner (GP) or an Intellectual Disability physician (ID-physician) is the principal 
physician and responsible for medical care. When the GP is the principal physician the ID-physician 
only provides care on GPs request or care for disability-related problems (e.g., behavioural 
problems or epilepsy). 
¨  ID-physicians complete a three-year educational training, Intellectual Disability Medicine, which 
is a medical specialism acknowledged in the Netherlands since 2000. 
¨  Although in the 90s the Dutch Government’s policy was to stimulate de-institutionalization (i.e. 
moving from the central residential settings (‘institutions’) to supported accommodation in the 
community), a relatively large group of people with ID in the Netherlands still lives in these central 
residential settings today.
¨  In the central residential settings, people with ID live together on one location in homes housing 
3 to 13 people. Daily care professionals (DCPs, with a social work education or nursing education) 
deliver care on a 24-hours basis. 
¨  The amount of care provided in the community varies from a number of hours a week to 24-hours 
a day. For medical care, these people primarily rely on a GP.
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Methods
Development of PALLI: procedure and measures
We used a five-stage mixed-methods procedure to develop PALLI.
Step 1: Retrospective survey
Between September and November 2013, 16 General Practitioners (GPs)and 81 ID-
physicians completed an online retrospective survey about their last patient with ID 
who did not die suddenly and for whom they had provided palliative care.82 The survey 
consisted, among others, of questions about the moment of physicians’ recognition of 
death in the foreseeable future and signals that led to the recognition of death in the 
foreseeable future. We recruited ID-physicians via the Netherlands’ Society of Physicians 
for People with Intellectual Disabilities (NVAVG) and GPs via the authors’ network or via 
the primary care network around Radboud University Medical Centre Nijmegen.
Step 2: Interviews
Between October and December 2013, we performed interviews with 10 ID-physicians, 
6 GPs and 14 Daily Care Professionals (DCPs; see Box 1). The semi-structured interview 
guide consisted of questions about the professionals’ experiences with identifying 
the need for palliative care in people with ID and was based on the guide used by 
Claessen et al. (2013)28 (see the Appendix in Vrijmoeth et al., 2016a)106. All physicians 
were recruited out of the physicians who completed the retrospective survey. DCPs were 
recruited via the authors’ network and via an online announcement on the website of 
Agora, the Dutch centre for support and information on palliative care (www.agora.nl). 
All interviews were audio recorded. During the interviews, the interviewer made notes 
of the most important findings.
Step 3: Draft version
The draft version of PALLI was developed in an iterative process. First, we extracted 
reported signals that may lead to awareness of the need for palliative care from the data 
collected in step 1 and step 2 (examples provided in Table 1 in Vrijmoeth et al. (2016a)106 
and Table 3 in Vrijmoeth et al. (2016b)82). Based on these signals [first author] made a list 
of possible items and subsequently a draft version of PALLI. This version was discussed 
and changed by the first and fourth author and then between the principal investigators 
(first, second, fourth and last author). This process of discussion and alteration of PALLI 
was performed three times between December 2013 and January 2014.
Step 4: Focus groups
In January and February 2014, we organized five focus groups to discuss the draft version 
of PALLI. These were with (a) ID-physicians (N=11), (b) GPs (N=5), (c) palliative care nurses 
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for people with ID114 (PCNs, N=10), and (d) two focus groups with DCPs from two care 
organizations for people with ID (N=7 and N=7). Beforehand, the principal investigators 
discussed and defined the topics of the focus groups (e.g. general impression of 
applicability and feasibility, content and priority of items, wording and language of items, 
scoring of items) and made a list of related questions (see Appendix 1). Each focus group 
was led by a skilled moderator appropriate to the group at hand. The nature of the focus 
groups was open, which meant that the moderator could change the order of questions 
depending on the content and flow of the discussions. Focus groups took on average 
118 minutes (SD = 22 minutes). ID-physicians were recruited from the physicians who 
completed the retrospective survey. GPs were recruited via the authors’ network and the 
online announcement, PCNs via the HAN University of Applied Sciences and both groups 
of DCPs via the authors’ network. All focus groups were audio-recorded and during the 
session one of the researchers made notes of the most important findings.
Step 5: Finalisation for testing in practice
In March and April 2014, we modified the draft version of PALLI into a version ready for 
testing applicability, feasibility and validity in a prospective follow-up study. For each 
focus group, the researcher who made notes re-listened the audiotape and subsequently 
made a document with answers to the predetermined list of questions. Based on this 
data the first author made a list of alterations, which were then discussed between the 
principal investigators until consensus was reached.
Prospective follow-up: procedure and measures
Between May and November 2014, 9 participating organizations, throughout the 
Netherlands in both rural and urban areas, that provide care to people with ID in the 
Netherlands selected and included eligible people for our study. We used a convenience 
sample; organizations were recruited via the authors’ network. In each organization we 
asked all ID-physicians or a convenient selection of ID-physicians, or for some GP patients 
a coordinating DCP, to select a number of people with ID aged 18 years or older based on 
a negative response on the ‘Surprise Question’ “Would you be surprised if this person were 
to die in the next year?”.115,116
We used the ‘Surprise Question’ as a method to differentiate people more likely to 
be in need of palliative care from those people not likely to be in need of palliative. We 
explicitly explained that the question was not about whether the professional expected 
the patient to die, rather whether he would be surprised if the person were to die within 
a year. For research efficiency purposes, we asked to select a feasible number of people 
for whom the physician or DCP could complete surveys. All levels of ID were eligible, from 
borderline ID to profound ID. People with ID were included after written informed consent 
was obtained from the person or legal representative. After inclusion, a DCP of the person 
with ID was asked to participate; this was most of the times the coordinating DCP.
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People were followed over a 10 to 12-month period. For each person an ID-physician 
or GP and a DCP completed a coded online survey including PALLI at baseline, after 5 to 
6 months and after 10 to 12 months. After completing PALLI at T0, a physician and DCP 
of a selected subsample of around fifty percent of the included people with ID answered 
in their own words “Were the questions relevant and applicable to the person with ID?” and 
“Were the questions clear to you (or were there any ambiguities)?”. Before completing PALLI 
at T1, all physicians and DCPs answered “Did answering the questions at baseline made 
you reflect on the person with ID?” with ‘yes’, ‘no’ or ‘don’t know’ and supplemented their 
answer in own words.
 
Prospective follow-up: data analysis
Descriptive statistics were used for the characteristics of the participating physicians 
and DCPs. Differences in characteristics between samples were tested comparing 95% 
confidence intervals (CI). With regard to the applicability questions, the first and last 
author read and reread the answers for familiarization. They independently analysed and 
coded the applicability data at baseline and a selection of 20 cases for the applicability 
data at T1 through a process of open, axial and selective coding98 and then compared 
and discussed codes until consensus about overarching themes was reached. For the 
data at baseline, they assigned ‘yes’ or ‘no’ to the answers. The remaining data at T1 was 
coded by the first author. The results of the analyses were discussed and approved by the 
first and last author. The quotations presented in the results were translated by the first 
author and then checked by the last author.
Ethics 
The Ethical Review Committee of Radboudumc concluded that the study protocol did 
not fall within the remit of the Dutch Act on Human Research, therefore ethical clearance 
was not needed (reference number: 2014/074). Participating physicians and DCPs, the 
people with ID (where possible given their literacy) and/or their legal representative 
were provided with written information about the study. Informed consent material for 
people with ID was adjusted (i.e., simplified text, support of pictograms).
Results
Development of PALLI
The final version of PALLI included 39 questions that can be answered with ‘yes’, ‘no’, 
or ‘don’t know’ (see Appendix 2). All items are categorized in overarching themes, for 
example physical decline, decline in activities, changes in characteristic behaviour, 
statements of people with ID and family regarding decline, increases in symptom burden, 
recurrence of infections, frailty, presence of serious illnesses and prognosis. The items 
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refer to a current health status compared to a previous period of three to six months, 
except for frailty, presence of serious illnesses and prognosis items. Space for remarks is 
provided after each theme.
Figure 1. Flowchart of study inclusion and response
Prospective follow-up
People with ID
A total of 291 people with ID were selected of which 190 people or their representative 
provided informed consent and were included (65.3% response). Figure 1 provides a 
further overview of the response at the moments of measurement. Characteristics of 
people with ID with baseline data are presented in Table 1.
Inclusion
(N=190)
Baseline (N=185)
51 physicians completed surveys for 173 persons
140 DCPs completed surveys for 181 persons
Subsample
37 physicians and 75 DCPs reported data on
relevance and clearness of the questions for 90
persons
T1 (N=160)
47 physicians and 121 DCPs reported data on
encouragement to reflect on the person with ID for 147
and 154 persons respectively
Death (N=2)
Physician and DCP did not complete 1st survey (N=3)
Death (N=15)
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Table 1. Characteristics of the people with ID with baseline data, as documented in the personal or medical 
file (N=185)
Mean (SD)
Age (years) 64 (13.8)
N (%)
Sex
Male 118 (62%)
Female 69 (38%)
Level of ID
Mild to borderline ID 24 (13%)
Moderate ID 57 (31%)
Severe ID 52 (28%)
Profound ID 48 (26%)
Unknown 5 (2%)
Cause of ID
Down syndrome 39 (21%)
Other genetic syndrome 16 (9%)
Other (e.g., acquired brain injury, metabolic diseases) 38 (20%)
Unknown 92 (50%
Residential status
Central setting 124 (65%)
Community-based home 54 (29%)
Other (Independent with ambulatory support, unknown) 12 (6%)
Physicians and DCPs
Baseline characteristics of the physicians and DCPs who completed the survey at 
baseline are presented in Table 2. Not all professionals provided personal information 
about themselves. 95% CI of the characteristics of the subsample at baseline and group 
who provided data at T1 did not differ from the 95% CI of the baseline characteristics 
presented in Table 2.
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Table 2. Characteristics at baseline of the participating physicians (N=51) and DCPs (N= 140)
Physicians DCPs
Mean (SD) Mean (SD)
Age (N=46) 46.1 (11.9) Age (N=101) 40.9 (10.4)
N (%) N (%)
Sex Sex
Male 17 (33%) Male 14 (10%)
Female 34 (67%) Female 126 (90%)
Training in palliative carea 
(N=46)
Training in palliative carea 
(N=104)
Yes 35 (76%) Yes 51 (49%)
No 11 (24%) No 53 (51%)
Type of physician Type of education (N=104)
ID-physician 29 (57%) Social studies 47 (45%)
ID-physician in training 7 (14%) Nursing studies 43 (41%)
General Practitioner 7 (14%) Both social and nursing 7 (7%)
Otherb 8 (15%) Other 7 (7%)
a Respondent had followed some form of training in palliative care, ranging from a single course in palliative 
care to an extensive and accredited training program.
b Other types of physicians connected to a care organization for people with ID; including one nurse specialised 
in the care for people with ID who completed surveys instead of the principal physician.
Applicability
Here, we present per question the number of people with a positive and negative answer. 
In addition, we thematically discuss the comments provided.
1. Were the questions relevant and applicable to the person with ID?
For 78% (N = 70) of the people with ID the physician explicitly answered that the 
questions were relevant for and applicable to the person with ID. Only in two cases (2%), 
the physician provided a negative answer. Based on DCP reports this was 73% (N = 66) 
versus 7% (N = 6). In the other cases, the provided answer could not be coded as yes or 
no.
Relationship with health status and/or problems
Some respondents stated that some questions presume an ability that is not applicable 
to the person, because of the level of (intellectual) functioning or physical abilities: e.g., 
“Not all; my client is unable to speak and has such severe ID that it is difficult to diagnose 
depression and so forth. Furthermore, she is confined to a wheelchair, therefore falling and 
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difficulties walking are unanswerable”. In line with this, a DCP answered ‘no’ because 
the person with ID “already is in an advanced stage of Alzheimer’s disease”. Another DCP 
agreed that not all questions might be applicable because the person with ID is not 
affected by the problems asked in PALLI (e.g. seizures or spasticity). Furthermore, a 
physician stated that PALLI is age-dependent, because at a higher age “you just have a 
shorter life expectancy”.
Period of retrospect
For some people with ID the period of retrospect (3-6 months) was not applicable, for 
example when the person had shown a “slow decline over a longer period than 3-6 months, 
therefore questions are often less relevant”. Other people had experienced a period of 
severe deterioration before; however, the situation in the period of retrospect and at 
that moment was frail, but stable.
Knowledge of respondent
This theme was only brought forward by physicians. An ID-physician mentioned that he 
did not always know the answer and that DCPs are likely to be more acquainted with all 
questions: “especially the first questions are difficult to answer, because these are in the area 
of the DCPs ...”. Moreover, a GP suggested that there might also be a difference between 
GPs and ID-physicians in that the first group may even know less answers to questions, 
“especially the questions regarding apathy and so forth”. Lastly, one ID-physician had 
recently started working in the care organization and did not know the person with ID 
that well yet.
Questioning and answering
According to a DCP, the questions were relevant, however, answering categories with 
more nuance such as “often, sometimes or never” would have been more applicable.
2. Were the questions clear to you?
For nearly three quart of the people with ID (74%; N = 67) the physician explicitly stated 
that the questions were clear and reported no ambiguities. In six cases (7%), the physician 
provided a negative answer. Based on DCPs this was 90% (N = 81) versus 4% (N = 4). In 
the other cases, the provided answer could not be coded as yes or no.
Relationship with health status and/or problems
As mentioned before, difficulties in answering questions were related to the level of 
ID, way of communicating (verbal vs. non-verbal) and physical abilities. Respondents 
found it more difficult to provide the right answer when the person had severe ID, 
communicated non-verbally and/or was completely dependent on proxies.
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Knowledge of respondent
Physicians did not know every person with ID that well; therefore, some of the changes in 
health and wellbeing we asked for were “better observed by DCPs”. Physicians were often 
reliant on their knowledge of the health status as it was the last time they were consulted, 
which may be a long time ago: “The difficulty with answering is that I regularly need to fill in 
‘don’t know’ because a certain topic has not been discussed in the previous period. You can’t 
assume that the answer is ‘no’ when DCPs haven’t brought it up”. Another physician stated 
that he sometimes answered ‘don’t know’ because he was still investigating an item, “for 
instance pain”. On the other hand, a DCP noted that she found herself not able to answer 
whether or not the effect of antibiotics had decreased, which might be a question more 
easily answered by physicians.
Questioning and answering
One DCP indicated that the additional information under some questions was helpful. 
One of the physicians found it not possible to provide nuances. For this purpose, another 
physician suggested more space for remarks.
3. Did answering the questions made you reflect on the person with ID?
Of the physicians, 31% (N = 46) answered ‘yes’, 61% (N = 90) answered ‘no’ and 8% (N = 
11) did not know. For, DCPs these numbers were 34% (N = 53), 49% (N = 75) and 17% (N 
= 26) respectively.
Yes
The main theme that arose from the data was awareness. PALLI helped the respondents 
to reflect on a meta-level on the person with ID and created awareness among physicians 
and DCPs with regard to the persons’ health status, the process of decline in health and 
the possible changes in care needs.
One of the physicians suggested PALLI helped him to systematically check the 
persons’ health status, which was something he had not done before. For other physicians, 
PALLI acted as an agent to think about whether something needed further investigation 
or whether the current provided care was still in line with the care needs. Furthermore, 
it made physicians think about the process of further decline in health, prognosis and 
anticipate future problems. Some respondents indicated that they organized a meeting, 
either with family or within the multidisciplinary team, for example to discuss specific 
problems (“recurrent infections did lead to a meeting with family to discuss the infections”). 
DCPs indicated that PALLI helped them becoming aware of problems or needs that they 
were not yet aware of or that needed more observation, such as “behaviour that may 
indicate non-wellbeing”.
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No
The main reason for the answer ‘no’ was that the respondent was already fully informed 
about the health status of the person with ID, the possible decline in health, and the care 
needs. This was mostly because they were already intensively involved in the care and 
because of frequent multidisciplinary evaluation. Completing PALLI did not provide new 
insights these professionals.
Discussion
In this paper, we described the developmental process and explored applicability of 
PALLI, a new tool for identification of people with ID who are in need of palliative care. 
PALLI was developed in five steps based on data from practice. This allowed us to include 
signals relevant and characteristic to people with ID. In comparison to tools such as the 
SPICT,24 RADPAC25 or NECPAL CCOMS-ICO Tool,110 PALLI is less driven by diagnosis, which 
makes it valuable even when diagnoses are not known. Furthermore, it is more focused 
on changes in characteristic behaviour, daily functioning and symptoms indicative 
of deteriorating health. The combination of changes in day-to-day experiences and 
more overarching medical knowledge (e.g., frailty and prognosis) makes it possible for 
both physicians (provided that they are familiar with the person with ID) and DCPs to 
complete PALLI. DCPs as proxies are important information sources about changes in 
health and wellbeing,82,108 which is confirmed by physicians in this study. However, DCPs 
often rely on physicians to interpret meaning and cause, to place signals in an end-of-life 
perspective and to start discussing palliative care. In order to join expertise and combine 
perspectives, we therefore argue that multidisciplinary discussion about a completed 
PALLI provides the most accurate picture of a person’s needs.
We found promising results regarding relevance and clarity of PALLI. In a majority 
of the cases, the items were deemed relevant and applicable to the person with ID 
and no ambiguous questions were reported. Only in a relatively small group cases the 
answer was negative. For the interpretation of these results, we must note that there 
were also answers that we could not code as yes or no (e.g., an answer that starts with 
“Not all [...]”). This is due to the design of our survey as we used an open-ended response 
format instead of fixed choices which could be supplemented in own words. Use of 
the latter may have yielded a higher percentage with a positive answer than this study 
currently presents. Still, the comments provide us with interesting insights in how PALLI 
is perceived in practice.
According to some professionals, items were not always applicable or clear because 
these presumed a decline in abilities or problems that was not applicable to the specific 
person or because the period of retrospect (3-6 months) was not appropriate. This is not 
surprising given the diversity in the population of people with ID (e.g., cause and level 
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of ID, functional abilities, intensity of support). Still, we feel it is possible to examine the 
level of deteriorating health and to use PALLI as indication for the need for palliative care 
based on appraisal of other items. Regarding the period of retrospect, when comparison 
over a longer period seems more appropriate we advise to do so. Based on our results, 
it seems that the health status of those people with ID as we included in our study may 
show a somewhat unpredictable course (e.g., a person with a deterioration in health 
more than 6 months ago who then remains frail, but stable in the following period).
For a majority of the physicians and DCPs PALLI seemed not to encourage reflection 
on the person with ID. PALLI did not provide them with new insights about the person 
with ID, mainly because they were already familiar with the health status and care 
needs. An explanation might be that in most care organizations for people with ID in 
the Netherlands the person’s health and wellbeing is often periodically evaluated by a 
multidisciplinary team with or without the person with ID. This facilitates involvement 
in care and shared knowledge about needs. We must note that recall bias due to the 
period between completing PALLI and answering the question may have influenced the 
answer of the professional. It is probable that the percentage answering ‘yes’ might be 
higher when PALLI and the question were in the same survey. For those who answered 
‘yes’, the added value of PALLI was reflecting on and becoming aware of the process of 
decline in health, changing care needs and whether or not provided care meets these 
needs. Furthermore, we feel that even when PALLI does not provide new insights it has 
added value as it combines available knowledge about the health status, even implicit 
knowledge, and presents this in an explicit form.
Strengths and limitations
To our knowledge, PALLI is the first tool specifically developed to support identification 
of the need for palliative care in people with ID. We used a stepwise consensus 
approach based on data provided by a diverse group of healthcare professionals for the 
development. A limitation, however, is that we did not involve people with ID and their 
family in the process of development. Furthermore, we lacked input from psychologists 
or remedial educationalists for people with ID. These disciplines are often involved in the 
care for this population in the Netherlands. We acknowledge that PALLI is developed as 
a tool for proxies, who do not always get it right in people with severe communication 
problems. Still, proxy measurements on health in people with ID are common, feasible 
and provide meaningful results when the professionals know the person well (e.g., 
Hilgenkamp et al., 2011)117.
With regard to applicability, some limitations are worth mentioning. Although we 
gathered interesting data from a large group of professionals, our results are based on 
answers provided via an online survey. We therefore gathered less detailed information 
compared to information from in depth interviews. Next to this, we did not perform 
a member or saturation check. Based on the personal characteristics we feel that our 
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results may be most applicable to more vulnerable or older people with ID with a higher 
level of dependency who live in central residential care settings or in community based 
homes. We do not know whether our results are sufficiently generalizable to younger 
people (e.g., young people with profound and multiple intellectual disabilities68) or 
people who live independent with ambulatory support or with their family and who 
need less care. Moreover, results reflect the care structure in the Netherlands and may 
be different in other countries.
In interpreting the results, the procedure regarding the use of the ‘Surprise 
Question’ should be taken into account. Because of research efficiency purposes (e.g., 
number of people for whom the physician or DCP was able to complete surveys), in 
most care organizations not all people with a possible negative answer on the ‘Surprise 
Question’ were selected. Despite explicit explanation of its use the ‘Surprise Question’ 
may have caused a selection effect, for example inclusion of those who were more 
likely to die within a year (e.g., frail people of older age). Consequently, results may be 
different when all people in the participating organizations with a negative answer on 
the ‘Surprise Question’ were included.
Implications for use in practice
We found promising results that support the use of PALLI as a tool for screening and 
reporting deteriorating health in people with ID, indicative of limited life expectancy. 
Answers provided on PALLI can be used as an indication for the need for palliative 
care. PALLI was not developed with a cut-off point at which palliative care is needed. 
Rather we feel that decisions regarding provision of palliative care should be made 
based on discussion between healthcare professionals together with the person with 
ID and family. This is more in line with palliative care as gradual approach20,103,118 and the 
notion of ‘predicting needs rather than exact prognostication’.23 With their knowledge of 
prior health and functioning and possible underlying diseases they are best able to put 
PALLI in an end-of-life perspective. This allows differentiating a PALLI score due to an 
irreversible process towards the end of life from a PALLI score due to reversible physical 
or mental health conditions, like a major depressive period. Moreover, just like in people 
with dementia it is likely that in our population the various people involved differ in 
their perspective when palliative care should be provided. 119 For these reasons, to our 
opinion, PALLI has much potential to be used as a tool for creating consensus about 
palliative care provision. PALLI can facilitate timely discussion about whether palliative 
care is indicated and thereby about people’s needs and preferences. PALLI can act as a 
reference for such a discussion, even for those professionals who are already familiar 
with the health status and care needs of the person with ID.
Implications for research
Because we provide the first results regarding applicability of PALLI, future research 
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should be performed to replicate our findings. Furthermore, it is useful to study 
the applicability of PALLI in other samples, for example in people with ID who live 
independent or who live with their family. It may also be interesting to compare, in 
future research, PALLI with tools developed for a general population.39 There is a great 
diversity within the population of people with ID and these tools may be applicable to 
specific subgroups of people with ID, such as people with borderline to mild ID living in 
the community. But most importantly, research is needed to explore how PALLI can be 
implemented best in practice so that it really facilitates timely discussion about whether 
or not palliative care is needed, what the actual palliative care needs are, and how care 
should be organised. Action-based research in another prospective study, where PALLI is 
used to identify people with ID in need of palliative care, may be an interesting method 
for studying implementation.120
Conclusion
In this paper, we presented the developmental process and explored applicability of 
PALLI. PALLI was stepwise developed based on data from practice, which makes PALLI 
relevant and characteristic to people with ID. We conclude that PALLI is applicable as 
a measure for deteriorating health, indicative of limited life expectancy. Questions are 
clear and relevant to people with ID. Added value of PALLI is reflecting on and creating 
awareness of the process of decline in health and changing care needs, and combining 
this knowledge and presenting this in an explicit form. Based on our results we think that 
PALLI has potential as a screening tool to timely identify people with ID who may benefit 
from palliative care and to facilitate discussion and creating consensus about planning 
and provision of palliative care. This may help to attain the highest level of the quality of 
end-of-life for the person with ID. Future research is needed to explore how PALLI can be 
implemented best in practice.
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Appendix 1. Questions for the focus groups
1. General impression of applicability and feasibility (1)
–  Do you recognize the information (i.e. explanation, questions and examples) in 
PALLI?
– Would PALLI (or a shorter version of PALLI) be feasible in practice?
2. Content of questions
– Which items are good? 
– Which items should be changed (e.g., deleted, combined)?
– Which items are not included and should be added?
– What do you think of the sequence of the questions in PALLI?
3. Questioning
– How are the questions formulated?
– Are there any difficult or unclear words or phrases?
– What do you think of the examples or explanation after some questions?
4. Answering
– How should the questions be scored? (e.g. yes – no – don’t know; never – 
 sometimes – always)
– How comprehensive should the items be scored? (i.e. how long should it take to 
 complete all questions, should the medical file be needed for answering)
– How do we interpret the results of PALLI?
5. General impression of applicability and feasibility (2)
– To which period should the questions refer? (e.g. 3 months, six months, a year)
– Do you (especially physicians and DCPs) have sufficient knowledge to complete 
 all questions?
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Appendix 2. PALLI
Physical How are things going at the moment, when compared with the previous 3-6 months?
1. Does the person have a worse physical condition or is the person tired more quickly?
2. Does the person spend more time in bed?
3. Is the person more sleepy or drowsy?
4. Is the person less able to move?
(For example: more need for help with moving, more falls)
Activities How are things going at the moment, when compared with the previous 3-6 months?
5. Does the person take less initiative or is it more difficult to motivate him/her?
6. Does the person more frequently decline to do or undertake things?
(For example: getting out of bed, moving, activities, work, daily activities)
7. Is the person less able to perform activities in daily living (ADL) himself/herself, as a result of 
which caregivers need to do more?
8. Are there any signs that the person does not manage activities or routines, work or daily 
activities as well as before, as a result of which daily caregivers need to assist more?
Characteristic behaviour How are things going at the moment, when compared with the 
previous 3-6 months?
9. Does the person make more or less contact or does he/she make contact in a different way?
(For example: responds differently to (the presence of ) others, less talkative/communicative, 
trying to approach someone more often)
10. Is the person more passive or apathetic?
(For example: has become more docile, listless, less able or inclined to do things, reduced zest 
for life)
11. Is the person more withdrawn?
(For example: more need for peace and quiet, more easily over strung)
12. Does the person display more challenging or restless behaviour?
(For example: more irritable, obstinate, aggressive or angry)
13. Is the person more low in mood or depressed?
14. Is the person more anxious?
Statements This concerns things that have been said during the previous 3-6 months.
15. Did the person say anything that indicated a change in health?
(For example: “I feel…”, “I don’t want… anymore”, “I’m frightened…”)
16. Did family members/loved ones say anything that indicated a change in health?
(For example: “not feeling well”, “he is not himself”, “there’s something going on”, “he used to enjoy 
this, now he doesn’t anymore”)
Signs and symptoms How are things going at the moment, when compared with the previous 
3-6 months?
17. Has the person lost weight or is he/she becoming thinner?
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18. Has the person’s food intake decreased?
(For example: less appetite, cannot or doesn’t want to eat as much, preference for a certain kind 
of food) 
19. Has the person’s fluid intake decreased?
(For example: cannot or doesn’t want to drink as much, preference for certain drinks) 
20. Does the person have more problems swallowing?
21. Does the person have more problems with bowel movements? 
(For example: constipation, diarrhoea)
22. Does the person have more problems with nausea or vomiting?
23. Does the person show more (observable) signs of unwellness?
(For example: (nocturnal) agitation, restless movements, facial expressions, noises made by the person, 
characteristic movements of discomfort)
24. Does the person have more pain?
25. Is the person more confused?
26. Has the person’s cognition deteriorated?
(For example: remembers less, less orientated in time and place, loss of practical skills)
27. Does the person have more sleep problems?
(For example: problems falling asleep, problems staying asleep, changes in day/night rhythm) 
28. Does the person have worse, or less well controlled, epilepsy?
29. Does the person have worse spasticity?
30. Is the person more dehydrated?
(For example: less urine production)
31. Does the person experience more shortness of breath?
(For example: clearly audible breathing, faster breathing, difficulty breathing)
Infections or episodes of fever How are things going at the moment, when compared with the 
previous 3-6 months?
32. Does the person have recurrent infections or episodes of fever?
(For example: pneumonia, cystitis, other infections or episodes of fever)
33. Does the effect of antibiotics decrease with each infection or episode of fever?
34. Does the person recover less well or have a longer recovery period after each infection or 
episode of fever?
Frailty
35. Are there several health problems that together increase the person’s vulnerability to a 
(further) decline in health?
(Health problems relate to psychical, psychological and social wellbeing)
Disorder or illness
36. Is there a diagnosis or a strong suspicion of the existence of a serious (chronic) illness?
(For example: dementia, lung diseases, cardiovascular diseases, diabetes, rheumatism or cancer 
etc.)
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37. Is there a serious (chronic) illness that cannot be treated or for which treatment is not 
indicated (anymore)?
(For example: there is no treatment or the treatment has no effect, the person doesn’t respond 
to the treatment due to complications or side effects, treatment can’t be carried out, or the 
treatment burden outweighs possible benefits for length or quality of life)
Prognosis
38. Is there a shortened life expectancy and is the person approaching the end of life?
(What is your assessment, perhaps based on changes in health or diagnosis of a serious (chronic) 
illness?) 
39. Would you be surprised if this person were to die in the next 12 months?
(This is not about whether you expect the person to die, but whether you’d be surprised if this 
person were to die within a year)
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Abstract
Background
There is a need for a specific tool that supports healthcare professionals in timely 
identifying people with intellectual disabilities (ID) in need of palliative care. Therefore, 
we developed PALLI: a tool for screening deteriorating health, indicative of a limited life 
expectancy.
Aims
We evaluated feasibility, construct validity and predictive validity of PALLI.
Methods
190 people with ID likely to be in need of palliative care were included. Physicians and 
daily care professionals (DCPs) completed PALLI and provided information on health 
outcomes at baseline, after 5-6 months and after 10-12 months. Linear Mixed Models 
and Generalized Linear Mixed Models were used to test validity.
Results
Feasibility was adequate: physicians and DCPs were able to answer most items with ‘yes’ 
or ‘no’ and within a short amount of time. Construct validity was promising: a higher PALLI 
score at baseline was related to a higher level of decline in health, a higher symptom 
burden, a lower quality of life and more ADL-dependency at baseline. Predictive validity: 
only a higher physician-reported PALLI score at baseline significantly increased risk of 
death within 12 months.
Conclusions
PALLI shows promising feasibility and validity and has potential as a tool for timely 
identifying people with ID who may benefit from palliative care.
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Introduction
There is a growing interest in palliative care, “an approach that improves the quality of life 
of patients and their families facing the problems associated with life-threatening illness” 
(World Health Organization Definition of Palliative Care(15)), for people with intellectual 
disabilities (ID), in research as well as in practice (11, 12, 16, 121). Healthcare professionals in 
the care for people with ID are increasingly interested in timely identification of the 
people with ID who may benefit from palliative care, because it enables anticipatory 
care provision in which people’s needs and preferences are discussed early in the course 
of a serious illness. Furthermore, informed decisions about the planning and provision of 
palliative care can be made (79, 94, 103), such as about the best place to provide this palliative 
care.(105) Timely identification of people in need of palliative care may help attain the 
highest level of quality of the end of life. Up to now, it seems that timely identification 
in people with ID is not a common or conscious practice. Therefore, in this study we 
evaluated feasibility, construct validity and predictive validity of a newly developed 
screening tool that was designed to help healthcare professionals identify people with 
ID in need for palliative care.
A recent Dutch study reported that for Intellectual Disability Physicians (ID-
physicians) the identification of people with ID in need of palliative care is often a result 
from a process in which multiple signals provided by different information sources 
converge and lead to growing awareness. (106) Each individual process has unique features 
and its development can be complex and difficult because of the variety of factors 
involved: whether or not underlying diseases are identified, the stage and prognosis of 
the disease and the remaining treatment options, the quality of communication between 
physician and person with ID, familiarity with the person with ID, and how physicians 
value communication with proxies as providers of contextual information. Delays in 
and uncertainties about diagnosis of underlying diseases are common because of the 
communicational challenges, the a-specific presentation of problems and the reliance 
on proxies. (6, 11, 108, 122)
This calls for a specific tool that supports healthcare professionals in identifying 
people with ID who are in need for palliative care at the earliest stage possible. For 
the general population such tools have already been developed, (39) such as the GSF 
Prognostic Identification Guidance,(109) the Supportive and Palliative Care Indicators 
Tool (SPICT(24)), and the Radboud Indicators for Palliative Care Needs (RADPAC(25)) or the 
Necesidades Paliativas Centro Colaborador de la Organización Mundial de la Salud – 
Institut Català d’Oncologia tool (NECPAL CCOMS-ICO Tool(110)). These tools are valuable, 
however, we anticipate that they often may not be applicable to people with ID. This 
is because in people with ID diseases may be diagnosed late or not diagnosed at all, 
while these tools rely on clinical indicators categorised for different diseases (e.g., cancer, 
dementia, organ failure). Furthermore, the included general indicators of decline in 
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these tools are not specific to people with ID and may not be the norm for people with 
ID due to an early onset of frailty,(102) a high risk of multimorbidity, (4, 111) and because of 
the a-specific presentation of problems and communicational challenges in caring for 
people with ID.
Therefore, we developed PALLI (PALliative care: Learning to Identify in people 
with ID): a tool that can be used to screen people with ID for deteriorating health 
indicative of a limited life expectancy.(112) It provides a quick overview of the current 
health status compared to a previous period of three to six months. With this tool, 
healthcare professionals should be able to identify people with ID in need of palliative 
care provision. PALLI was developed using a consensus approach, based on data from 
healthcare professionals in a survey,(82) interviews(106) and focus groups. Compared to 
other tools, like SPICT and RADPAC, PALLI is less diagnosis-driven and focuses more on 
relevant changes in characteristic behaviour, daily functioning and symptoms indicative 
of deteriorating health. It combines items on changes in day-to-day experiences specific 
for people with ID and items on more overarching medical knowledge, which makes it 
possible for not only physicians, but also for daily care professionals (DCPs, see Box 1) to 
complete PALLI. These DCPs are important sources of information.(106, 122)
For the work we present here, physicians and DCPs completed PALLI for a selected 
group of people with ID in a prospective follow-up study. Our first aim was to explore the 
feasibility of PALLI for use by both professionals by means of exploring ability to provide 
an answer of ‘yes’ or ‘no’, number of items not known, total PALLI score and time needed 
for completion. Secondly, we aimed to explore the construct validity of PALLI by means 
of the association with outcomes related to deteriorating health, i.e. overall decline, 
symptom burden, illness burden, quality of life (QoL), and dependency in activities of 
daily living (ADL). Thirdly, we aimed to explore the predictive validity of PALLI by means 
of the association with these outcomes at follow-up and with death within 12 months.
Methods
Sample and procedure
Between May and November 2014, we requested 9 organizations, throughout the 
Netherlands in both rural and urban areas, that provide care to people with ID in the 
Netherlands to select and include eligible people for our study. We used a convenience 
sample; organizations were recruited via the authors’ network. In each organization we 
asked all ID-physicians or a convenient selection of ID-physicians, or for some GP patients 
a coordinating DCP, to select a number of people with ID aged 18 years or older based on 
a negative response on the ‘Surprise Question’ “Would you be surprised if this person were 
to die in the next year?” (e.g., Romo & Lynn(116)).
We used the ‘Surprise Question’ as a method to differentiate people more likely to 
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be in need of palliative care from those people not likely to be in need of palliative. We 
explicitly explained that the question was not about whether the professional expected 
the patient to die, rather whether he would be surprised if the person were to die within 
a year. For research efficiency purposes, we asked to select a feasible number of people 
for whom the physician or DCP could complete surveys. All levels of ID were eligible, 
from borderline ID to profound ID. People with ID were included after written informed 
consent was obtained from the person or legal representative. After inclusion, a DCP of 
the person with ID was asked to participate; this was most of the times the coordinating 
DCP.
A priori we used a linear multiple regression model to test whether PALLI could 
cause a small change in outcome variables (effect size=.2) controlling for four other 
factors. Power was set to .9, and the alpha error probability to .05. Using G*Power 3.1,(63) 
we determined the sample size to be at least 89.
People were followed over a 10 to 12-month period. For each person with ID the 
principal physician and a DCP completed a coded online survey at baseline (T0), follow-
up after 5 to 6 months (T1) and follow-up after 10 to 12 months (T2). The surveys included 
PALLI and questions regarding health outcomes. For this study, we only used PALLI data 
at T0. More information on the sample and procedure can be found in Christians et 
al.(112) 
Measures
Characteristics of people with ID
Two of the authors (CV and MC) checked the medical files for the personal characteristics 
(e.g., level and cause of ID), co-morbid conditions, and whether or not resuscitation or 
artificial respiration was discussed and documented in the medical file.
PALLI
PALLI includes 39 questions that can be answered with ‘yes’, ‘no’, or ‘don’t know’ (see 
Appendix 1). The tool consists of items regarding physical decline, decline in activities, 
changes in characteristic behaviour, statements of people with ID and family regarding 
decline, increases in symptom burden, recurrence of infections, frailty, presence of serious 
illnesses and prognosis. It was developed in five steps using a consensus approach 
based on knowledge and experiences provided by healthcare professionals caring for 
people with ID. In the first step of the developmental process, physicians completed a 
retrospective survey about their last patient with ID with a non-sudden death. Secondly, 
we conducted interviews with a selection of physicians who completed the retrospective 
survey and with DCPs. These steps generated relevant items for a draft version of PALLI, 
which was built in the third step. Fourthly, this version was discussed in multiple focus 
groups with physicians, DCPs, and palliative care nurses for people with ID. In the fifth 
step, we modified the draft version into a version ready for testing applicability, feasibility 
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and validity in a prospective follow-up study. Detailed information on the development 
can be found in Christians et al.(112)
A total PALLI score is calculated by dividing the sum of items scored with ‘yes’ by 
the total number of items scored with ‘yes’ or ‘no’. This results in a score for each person 
with ID between 0 (no items present) and 1 (all items present). An example: if a physician 
scores 4 items with ‘don’t know’, scores 35 items with ‘yes’ or ‘no’ and of those 35 items 
scores 10 with ‘yes’, the total PALLI score is 10/35=0.29. This score can be multiplied by 
100 in order to get a percentage for the number of items scored with ‘yes’: 0.29*100=29%.
Box 1. Overview of the care structure for people with ID in the Netherlands
¨  Organizations provide care to a broad spectrum of people with ID – varying in level of ID, 
mobility and co morbid conditions – and include central residential settings, community-based 
homes, supported living and day activity centres.
¨  A General Practitioner (GP) or an Intellectual Disability physician (ID-physician) is the principal 
physician and responsible for medical care. When the GP is the principal physician the ID-
physician only provides care on GPs request or care for disability-related problems (e.g., 
behavioural problems or epilepsy). 
¨  ID-physicians complete a three-year educational training, Intellectual Disability Medicine, which 
is a medical specialism acknowledged in the Netherlands since 2000. 
¨  Although in the 90s the Dutch Government’s policy was to stimulate de-institutionalization (i.e. 
moving from the central residential settings (‘institutions’) to supported accommodation in the 
community), a relatively large group of people with ID in the Netherlands still lives in these 
central residential settings today.
¨  In the central residential settings, people with ID live together on one location in homes 
housing 3 to 13 people. Daily care professionals (DCPs, with a social work education or nursing 
education) deliver care on a 24-hours basis. 
¨  The amount of care provided in the community varies from a number of hours a week to  
24-hours a day. For medical care, these people primarily rely on a GP.
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Outcome variables
Illness burden
Physicians completed the Cumulative Illness Rating Scale (CIRS).(42, 43) The CIRS consists of 
thirteen items in seven body systems categories: cardiac/vascular/respiratory; eyes-ears-
nose-throat; gastrointestinal; urogenital; musculoskeletal/integuments; neurological/
psychiatric; endocrine/metabolic. For each item, the illness burden is rated on a 5-point 
Likert scale, ranging from 0 (no problem) to 4 (extremely severe problem). The CIRS has 
proven to be reliable, valid and suitable for use in assessment of illness burden.(123)
Overall decline
DCPs answered the question “Has this person experienced overall decline over the past 
3-6 months?” using an 11-point numeric rating scale, ranging from 0 (no decline) to 10 
(highest level of decline).
Symptom burden
DCPs completed the Utrecht Symptom Diary (USD), a modified and extended Dutch 
version of the well validated Edmonton Symptom Assessment System (ESAS).(51) The USD 
includes pain, sleeping problems, dry mouth, dysphagia, appetite, defecation, nausea, 
shortness of breath, tiredness, confusion, anxiety, depression and wellbeing. For each 
symptom the burden at that moment is rated using an 11-point numeric rating scale, 
ranging from 0 (no symptom burden) to 10 (highest symptom burden). The USD has 
been used before in other studies in the Netherlands, for example in a study of de Graaf 
et al.(124)
QoL
DCPs answered the question “How is the quality of life of this person currently?” using an 
11-point numeric rating scale, ranging from 0 (worst possible QoL) to 10 (best possible 
QoL). This question is part of the Brief Hospice Inventory, which showed promising 
results regarding reliability and construct validity of assessing QoL outcomes.(53)
ADL-dependency
DCPs completed the Barthel-Index (BI),(125) which consists of ten items: bowels, bladder, 
toilet use, bathing, grooming, dressing, feeding, transfers (bed to chair and back), 
mobility on level surfaces, and mobility on stairs. For each activity, the dependency is 
rated on a two-, three- or four-point scale. The total ADL score ranges from 0 (completely 
dependent) to 20 (completely independent). The BI has been used before with good 
results in a study in people with ID.(48)
Death
After the study period, we checked the medical files for death within 12 months after T0.
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Data analyses
Data analyses were performed using SPSS 22. We calculated a physician-reported as 
well as a DCP-reported total PALLI score. We checked data for normality using skewness, 
kurtosis, and Kolmogorov–Smirnov tests. Non-normal data was analysed with non-
parametric tests.
Feasibility
We used descriptive statistics for the percentages of physicians and DCPs scoring 
‘yes’, ‘no’, or ‘don’t know’ on each individual item of PALLI. We performed a Wilcoxon 
signed-rank test for the difference in the number of items answered with ‘don’t know’ 
between physicians and DCPs. We used a paired sample t-test to test the differences in 
the mean total PALLI scores as reported by physicians and DCPs and calculated Cohen’s 
d. Descriptive statistics were used for the time needed for completion. To test whether 
the number of items answered with ‘don’t know’ was associated with the score on PALLI, 
Spearman’s rho was calculated.
2.3.3 Construct validity and predictive validity
We performed paired sample t-tests and Chi square tests for the differences in the 
outcome measures between the different moments of measurement for the people 
with ID with T0 and T1 and T0 and T2 data. Associations between the score on PALLI at 
T0 and the outcome measures were tested using Linear Mixed Models and Generalized 
Linear Mixed Models, in order to control for nested data in the outcome measure on the 
level of physician or DCP. Separate tests were performed with the physician-reported 
and DCP-reported PALLI scores. For each outcome measure we tested the associations in 
uncorrected models (without potential confounders) and in corrected models (including 
sex, age, level of ID and Down syndrome at T0). In order to compute a score for symptom 
burden, we counted the number of symptoms as measured with the USD with a score ≥4 
for each person.(126) Because in ADL-dependency a floor effect arose we divided people 
into two categories based on a clinical interpretation of the total score on the Barthel-
Index: completely to severely dependent (score 0-9) versus moderately dependent to 
independent (score 10-20).(127)
Ethics 
The Ethical Review Committee of Radboudumc concluded that the study protocol did 
not fall within the remit of the Dutch Act on Human Research, therefore ethical clearance 
was not needed (reference number: 2014/074). All participants throughout the study 
were provided with written information about the study.
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Inclusion (N=190)
T0 data available (N=163)
T0 and T1 data available (N=122)
T0, T1 and T2 data available (N=95)
Death (n=2)
Physician answered too many items with ‘don’t know’ (n=6)
Physician and/or DCP did not complete 1st survey (n=19)
Death (n=15)
Physician and/or DCP did not complete 2nd survey (n=26)
Death (n=17)
Physician and/or DCP did not complete 3rd survey (n=10)
Figure 1. Flowchart with number of people with data at T0, T0 – T1 and T0 –T2
Results
People with ID
A total of 291 people with ID were selected based on the ‘Surprise Question’; for 190 of 
these people informed consent was given (65.3% response). Figure 1 provides a further 
overview of the response of physicians and DCPs at the moments of measurement. We 
excluded six of the 190 people with ID because the physician answered too many items 
with ‘don’t know’ at T0 (range 22 to 30 items). For five of these people the participating 
GP indicated that he did not know answers because of unfamiliarity with the patient. For 
one ID-physician patient, the reason for the high number of items answered with ‘don’t 
know’ was unknown. Table 1 shows the baseline characteristics of the included people 
with ID. The presented characteristics were similar for the people with T0 – T1 and T0 – T2 
data.
114
Feasibility and validity oF a tool For identiFication oF people with intellectual disabilities in need oF palliative 
care (palli)
Table 1. Baseline characteristics of people with ID (N = 163)
T0
(N = 163)
T1
(N = 122)
T2
(N = 95)
Mean (SD) Mean (SD) Mean (SD)
Age 64.3 (13.2) 65.4 (12.2) 64.8 (13.2)
N (%) N (%) N (%)
Sex
Male 103 (63) 79 (65) 60 (63)
Female 60 (37) 43 (35) 35 (37)
Level of ID
Mild to borderline ID 22 (13) 16 (13) 12 (13)
Moderate ID 51 (31) 45 (37) 31 (33)
Severe ID 45 (28) 33 (27) 27 (28)
Profound ID 42 (26) 27 (22) 24 (25)
Unknown 3 (2) 1 (1) 1 (1)
Cause of ID
Down syndrome 37 (23) 29 (24) 22 (23)
Other genetic syndrome 13 (8) 8 (6) 5 (5)
Other (e.g., acquired brain injury, metabolic 
diseases)
28 (17) 18 (15) 12 (13)
Unknown 85 (52) 67 (55) 56 (59)
Residential status
Central setting 113 (69) 81 (66) 62 (65)
Community-based home 47 (29) 38 (31) 30 (32)
Unknown 3 (2) 3 (3) 3 (3)
Co-morbid conditionsa
Cardiovascular diseases 72 (44) 55 (45) 43 (45)
Cancer 16 (10) 11 (9) 9 (10)
Respiratory diseases 29 (18) 22 (18) 19 (20)
Endocrine diseases 59 (36) 42 (34) 32 (34)
Gastro-intestinal diseases 114 (70) 84 (69) 70 (74)
Neurological diseases 101 (62) 74 (61) 57 (60)
Psychiatric/behavioural problems 68 (42) 51 (42) 41 (43)
Musculoskeletal diseases 56 (34) 44 (36) 36 (38)
Visual impairment 63 (39) 47 (39) 43 (45)
Hearing impairment 92 (56) 69 (57) 53 (56)
Do not resuscitate or artificially respirate 
(discussed and documented in the medical file)
110 (68) 83 (68) 67 (71)
a Co-morbid conditions are presented as percentage people with ID with at least one condition of that category.
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Physicians and DCPs
At T0, 47 physicians (range 1-14 people per physician) and 129 DCPs (range 1-7 people 
per DCP) completed the surveys for the 163 people with ID. There was no missing data 
in completed surveys. Baseline characteristics of the participating professionals are 
presented in Table 2. Not all physicians and DCPs provided personal information about 
themselves. 
Table 2. Baseline characteristics of the participating physicians and DCPs 
Physicians (N = 46) DCPS (N = 94)
Mean (SD) Mean (SD)
Age 46.1 (11.9) Age 41.1 (10.5)
n (%) n (%)
Sex Sex
Male 15 (33) Male 10 (11)
Female 31 (67) Female 84 (89)
Type of physician Type of education
ID-physician 27 (59) Social studies 44 (47)
ID-physician in training 6 (13) Nursing studies 37 (39)
General Practitioner 5 (11) Both social and nursing 8 (9)
Othera 8 (17) Other 5 (5)
Training in palliative careb 35 (76) Training in palliative careb 47 (50)
a Other types of physicians connected to a care organization for people with ID; including one nurse specialised 
in the care for people with ID who completed surveys instead of the principal physician.
b Respondent had followed some form of training in palliative care, ranging from a single course in palliative 
care to an extensive and accredited training program.
Feasibility
The scoring of the individual items of PALLI is presented in Appendix 1. The maximum 
percentage for an item for which physicians indicated that they did not know was 17% 
(depressed mood). For DCPs, this percentage was 22% (pain). For most items in the 
categories physical decline, decline in functioning, changes in characteristic behaviour 
and increase in symptom burden, problems were more often observed by DCPs than by 
physicians. Furthermore, physicians were more likely to fill in ‘don’t know’ for these items, 
except for the symptoms anxiety, pain, confusion, spasticity and cognitive decline. With 
regard to items about recurrence of infections, frailty, presence of serious illnesses, and 
prognostication the distribution of percentages was reverse: physicians were better able 
to answer items with ‘yes’ or ‘no’ and more often noted problems. Physicians more often 
answered that they would not be surprised if the person were to die within a year.
Physicians answered ‘don’t know’ more often than DCPs [median=2 (IQR=0-3; 
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range=0-9) versus median=1 (IQR=0-2; range=0-14); p<.01]. DCPs provided a higher 
total PALLI score at T0 than physicians [M=35.8 (SD=20.1) versus M=30.8 (SD=19.2); 
p=.001; Cohen’s d=.25]. The correlation between the total PALLI score and the number 
of items answered with ‘don’t know’ was low (Ρ=.12) and not statistically significant. 
Not all respondents filled in the time needed for completion. Mean completion time 
for physicians was 10.5 minutes (SD = 5.9; range = 5 – 30 min; n = 76) and for DCPs 10.1 
minutes (SD = 4.3; range = 3 – 20 min; n = 70).
Table 3. Descriptive statistics of the outcome measures at T0 (N = 163)
T0
(N = 163)
T1
(N = 122)
T2
(N = 95)
Mean (SD) Mean (SD) Mean (SD)
Illness burden 12.1 (5.6) 12 (6) 12.3 (5.1)
Overall decline 4.4 (3.3) 3.4 (3.1) 3.8 (3.3)
Symptom burden 3.7 (2.8) 3.7 (2.7) 4 (3.5)
QoL 6.8 (2.1) 6.8 (1.8) 6.8 (2.2)
N (%) N (%) N (%)
ADL dependency Completely to severely 
dependent
113 (69) 87 (71) 68 (72) 
Moderately dependent to 
independent
50 (31) 35 (29) 27 (28)
Death within 12 months Yes 36 (22)
No 127 (78)
Note. Ranges: illness burden = 0 – 52, overall decline = 0 – 10, symptom burden = 0 – 13; QoL = 0 – 10.
Construct validity and predictive validity
Table 3 shows the descriptive statistics of the outcome measures. The statistics did not 
change significantly during follow-up for the people with ID with T0 and T1 and T0 
and T2 data. The association of PALLI at T0 with outcome measures at T0, T1 and T2 is 
presented in Table 4.
Construct validity
In the uncorrected models at T0, we found that PALLI score, as reported by both physicians 
and DCPs, is related to all outcome measures, except illness burden. The associations 
remained statistically significant when controlling for personal characteristics. A higher 
score on PALLI at T0 was related to a greater overall decline in the last 3 to 6 months, a 
higher symptom burden, a lower QoL and a greater risk to be completely to severely ADL 
dependent.
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Predictive validity
A higher score on PALLI increased the risk of death within 12 months; however when 
controlling for personal characteristics this was only significant for the physician-
reported PALLI data (4% more risk per positive item).
Over time, we found that the association of the total PALLI score with the outcome 
variables decreased. A higher PALLI score at T0 as reported by DCPs was still significantly 
related to a greater overall decline, a higher symptom burden, a lower QoL and a greater 
risk being ADL dependent at T1, but only significantly related to a greater overall decline 
and higher symptom burden at T2. Based on physician reports, a higher PALLI score was 
only significantly related to a greater risk being ADL dependent at T1 and T2.
Discussion
Primary findings
We found promising results regarding feasibility and construct validity of PALLI. Both 
physicians and DCPs were able to complete PALLI (i.e. were able to provide an answer 
of ‘yes’ or ‘no’ for most items, low number of items not known) in a short period of time. 
Some items (e.g., characteristic behaviour) were more often observed by DCPs, whereas 
for other items physicians were better able to answer (e.g., presence of serious illnesses). 
Furthermore, our results showed that at T0 a higher PALLI score was related to a higher 
level of decline in health, a higher symptom burden, a lower QoL and ADL-dependency. 
Noteworthy, PALLI was not related to illness burden (i.e. total level of problems in 
different body systems). This may indicate that irrespectively of illness burden, a person 
with ID can experience more or less deteriorating health. Another explanation is that 
PALLI focuses on (physical) functioning, behaviour and symptom burden and to a lesser 
extent on diseases as such.
We found less and mixed evidence for the predictive validity. A higher score on 
PALLI increased the risk of death within 12 months with 2-4% per positive item, but this 
was only significant for the physician reports. Physicians answered ‘don’t know’ more 
often than DCPs. We could speculate that this may indicate that physicians were more 
inclined to be able to support an answer of ‘yes’ or ‘no’ and to reduce the risk of providing 
a false answer. This may have led to less error in the physician reports and therefore 
more power, which may explain why the effect was only significant for physicians. Over 
time, we found that the association of the total PALLI score with the outcome variables 
decreased. Eventually, for physicians, only the increased risk of being severely to 
completely ADL dependent at T2, and for DCPs, only the positive association with overall 
decline in health and symptom burden at T2, remained significant. The associations over 
time may suggest that the health status of those people with ID as we included in our 
study shows a somewhat unpredictable course (e.g., a person with deteriorating health 
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at baseline who remained frail, but stable throughout the follow-up period or a person 
with a better health status at baseline who experienced a severe deterioration in health 
before T2). This may indicate that PALLI is best used as a tool that provides an overview 
of the current health status rather than predicting a future health status.
Strengths and limitations
To our knowledge this is the first study to explore feasibility and validity of a tool 
specifically designed to help healthcare professionals identify people with ID in need of 
palliative care. By including and following 190 people with ID from 9 care organizations 
across the Netherlands, we were able to explore feasibility and validity in a group of 
people with ID with a broad range of characteristics: all levels of ID, different age groups, 
and a variety of co-morbid conditions. Based on the personal characteristics we feel that 
our results may be most applicable to more vulnerable or older people with ID with a 
higher level of dependency who live in central residential care settings or in community 
based homes. We do not know whether our results are sufficiently generalizable to 
younger people with ID (e.g., young people with profound and multiple intellectual 
disabilities) or people with ID who live independent with ambulatory support or with 
their family and who need less care.
In interpreting the results, the procedure regarding the use of the ‘Surprise 
Question’ “Would you be surprised if this person were to die in the next year?” should be 
taken into account. We used the ‘Surprise Question’ as a method to differentiate people 
who were more likely to be in need of palliative care from those people not likely to 
be in need of palliative care. However, in most care organizations not all people with a 
possible negative answer on the ‘Surprise Question’ were selected, because of research 
efficiency purposes. Although we explicitly explained that the question was not about 
whether the professional expected the person to die within one year, rather whether he 
or she would be surprised if the person were to die within a year, the use of the ‘Surprise 
Question’ may have caused a selection effect. For example, we may have included a high 
proportion of people with ID who were most likely to die within a year (e.g., frail people of 
older age). Consequently, results might be different when all people in the participating 
organizations with a negative answer on the ‘Surprise Question’ were included.
Implications for use in practice
Results showed promising results regarding the utility of PALLI as a tool for screening 
deteriorating health, indicative of limited life expectancy, in people with ID. The answers 
provided on PALLI can be used in practice as an indication for the need for palliative care. 
Whether palliative care is needed and to which level should be discussed next. We did not 
perform analyses to establish a fixed cut-off point for this decision. Based on progressive 
insight we feel this is more in line with ideas of palliative care as a gradual care approach(20, 
103, 118) and the notion of ‘predicting needs rather than exact prognostication’.(23) We think it 
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is more appropriate to leave the discussion about whether palliative care is indicated to 
the healthcare professionals together with the person with ID and his or her family. With 
their knowledge of prior health and functioning, they are best able to put PALLI in an 
end-of-life perspective. In the application of PALLI, it is essential to differentiate people 
in an irreversible process towards the end of life from people with a reversible physical 
or mental health condition, such as major depression. Moreover, just like in people with 
dementia it is likely that in the care for people with ID the various people involved differ 
in their perspective when palliative care should be provided. (119) With this in mind, to our 
opinion, PALLI has much potential to be used for creating consensus about palliative care 
provision; it can facilitate timely discussion about whether palliative care is indicated 
and thereby about people’s needs and preferences.
Differences between physicians and DCPs in how PALLI is scored and differences 
in associations with the outcomes variables may stress the added value of expertise 
of both professionals, provided that they are familiar with the person with ID. DCPs 
are more familiar with the day-to-day functioning and behaviour. It is likely that they 
therefore have more knowledge about items regarding for example functional decline, 
characteristic behaviour and symptoms such as weight loss. Physicians see people more 
often on a consult basis and are reliant on proxies for this information.(106, 108, 122) On the 
other hand, physicians are more likely to have knowledge about more overarching 
medical knowledge (e.g., presence of serious illnesses, frailty and prognosis). PALLI can be 
completed by both physicians and DCPs, but in order to join expertise and perspectives, 
multidisciplinary discussion of a completed PALLI may provide the most accurate picture 
of a persons’ health status.
Implications for future research
Because we provide the first results regarding feasibility and validity of PALLI, more studies 
should be performed to replicate and support our findings. Preferably, these studies 
should be conducted in a larger sample where all people with ID in one organization 
for whom professionals would not be surprised if they would die within the next year 
are included. Furthermore, it is useful to explore differences between subgroups, for 
example based on age, level of ID, underlying diseases or residential setting. It may also 
be interesting in future research to compare PALLI with tools developed for a general 
population, such as the NECPAL CCOMS-ICO Tool,(109) RADPAC(25) or SPICT(24). There is a 
great diversity within the population of people with ID and these tools may be applicable 
to specific subgroups of people with ID, such as people with borderline to mild ID living in 
the community. However, most importantly, additional research is needed on how PALLI 
can be best implemented in daily practice, so that it really facilitates timely discussion 
about whether or not palliative care is needed, actual palliative needs and how this 
should be organised. This may also create a better understanding of the variability in 
scoring between different disciplines and provide recommendations for dealing with 
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this variability when using PALLI. Action-based research in another prospective study, 
where PALLI is used to identify people with ID in need of palliative care, may be an 
interesting method for studying implementation.(120)
4.4 Conclusion
This study presented feasibility, construct validity and predictive validity of PALLI. We 
conclude that PALLI is feasible for physicians as well as DCPs to complete, provided that 
they are familiar with the person with ID. As a measure for screening deteriorating health, 
indicative of a limited life expectancy, PALLI showed promising construct validity. We 
found less and mixed results with regard to the predictive validity. Based on our results 
we think that PALLI has potential as a screening tool to timely identify people with ID 
who may benefit from palliative care and to facilitate discussion and creating consensus 
about (future) planning and provision of palliative care. This may help to attain the 
highest level of the quality of end-of-life for the person with ID. Future research is needed 
to explore how PALLI can best be implemented in practice.
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Appendix 1. The scores (%) of DCPs and physicians on the 
individual items of PALLI at T0 (N = 163 people with ID)
DCPs
(% people with ID)
Physicians
(% people with ID)
Yes No Don’t 
know
Yes No Don’t 
know
Physical How are things going at the moment, 
when compared with the previous 3-6 months?
1. Does the person have a worse physical 
condition or is the person tired more quickly?
68.7 29.4 1.8 58.9 38.7 2.5
2. Does the person spend more time in bed? 21.5 78.5 0 28.2 69.3 2.5
3. Is the person more sleepy or drowsy? 54 46 0 35.6 59.5 4.9
4. Is the person less able to move?
(For example: more need for help with moving, 
more falls)
46.6 51.5 1.8 49.1 48.5 2.5
Activities How are things going at the moment, 
when compared with the previous 3-6 months?
5. Does the person take less initiative or is it 
more difficult to motivate him/her? 
47.9 50.3 1.8 41.7 49.1 9.2
6. Does the person more frequently decline to 
do or undertake things?
(For example: getting out of bed, moving, 
activities, work, daily activities)
36.2 58.9 4.9 27.6 60.7 11.7
7. Is the person less able to perform activities in 
daily living (ADL) himself/herself, as a result of 
which caregivers need to do more?
55.8 43.6 0.6 44.8 50.3 4.9
8. Are there any signs that the person does not 
manage activities or routines, work or daily 
activities as well as before, as a result of which 
daily caregivers need to assist more?
58.9 39.9 1.2 50.3 40.5 9.2
Characteristic behaviour How are things going 
at the moment, when compared with the previous 
3-6 months?
9. Does the person make more or less contact 
or does he/she make contact in a different way?
(For example: responds differently to 
(the presence of ) others, less talkative/
communicative, trying to approach someone 
more often)
51.5 46.6 1.8 28.2 63.2 8.6
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10. Is the person more passive or apathetic? 
(For example: has become more docile, listless, 
less able or inclined to do things, reduced zest 
for life)
46.6 52.1 1.2 36.8 58.9 4.3
11. Is the person more withdrawn?
(For example: more need for peace and quiet, 
more easily over strung)
40.5 58.3 1.2 28.2 66.3 5.5
12. Does the person display more challenging 
or restless behaviour? 
(For example: more irritable, obstinate, 
aggressive or angry) 
33.1 65 1.8 21.5 74.2 4.3
13. Is the person more low in mood or 
depressed?
20.9 67.5 11.7 12.3 70.6 17.2
14. Is the person more anxious? 27.6 58.9 13.5 17.2 75.5 7.4
Statements This concerns things that have been 
said during the previous 3-6 months.
15. Did the person say anything that indicated a 
change in health? 
(For example: “I feel…”, “I don’t want… 
anymore”, “I’m frightened…”)
15.3 82.8 1.8 5.5 84.7 9.8
16. Did family members/loved ones say 
anything that indicated a change in health? 
(For example: “not feeling well”, “he is not 
himself”, “there’s something going on”, “he used to 
enjoy this, now he doesn’t anymore”)
33.7 65 1.2 35.6 48.5 16
Signs and symptoms How are things going at 
the moment, when compared with the previous 3-6 
months?
17. Has the person lost weight or is he/she 
becoming thinner? 
28.2 70.6 1.2 22.7 69.3 8
18. Has the person’s food intake decreased? 
(For example: less appetite, cannot or doesn’t 
want to eat as much, preference for a certain 
kind of food) 
30.1 69.3 0.6 24.5 68.7 6.7
19. Has the person’s fluid intake decreased? 
(For example: cannot or doesn’t want to drink as 
much, preference for certain drinks) 
19.6 79.1 1.2 13.5 79.8 6.7
20. Does the person have more problems 
swallowing?
33.1 63.8 3.1 19.6 76.1 4.3
21. Does the person have more problems with 
bowel movements? 
(For example: constipation, diarrhoea)
22.7 74.8 2.5 12.9 81.6 5.5
22. Does the person have more problems with 
nausea or vomiting? 
7.4 89 3.7 3.7 91.4 4.9
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23. Does the person show more (observable) 
signs of unwellness? 
(For example: (nocturnal) agitation, restless 
movements, facial expressions, noises made 
by the person, characteristic movements of 
discomfort)
47.2 50.3 2.5 41.7 50.9 7.4
24. Does the person have more pain? 20.2 58.3 21.5 16.6 72.4 11
25. Is the person more confused? 28.8 62 9.2 19 74.2 6.7
26. Has the person’s cognition deteriorated?
(For example: remembers less, less orientated 
in time and place, loss of practical skills)
39.3 46.6 14.1 40.5 49.7 9.8
27. Does the person have more sleep 
problems?
(For example: problems falling asleep, problems 
staying asleep, changes in day/night rhythm) 
25.8 69.9 4.3 15.3 71.2 13.5
28. Does the person have worse, or less well 
controlled, epilepsy?
16 83.4 0.6 12.9 85.3 1.8
29. Does the person have worse spasticity? 6.7 91.4 1.8 4.9 93.9 1.2
30. Is the person more dehydrated? 
(For example: less urine production) 
3.7 93.9 2.5 1.8 93.9 4.3
31. Does the person experience more shortness 
of breath?
(For example: clearly audible breathing, faster 
breathing, difficulty breathing)
28.8 69.9 1.2 14.7 81.6 3.7
Infections or episodes of fever How are things 
going at the moment, when compared with the 
previous 3-6 months?
32. Does the person have recurrent infections 
or episodes of fever?
(For example: pneumonia, cystitis, other 
infections or episodes of fever)
30.1 69.3 0.6 24.5 75.5 0
33. Does the effect of antibiotics decrease with 
each infection or episode of fever? (N=49 and 
N=40)
22.4 59.2 18.4 17.5 77.5 5
34. Does the person recover less well or have a 
longer recovery period after each infection or 
episode of fever? (N=49 and N=40)
59.2 30.6 10.2 52.5 40.0 7.5
Frailty
35. Are there several health problems that 
together increase the person’s vulnerability to a 
(further) decline in health?
(Health problems relate to physical, 
psychological and social wellbeing)
73 24.5 2.5 84 15.3 0.6
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Disorder or illness
36. Is there a diagnosis or a strong suspicion of 
the existence of a serious (chronic) illness?
(For example: dementia, lung diseases, 
cardiovascular diseases, diabetes, rheumatism 
or cancer etc.)
55.2 41.7 3.1 73.6 26.4 0
37. Is there a serious (chronic) illness that 
cannot be treated or for which treatment is not 
indicated (anymore)?
(For example: there is no treatment or the 
treatment has no effect, the person doesn’t 
respond to the treatment due to complications 
or side effects, treatment can’t be carried out, 
or the treatment burden outweighs possible 
benefits for length or quality of life)
52.2 42.2 5.6 55.8 40.8 3.3
Prognosis
38. Is there a shortened life expectancy and is 
the person approaching the end of life?
(What is your assessment, perhaps based on 
changes in health or diagnosis of a serious 
(chronic) illness?)
24.5 57.7 17.8 35.6 51.5 12.9
39. Would you be surprised if this person 
were to die in the next 12 months?
(This is not about whether you expect the 
person to die, but whether you’d be surprised if 
this person were to die within a year)
22.1 72.4 5.5 13.5 85.3 1.2
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Timely identification of people with intellectual disabilities (ID) in need of palliative care 
is important for discussing their needs and preferences timely in the course towards the 
end of life. In the care for people with ID, identification of those in need of palliative care 
is not a common or conscious practice and has not yet been addressed in research. This 
calls for a tool that aids healthcare professionals in timely identifying people with ID 
who may benefit from palliative care. Because of the specific challenges of care in this 
population, we anticipated that existing tools, developed for and used in the general 
population, may not be applicable to people with ID. Therefore, the aim of this thesis 
was to develop and evaluate an applicable, feasible and valid tool for timely identifying 
people with ID in need of palliative care: PALLI (PALliative care: Learning to Identify in 
people with ID).
We used a five-stage mixed-methods procedure for developing PALLI based on 
healthcare professionals’ experiences and a prospective follow-up study for exploring 
applicability, feasibility and validity of PALLI. In this discussion, we present an overview 
of our primary findings. Subsequently, we discuss methodological considerations as well 
as recommendations for implementation and research.
Primary findings
Development of PALLI
In the first step, General Practitioners (GPs) and Physicians for People with Intellectual 
Disabilities (ID-physicians) completed a survey about their last patient with ID with a 
non-sudden death. We examined when and based on which signals these physicians 
recognized death in the foreseeable future and when they discussed the start of the 
palliative care phase (Chapter 3). In a number of cases, the moment of foreseeing death 
and discussing palliative care was reported at a late stage. In more than a fifth of the 
cases, the physicians foresaw death not until the last week of life. This is comparable to 
the 26% noted by Claessen et al.(41) in 2013 in a Dutch general population of patients 
with other diseases than cancer and almost four times higher than the 6% noted by 
Claessen et al. in patients with cancer. The start of the palliative care phase was not 
discussed before the last week of life in 30% of the cases and seemed to be connected to 
the moment of foreseeing death in 56% of the cases. These results stress the importance 
of support in timely identifying people with ID in need of palliative care and the need 
for a tool like PALLI. Both physicians and DCPs are important in noticing and interpreting 
signals, as these signals are not only medical, but also include characteristic changes in 
behaviour, mood or daily functioning.
Based on the survey we also studied symptom prevalence and collected data on 
the interventions the physicians provided in people with ID approaching the end of life 
as reported by ID-physicians (Chapter 4). Regarding symptoms, physicians reported a 
median number of three out of the eight Edmonton Symptom Assessment Scale (ESAS) 
symptoms per patient. Fatigue was the most reported symptom, followed by drowsiness 
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and decreased appetite. Compared to a study in a general population of patients 
receiving palliative care for at least three months from Dutch GPs, our results regarding 
symptom prevalence somewhat differ. For example, for pain, anxiety and depressed 
mood the percentage in people with ID was lower, whereas for fatigue and shortness 
of breath the percentage in people with ID was higher. However, these comparisons 
should be interpreted with caution because of differences in sample characteristics and 
the tendency of healthcare professionals to miss symptoms in people with ID.(11, 80, 81) 
Physicians reported a median number of four interventions per patient. Most reported 
interventions were aimed at somatic problems, such as pain or shortness of breath.
In the second step, we explored in interviews how physicians and DCPs identify the 
patients with ID in need of palliative care. Results from the interviews with ID-physicians 
in Chapter 5 suggest that in most cases identification is the result of a process in which 
multiple signals from different information sources converge and over time lead to a 
growing awareness of the need for palliative care. This leads to a shift in expectation 
when the palliative care phase is determined; the ID-physician does not expect the 
patient with ID to return to a prior level of health or functioning, but rather expects a 
further irreversible decline leading to death. The process of identification depends 
on several factors: whether or not underlying diseases are identified, the stage and 
prognosis of these diseases, remaining treatment options, physicians’ experience and 
knowledge, physician-patient familiarity, and physicians’ communication with proxies as 
providers of contextual information. Our results correspond with a study by Claessen et 
al.(28) in patients of Dutch GPs, which may suggest similarities in the way people with and 
without ID are identified as being in need of palliative care. However, care characteristics 
such as a specific presentation of problems, communicational challenges and diagnostic 
uncertainties (6, 11, 108, 122) make processes in people with ID unique. These differences 
support the need for a tool specifically designed for use in people with ID.
The results of the survey and interviews generated relevant ID-related items 
for a draft version of PALLI in the third step. For example, items regarding physical 
functioning, activities, characteristic behaviour, symptoms and recurrent infections and 
more overarching items regarding statements of the person with ID or family, frailty, 
presence of serious illnesses and prognosis. The content of the items differentiate PALLI 
from comparable tools developed for a general population – such as the Gold Standard 
Framework Prognostic Identification Guidance,(109) the Supportive and Palliative Care 
Indicators Tool (SPICT), (24, 128) the Radboud Indicators for Palliative Care Needs (RADPAC)
(25) or the Necesidades Paliativas Centro Colaborador de la Organización Mundial de 
la Salud – Institut Català d’Oncologia tool (NECPAL CCOMS-ICO Tool).(109) Where those 
tools include clinical indicators categorised for different diseases (e.g., cancer, dementia, 
organ failure), PALLI is less diagnosis-driven and focuses more on relevant changes in 
day-to-day functioning indicative of deteriorating health. A clear diagnosis is likely 
to contribute to timely identification of the need for palliative care, because it allows 
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anticipating comorbid conditions and may provide directions for prognostication. 
However, in people with ID diseases may be diagnosed late or not diagnosed at all.
(6, 107) The combination of the specific items and more overarching items makes PALLI 
relevant for people with ID. Furthermore, this makes it possible for multiple healthcare 
professionals – e.g., physicians and DCPs – to complete PALLI and thereby combine day-
to-day experiences with overarching medical knowledge.
In the fourth step, the draft version was discussed in multiple focus groups with 
different healthcare professionals. We asked questions about general impression of 
applicability and feasibility, content and priority of items, wording and language of 
items, scoring of items. Based on their feedback we modified PALLI in the fifth step into a 
final version ready for testing applicability, feasibility and validity in a prospective follow-
up study.
Applicability, feasibility and validity of PALLI 
We found promising results regarding applicability of PALLI (Chapter 6). In a majority 
of the cases, the items were deemed relevant and applicable to the person with ID and 
no ambiguous questions were reported. According to some professionals, items were 
not always applicable or clear because of a presumed decline in abilities or problems 
that were not applicable to the specific person or because the period of retrospect (3-6 
months) was not appropriate. This is not surprising given the diversity in the population 
of people with ID (e.g., cause and level of ID, functional abilities, intensity of support). 
Still, we feel it is possible to examine the level of deteriorating health and to use PALLI 
as indication for the need for palliative care based on appraisal of other items. For a 
majority of the physicians and DCPs did not provide them with new insights about the 
person with ID, mainly because they were already familiar with the health status and 
care needs. An explanation might be that in most care organizations for people with ID 
in the Netherlands the person’s health and wellbeing is often periodically evaluated by 
a multidisciplinary team with or without the person with ID. This facilitates involvement 
in care and shared knowledge about needs. For those who answered ‘yes’, the added 
value of PALLI was reflecting on and becoming aware of the process of decline in health, 
changing care needs and whether or not provided care meets these needs. Furthermore, 
we feel that even when PALLI does not provide new insights it has added value as it 
combines available knowledge about the health status, even implicit knowledge, and 
presents this in an explicit form.
Feasibility and construct validity of PALLI were adequate (Chapter 7). Both 
physicians and DCPs were able to complete PALLI (i.e. were able to provide an answer of 
‘yes’ or ‘no’ for most items, low number of items not known) in a short amount of time. 
A higher PALLI score as reported by physicians and DCPs was related to a higher level 
of decline in health, a higher symptom burden, a lower QoL and ADL-dependency at 
baseline. We found less and mixed evidence for the predictive validity. A higher score 
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on PALLI increased the risk of death within 12 months with 2-4% per positive item, 
but this was only statistically significant when based on physician reports. Physicians 
answered ‘don’t know’ more often than DCPs. We could speculate that this may indicate 
that physicians were more inclined to be able to support an answer of ‘yes’ or ‘no’ and 
to reduce the risk of providing a false answer. This may have led to less error in the 
physician reports and therefore more power, which may explain why the effect was 
only significant for physicians. Furthermore, we found that the longer the follow-up, the 
lower the association of the total PALLI score with the outcome variables was. This may 
suggest that the health status of those people with ID as we included in our study shows 
a somewhat unpredictable course (e.g., a person with deteriorating health at baseline 
who remained frail, but stable throughout the follow-up period or a person with a better 
health status at baseline who experienced a severe deterioration in health at the end of 
the follow-up period).
The results from Chapter 6 and Chapter 7 indicate that PALLI is a promising tool 
that can be used for screening deteriorating health, indicative of limited life expectancy, 
in people with ID. The answers provided on PALLI can be used in practice as an indication 
for the need for palliative care. We chose not to perform analyses to calculate a fixed 
cut-off point for this. Based on progressive insight we feel this is in line with ideas of 
palliative care as a gradual care approach(20, 103, 118) and ‘predicting needs rather than exact 
prognostication’(23). We hereby also leave the discussion about whether palliative care is 
indicated to the healthcare professionals together with the person with ID and his or her 
family. With their knowledge of prior health and functioning, they are best able to put 
PALLI in an end-of-life perspective. It is essential to differentiate people in an irreversible 
process towards the end of life from people with a reversible physical or mental health 
condition, such as major depression. Moreover, just like in people with dementia(118) it 
is likely that in the care for people with ID the various caregivers involved differ in their 
perspective when palliative care should be provided. With this in mind, in our opinion, 
PALLI has much potential to be used for creating consensus about palliative care 
provision; it can facilitate timely discussion about whether palliative care is indicated 
and thereby about people’s needs and preferences. Furthermore, discussing important 
end-of-life decisions, such as (non-)disclosure of bad news of the life-limiting illness 
and death to the person with ID,(104, 129) place of providing care and place of death,(105) 
Do NotResuscitate (DNR) order(130) and hospital admissions can be supported by using 
PALLI.
Differences between physicians and DCPs in how PALLI is scored and the 
information they provided on applicability stresses the added value of expertise of 
multiple disciplines. DCPs are more familiar with day-to-day functioning and behaviour. 
It is likely that they therefore have more knowledge about items like functional decline, 
changes in characteristic behaviour and symptoms such as weight loss. Physicians see 
people more often on a consultation basis and are reliant on proxies for this information.
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(106, 108) On the other hand, physicians are more likely to have knowledge about medically 
oriented items (e.g., presence of serious illnesses) and more overarching items (e.g., 
frailty and prognosis). Taking this together, PALLI could be completed by the DCP as a 
way to put emphasis on their ‘gut feeling’ that something is wrong. In deliberation with 
a physician, they are then able to present and discuss this information. However, we also 
feel that physicians alone or together with a DCP, are able to complete PALLI, assuming 
that the physician is familiar with the person with ID. Either way, in order to join expertise 
and combine perspectives, multidisciplinary discussion about a completed PALLI 
provides the most accurate picture of a person’s health status.
Methodological considerations
Development of PALLI
A strength of the development is the use of a five-stage procedure that relied on the 
knowledge and experiences of a diverse group of healthcare professionals working with 
people with ID. This allowed us to develop PALLI based on signals from functioning, 
behaviour, symptoms and diseases that are relevant and characteristic to people with 
ID. We acknowledge that PALLI is developed as a tool for proxies, who do not always get 
it right in people with severe communication problems. Still, proxy measurements on 
health in people with ID are common, feasible and provide meaningful results when the 
professionals know the person well (e.g., Hilgenkamp et al., 2011)117
In retrospect, a limitation may be that people with ID and their family themselves 
were not involved in the process of development. Furthermore, we did not ask for 
psychologists or remedial educationalists for people with ID for their input. These 
disciplines are also often involved in caring for this population in the Netherlands. 
We may also have missed information from GPs, because we feel that this group was 
underrepresented throughout the developmental process. Another limitation may be 
our reliance on only self-reported retrospective data in the survey and interviews for 
developing PALLI. Physicians and DCPs may not have been able to recall all events and 
experiences. On the other hand, it might also have provided an opportunity to reflect 
and subsequently report events and experiences that would not have been reported 
while still in the process (prospectively). A last limitation may be that we did not validate 
our interpretation of modifying PALLI based on the feedback in the focus groups trough 
a member check.
Applicability, feasibility and validity of PALLI
By including and following 190 people with ID from nine care organizations across the 
Netherlands, we were able to explore applicability, feasibility and validity in a group of 
people with ID with a broad range of characteristics: all levels of ID, different age groups, 
and a variety of comorbid conditions. Based on personal characteristics (e.g., level of 
ID and residential status) and scores on outcome measures (e.g., ADL dependent) we 
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feel that our results may be most applicable to more frail people with ID with a higher 
level of dependency who receive professional care in central residential care settings or 
in community based homes. We lack results of the use of PALLI in people with ID who 
live independent with ambulatory support or with their family, and with low levels of 
professional support and care.
In interpreting the results, the procedure regarding the use of the ‘Surprise 
Question’(115) “Would you be surprised if this person were to die in the next year?” should be 
taken into account. We used the ‘Surprise Question’ as a method to differentiate people 
more likely to be in need of palliative care from those people not likely to be in need 
of palliative care. However, in most care organizations not all people with a possible 
negative answer on the ‘Surprise Question’ were selected, because of research efficiency 
purposes (e.g., number of people for whom the physician or DCP was able to complete 
surveys). Although we explicitly explained that the question was not about whether the 
professional expected the person to die within one year, rather whether he would be 
surprised if the person were to die within a year, the use of the ‘Surprise Question’ may 
have caused a selection effect. For example, inclusion of a high proportion of people 
with ID who were most likely to die within a year. Consequently, results might be 
different when all people in the participating organizations with a negative answer on 
the ‘Surprise Question’ were included.
With regard to the applicability, our results were based on answers provided via an 
online survey. We therefore gathered less detailed information compared to information 
from in-depth interviews. Furthermore, we did not perform a member and saturation 
check. With regard to the validity, the small changes over time in the outcome measures 
may suggest that the chosen timeframe of one year was insufficient and should be 
extended in order to measure significant changes. Despite careful selection upfront, 
it may also point out lacking applicability of the outcome measures for our sample of 
people with ID (e.g., floor effect in ADL-dependency). Results reflect the care structure in 
the Netherlands and may be different in other countries.
Recommendations for implementation of PALLI
In the next paragraphs, we discuss recommendations for implementation of PALLI. Box 1 
provides an overview of the most important recommendations.
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Box 1. Most important recommendations for implementation of PALLI in organizations for people with ID
Have a sustainable focus on palliative and end-of-life care.
Develop a specific organization protocol for the use of PALLI. 
Use PALLI to teach healthcare professionals to recognise situations where a person with 
ID is in need of palliative care. 
Use PALLI as a screening tool for identifying deteriorating health, indicative of limited 
life expectancy, and as an indication for the need for palliative care.
Use PALLI when there are indications of a risk of becoming increasingly frail and having 
a limited life expectancy. Alternatively, use PALLI annually from a specific level of age 
onwards.
Discuss the results of PALLI with all caregivers involved for a shared vision about the 
persons’ need for palliative care.
Evaluate the use of PALLI periodically.
The PALLI study provides healthcare professionals with a screening tool that supports 
them in identifying deteriorating health, indicative of limited life expectancy. And with 
the use of PALLI they are better able to meet one of the recently developed consensus 
norms for palliative care of people with ID in Europe(79):“All health and social care providers 
need to be able to recognise the situations where the people with intellectual disabilities 
whom they support need palliative care, across all settings (whether this is in the family 
home, in an institutional setting or in single or shared homes in the community). Those 
caring for them should be alert to the signs and symptoms of serious illness, end of life and 
the dying phase”.
As we have postulated above, we feel that PALLI can be completed by both physicians 
and DCPs or by physicians and DCPs together. As long as PALLI is multidisciplinary 
discussed after completion. Another important aspect of implementation is in which 
situations PALLI could be used. We suggest that people with ID are subject for screening 
when there are indications that they are at risk of becoming increasingly frail and 
having a limited life expectancy. Indications for this may be for example people with 
an (presumed) irreversible serious illness at an early stage (e.g., dementia, organ failure, 
cancer), people with multiple hospital admissions in the last six months for possible life 
threatening conditions (e.g. recurrent pneumonia), people at ‘high age’ (e.g. people with 
a syndrome associated with early aging – for example Down syndrome(131), aged 50 or 
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older, or more in general, all people with ID aged 60-70 or older(132)) who show signals of a 
decline in health, indicative of a limited life expectancy. Furthermore, a ‘gut-feeling’ from 
a proxy such as a DCP or family member that a person with ID is showing deterioration 
in health or functioning which may be related to having a limited life expectancy, may 
also be an importation indication for further screening.
It is also possible to use PALLI annually from a specific level of age onwards (e.g., 
>50 years; we know from recent research that people with ID aged 50-59 are as frail as a 
general population aged 70-79.(102) This may be more time-consuming and less relevant 
as it increases the risk of a high number of people in which palliative care is not indicated 
after discussing a completed PALLI. On the other hand, it decreases the risk of missing 
people with ID who actually are in need of palliative care. In all cases it is up to the 
professionals to do differential diagnosis, to place signals in an end-of-life perspective 
(e.g., by including the personal history of the person with ID) and to decide to use PALLI.
In organizations caring for people with ID, effective implementation of PALLI relies 
on shared agreement throughout the organization about when PALLI should be used, 
which professionals may initiate using PALLI, which professionals may complete PALLI, 
and how multidisciplinary discussion of the results should look like. For this purpose, we 
suggest developing a protocol for the use of PALLI in the organization and evaluating this 
periodically. It is advisable to give this task of development to a specific group of people, 
for example a palliative care team. From the organization, this asks for a sustainable 
focus on policy level on palliative care and end-of-life care for people with ID.(79, 133) Cross-
professional collaborations between the fields of palliative care and care for people with 
ID may be an essential facilitator for this purpose.
Recognizing the situations when people with ID need palliative care asks for internal 
or external training for professionals caring for people with ID. Use of PALLI for identifying 
deteriorating health and discussing the need for palliative care in individual cases of 
people with ID can be a valuable contribution to these trainings (for example, in the 
training program palliative care for people with ID from the Netherlands Comprehensive 
Cancer Organization (Integraal Kankercentrum Nederland/IKNL) for DCPs(134) or in the 
training program for palliative care nurses from IKNL and HAN University of Applied 
Sciences(114)).
Recommendations for research
Because PALLI is a newly developed tool and because in this thesis only first results 
regarding applicability, feasibility and validity of PALLI are provided, future research 
should be performed to replicate these results. Preferably, this should be in a greater 
cohort and over a longer period of follow-up. Furthermore, it would be interesting to 
explore differences and related (cost-)effectiveness of its application between subgroups 
(e.g., based on age, level of ID, underlying diseases or residential setting). It may also 
be interesting to compare, in future research, PALLI with tools developed for a general 
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population.39 There is a great diversity within the population of people with IDs and 
these tools may be applicable to specific subgroups of people with IDs, such as people 
with borderline to mild ID living in the community.
Further studies are needed to explore in depth how PALLI is best implemented, so 
that it facilitates shared vision about the persons’ need for palliative care. For this purpose, 
evaluation of implementation processes in care organizations for people with ID may 
provide more insight about when to use PALLI and how to interpret scores on PALLI. This 
may result in barriers and facilitators on patient, professional and organizational level that 
can be used by other care organizations and educational institutions to implement PALLI 
more effectively in daily practice and in training programs. Furthermore, this evaluation 
may also create a better understanding of the variability in scoring between different 
disciplines and provide specific recommendations for dealing with this variability when 
using PALLI. Action-based research in another prospective study, where PALLI is used 
to identify people with ID in need of palliative care, may be an interesting method for 
studying implementation.(123)
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SUMMARY
In Chapter 1, the rationale for this thesis on timely identification of people with 
intellectual disabilities (ID) in need of palliative care is explained. In practice as well as 
in research there is growing attention for palliative care for people with ID. Bottom line 
of this attention is that the care at the end of life for people with ID should be improved. 
For this purpose, it is essential that healthcare professionals know “when palliative care is 
needed?”. This calls for a tool that aids healthcare professionals in identifying people with 
ID who might benefit from palliative care. Several of such tools have been developed for 
a general population; however, we anticipated that these tools might not be applicable, 
because of the specific care challenges in this population. Therefore, we started the PALLI 
study: PALliative care: Learning to Identify in people with ID. With this study, we aimed to 
develop and evaluate an applicable, feasible and valid tool that supports healthcare 
professionals in identifying people with ID in need of palliative care: PALLI. PALLI was 
primarily aimed at physicians – either a General Practitioner (GP) or Physician for people 
with ID (ID-physician) – and Daily Care Professionals (DCPs; professionals who provide 
the daily care, with either a social or nursing education).
In Chapter 2, the initial design of the PALLI study is provided. We aimed to use a five-
stage mixed-methods procedure to develop PALLI based on knowledge from practice. In 
the first step of the developmental process, we wanted to ask GPs and ID-physicians to 
complete a retrospective survey about their last patient with ID with a non-sudden death. 
Secondly, we aimed to conduct interviews with a selection of physicians who completed 
the retrospective survey and with a number of DCPs about recognizing the need for 
palliative care in people with ID. These steps generated relevant items for a draft version 
of PALLI, which we intended to build in the third step. Fourthly, we wanted to discuss this 
version in multiple focus groups with physicians, DCPs, and palliative care nurses (PCNs) 
for people with ID. In the fifth step, we planned to modify the draft version into a version 
ready for testing applicability, feasibility and validity in a prospective follow-up study. 
For this study, we intended to follow 200 people with ID, included based on a negative 
answer on the ‘Surprise Question’ “Would you be surprised if this person died in the next 
year?”, for a period of 10 months. At baseline, 5 months and 10 months we aimed to ask 
the physician and DCP caring for each person with ID to complete PALLI and provide 
information on applicability as well as feasibility and on predetermined health outcomes 
that we could use for exploring validity of PALLI (e.g., symptom burden, level of decline 
in health).
In Chapter 3, we reported on when and based on which information sources and signals 
Dutch physicians recognized death in the foreseeable future in people with ID and when 
they discussed the start of the palliative care phase. We used data from 81 ID-physicians 
and 16 GPs who completed the retrospective survey about their last patient with ID 
with a non-sudden death. Both recognition and discussion seemed challenging: more 
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than a fifth of all physicians did not foresee death until the last week of life and 30% did 
not discuss the start of the palliative care phase until the last week. This points out the 
importance of support in timely identifying people with ID in need of palliative care 
and the need for a tool like PALLI. We found 40 different signals that lead to physicians’ 
foreseeing death; on average 5 different signals per patient. Both physicians and DCPs 
are important in noticing and interpreting these signals; as these are not only medical, 
but also include characteristic changes in behaviour, mood or daily functioning. 
In Chapter 4, we determined prevalence rates of ID-physician-reported symptoms 
from the Edmonton Symptom Assessment System (ESAS) at the moment physicians 
recognized death in the foreseeable future in people with ID. In addition, we explored 
provided interventions as reported by physicians in the period between physicians 
foreseeing death and patients’ actual death. We used data from 81 ID-physicians who 
completed the retrospective survey about their last patient with ID with a non-sudden 
death. On average, people with ID suffered from 3 out of the 8 ESAS symptoms. Fatigue, 
drowsiness and decreased appetite were most reported. ID-physicians reported a median 
number of 4 interventions, mostly aimed at somatic problems such as pain and shortness 
of breath. Burdensome interventions such as surgery or artificial respiration were least or 
not reported. Palliative sedation was provided in a third of all cases. Although a variety of 
symptoms and of provided interventions at the end of life were reported, using adequate 
symptom assessment tools suitable for people with ID and continuous multidisciplinary 
collaboration in palliative care are essential to capture symptoms as fully as possible. The 
questions that remain after this study indicate a need of further research in symptom 
assessment and management in people with ID at the end of life. 
In Chapter 5, we explored how the need for palliative care is recognized in people with 
ID. We used data from 10 ID-physicians who were interviewed after they completed 
the retrospective survey. Identification of people with ID in need for palliative care 
mostly results from a process in which multiple signals from different information 
sources converge and lead to a growing awareness. As a result, ID-physicians do not 
expect people to return to their prior level of health or functioning, but rather expect an 
irreversible decline leading to death. The presence, stage and prognosis of the disease, 
physician-patient interaction, and communication with proxies who provide contextual 
information are factors influencing the process. Our results suggest similarities in the 
way people with and without ID are identified as in need of palliative care. However, care 
characteristics such as communicational challenges, aspecific presentation of problems, 
diagnostic uncertainties and reliance on proxies make processes in people with ID 
unique. Communication with proxies who can provide contextual information regarding 
changes in health and wellbeing is essential in people with ID. 
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In Chapter 6, we described the development of PALLI and explored applicability of PALLI. 
A five-stage mixed-methods procedure was used to develop PALLI based on knowledge 
from practice. With data from 97 physicians in the retrospective survey and interview data 
from 16 physicians and 14 DCPs, we generated relevant items for a draft version of PALLI. 
This version was discussed in multiple focus groups with 16 physicians, 10 PCNs and 
14 DCPs and modified into a version for testing on applicability, feasibility and validity. 
For exploring applicability, we included 190 people with ID in a prospective follow-up 
study based on a negative answer on the ‘Surprise Question’: “Would you be surprised if 
this person died in the next year?”. We asked physicians and DCPs to complete PALLI and 
provide information on relevance and clarity of questions at baseline and encouragement 
to reflect on the person with ID after 5-6 months. Applicability was promising; most 
physicians and DCPs found PALLI relevant and reported no ambiguous questions. Added 
value of PALLI is reflecting on and creating awareness of the process of decline in health 
and changing care needs, and combining this knowledge and presenting this in an 
explicit form. Based on our results we think PALLI is applicable as a tool for screening 
deteriorating health, indicative of limited life expectancy, in people with ID.
In Chapter 7, we evaluated feasibility, construct validity and predictive validity of PALLI. 
We included 190 people with ID in a prospective follow-up study based on a negative 
answer on the ‘Surprise Question’: “Would you be surprised if this person died in the next 
year?”. We asked physicians and DCPs to complete PALLI and provide information on health 
outcomes at baseline, after 5-6 months and after 10-12 months. Feasibility was adequate; 
both physicians and DCPs were able to complete PALLI (i.e. were able to provide an answer 
of ‘yes’ or ‘no’ for most items, low number of items not known) in a short amount of time. 
Construct validity was promising; a higher PALLI score as reported by physicians and DCPs 
was related to a higher level of decline in health, a higher symptom burden, a lower quality 
of life and a greater ADL dependency at baseline. We found less and mixed evidence 
for the predictive validity. A higher score on PALLI increased the risk of death within 12 
months with 2-4% per positive item, but this was only statistically significant based on 
physician reports. We found that the longer the follow-up the lower the association of the 
total PALLI score with the outcome variables was: for physicians, only the increased risk of 
being severely to completely ADL dependent at T2 (10-12 months), and for DCPs, only the 
positive association with overall decline in health and symptom burden at T2, remained 
significant. Based on our results we think PALLI is a feasible and valid tool for screening 
deteriorating health, indicative of limited life expectancy, in people with ID.
In Chapter 8, we discuss the main findings and methodological considerations of the 
studies in this thesis. Furthermore, we discuss recommendations for implementation 
of PALLI and recommendations for future research. We feel PALLI is a useful tool in the 
daily care for people with ID for screening deteriorating health, indicative of limited 
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life expectancy. With this, PALLI has potential for timely identifying people with ID who 
may benefit from palliative care and for facilitating discussion and shared vision about 
planning and provision of palliative care. PALLI can have a valuable contribution in 
training programs, in order to support healthcare professionals to recognize situations 
where a person with ID is in need of palliative care. A sustainable focus on palliative and 
end-of-life care on a policy level and the development of a protocol for use of PALLI in the 
organization are needed for effective implementation in care organizations for people 
with ID. Priority of future research is to replicate our findings regarding applicability, 
feasibility and validity of PALLI and to evaluate how PALLI is best implemented in daily 
care.
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Hoofdstuk 1 is de inleiding van deze thesis over het tijdig identificeren van de behoefte 
aan palliatieve zorg bij mensen met verstandelijke beperkingen (VB). Zowel in de zorg 
als in onderzoek is de aandacht voor het verbeteren van palliatieve zorg voor deze 
doelgroep gegroeid. Om tijdig palliatieve zorg te kunnen leveren is het belangrijk 
dat zorgverleners weten wanneer deze zorg nodig is. Dit is echter een knelpunt dat 
vraagt om een hulpmiddel dat zorgverleners ondersteunt bij het identificeren van 
mensen met VB die mogelijk behoefte hebben aan palliatieve zorg. Verschillende 
hulpmiddelen (checklists) met dit doel zijn ontwikkeld voor een algemene populatie, 
maar we verwachtten dat deze onvoldoende toepasbaar zijn bij mensen met VB 
vanwege de specifieke uitdagingen in het zorgen voor deze populatie. Om deze reden 
zijn we de PALLI studie gestart: PALliatieve zorg: Leren Identificeren bij mensen met VB. 
Het doel van deze studie was om een toepasbare, haalbare en valide checklist (PALLI) 
te ontwikkelen die zorgverleners ondersteunt bij de identificatie van de behoefte aan 
palliatieve zorg. PALLI was voornamelijk bedoeld voor gebruik door artsen – huisarts 
of arts voor verstandelijk gehandicapten (AVG) – en begeleiders (met agogische en/of 
verpleegkundige achtergrond) van mensen met VB.
Hoofdstuk 2 beschrijft het oorspronkelijke design van de PALLI studie. Het doel 
was om in vijf stappen PALLI te ontwikkelen op basis van kennis uit de praktijk. In de 
eerste stap van het ontwikkelproces wilden we huisartsen en artsen voor verstandelijk 
gehandicapten (AVG’s) vragen om een retrospectieve survey in te vullen over hun 
laatste patiënt met VB die overleed na een ziekteproces (geen plotseling overlijden). 
In de tweede stap beoogden we een selectie van artsen en begeleiders te interviewen 
over het herkennen van de behoefte aan palliatieve zorg. In stap drie wilden we een 
voorlopige versie van PALLI opstellen op basis van relevante informatie uit de eerste 
twee stappen. In de vierde stap zou de voorlopige versie van PALLI besproken worden 
in focusgroepen met artsen, begeleiders en palliatief zorgconsulenten voor mensen 
met VB (PZC). In stap vijf streefden we er naar om op basis van de feedback uit de 
focusgroepen PALLI aan te passen tot een definitieve versie die getoetst kon worden op 
toepasbaarheid, haalbaarheid en validiteit in een prospectieve follow-up studie. Voor 
deze follow-up studie was onze intentie om 200 mensen met VB te selecteren op basis 
van een ontkennend antwoord op de ‘Surprise Question’ “Zou u verbaasd zijn wanneer 
deze persoon binnen een jaar zou overlijden?” en om hen te volgen voor tien maanden. Bij 
de start, na 5 en na 10 maanden was ons doel de arts en begeleider van iedere persoon 
met VB te vragen om PALLI in te vullen en informatie te geven over toepasbaarheid, 
haalbaarheid en vooraf vastgestelde gezondheidsmaten voor het onderzoeken van de 
validiteit (bijv. symptoomlast, niveau van achteruitgang in gezondheid).
Hoofdstuk 3 gaat over wanneer en gebaseerd op welke informatie(bronnen) artsen 
herkennen dat iemand met VB gaat overlijden binnen zekere tijd en wanneer zij de 
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start van de palliatieve zorgfase bespreken. We gebruikten hiervoor data van 81 AVG’s 
en 16 huisartsen die de retrospectieve vragenlijst over hun laatste patiënt met VB die 
overleed na een ziekteproces (geen plotseling overlijden). Meer dan een vijfde van alle 
artsen voorzag overlijden binnen een zekere tijd niet voor de laatste week. Daarnaast 
besprak 30% van de artsen de start van de palliatieve zorgfase pas in de laatste week. 
Deze resultaten benadrukken het belang van een ondersteunend hulpmiddel bij het 
tijdig identificeren van mensen met VB met behoefte aan palliatieve zorg. We vonden 40 
verschillende signalen die leidden tot het besef van naderend overlijden; gemiddeld 5 
signalen per patiënt. Artsen rapporteerden niet alleen medische of lichamelijke signalen, 
maar ook veranderingen in kenmerkend gedrag, stemming en dagelijks functioneren. 
Vanwege de diversiteit aan signalen zijn zowel artsen als begeleiders belangrijk voor het 
herkennen en interpreteren van deze signalen.
Hoofdstuk 4 omvat een studie waarin we de prevalentiescores onderzochten van 
de door AVG’s gerapporteerde symptomen op het moment van het herkennen van 
overlijden binnen zekere tijd. Daarnaast onderzochten we de toegepaste interventies 
in de periode tussen besef van overlijden binnen zekere tijd en het moment dat 
de patiënt met VB overleed. Hiervoor gebruikten we de data van de 81 AVG’s die de 
retrospectieve vragenlijst invulden. Gemiddeld hadden de mensen met VB last van 3 
van de 8 gevraagde symptomen van de Edmonton Symptom Assessment System (ESAS). 
Vermoeidheid, slaperigheid en verminderde eetlust werden het vaakst gerapporteerd. 
De meeste ingezette interventies waren gericht op somatische problemen zoals pijn 
en benauwdheid. Belastende interventies zoals chirurgie of kunstmatige beademing 
werden het minst tot niet gerapporteerd. Palliatieve sedatie was toegepast bij een 
derde van alle patiënten. Deze resultaten benadrukken het belang van adequate en 
voor mensen met VB bruikbare symptoom assessment hulpmiddelen. Tegelijk maakt de 
studie duidelijk dat er nog veel onderzoek nodig is op het gebied van signaleren en 
behandelen van symptomen bij mensen met VB rond het levenseinde.
Hoofdstuk 5 is een studie naar de herkenning van de behoefte aan palliatieve zorg 
bij mensen met VB. Hiervoor maakten we gebruik van data van 10 AVG’s die waren 
geïnterviewd nadat zij de retrospectieve vragenlijst hadden ingevuld. Identificatie 
van mensen met VB die behoefte hebben aan palliatieve zorg is meestal het resultaat 
van een opeenstapeling van meerdere signalen uit meerdere informatiebronnen die 
leidt tot een groeiend bewustzijn. Dit heeft als gevolg dat een arts verwacht dat de 
persoon niet meer terug zal komen op een vorig gezondheidsniveau, maar juist een 
onomkeerbare achteruitgang zal doormaken die leidt tot overlijden. De aanwezigheid, 
fase en prognose van een onderliggende aandoening, de arts-patiënt interactie, en 
communicatie met begeleiders en andere naasten van de patiënt zijn van invloed op 
dit proces. Onze resultaten suggereren belangrijke overeenkomsten tussen de manier 
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waarop de behoefte aan palliatieve zorg wordt herkend bij mensen met en zonder 
VB. Echter, specifieke zorgkenmerken zoals uitdagingen in communicatie, aspecifieke 
presentatie van problemen, onzekerheid over diagnoses en de afhankelijkheid van 
anderen maken deze processen bij mensen met VB uniek. Deze studie laat zien dat 
communicatie met mensen in de directe omgeving van een persoon met VB belangrijk 
is voor het signaleren van veranderingen in gezondheid en welzijn.
Hoofdstuk 6 beschrijft de ontwikkeling van PALLI en de toepasbaarheid van PALLI. We 
hebben PALLI ontwikkeld in vijf stappen op basis van kennis uit de praktijk. De data uit 
de retrospectieve survey van 97 artsen en de data uit de interviews met 16 artsen en 14 
begeleiders leverden relevante items op voor een voorlopige versie van PALLI. Deze versie 
is besproken in meerdere focusgroepen met in totaal 10 AVG’s, 6 huisartsen, 10 PZC’s en 
14 begeleiders en is op basis hiervan aangepast tot een definitieve versie die getoetst 
kon worden op toepasbaarheid, haalbaarheid en validiteit. Voor het onderzoeken van 
de toepasbaarheid hebben we 190 personen met VB geïncludeerd in een prospectieve 
follow-up studie op basis van een ontkennend antwoord op de ‘Surprise Question’ “Zou 
u verbaasd zijn wanneer deze persoon binnen een jaar zou overlijden?”. De betrokken 
begeleider en arts werden gevraagd om bij de eerste meting PALLI in te vullen en om 
vragen in te vullen over de relevantie en duidelijkheid van de vragen. Na 5-6 maanden 
werd hen gevraagd of het invullen van PALLI hen aan het denken had gezet over de 
persoon met VB. Toepasbaarheid was veelbelovend; de meeste artsen en begeleiders 
vonden PALLI relevant en rapporteerden geen onduidelijkheden. De genoemde 
toegevoegde waarde van PALLI is het reflecteren op en het creëren van bewustzijn van 
het proces van achteruitgang in gezondheid en veranderende zorgbehoeften. Daarnaast 
helpt PALLI bij het bundelen en duidelijk op papier zetten van deze kennis. Gebaseerd 
op de resultaten denken we dat PALLI toepasbaar is als hulpmiddel voor het screenen 
van een achteruitgang van gezondheid bij mensen met VB, indicatief voor een beperkte 
levensverwachting.
Hoofdstuk 7 gaat over het evalueren van de haalbaarheid, de construct validiteit en de 
predictieve validiteit van PALLI. Hiervoor hebben we 190 personen met VB geïncludeerd 
in een prospectieve follow-up studie op basis van een ontkennend antwoord op de 
‘Surprise Question’ “Zou u verbaasd zijn wanneer deze persoon binnen een jaar zou 
overlijden?”. De betrokken begeleider en arts werden gevraagd om PALLI in te vullen en 
om vragen in te vullen over gezondheidsuitkomsten bij de start, na 5-6 maanden en na 
10-12 maanden. Resultaten lieten zien dat PALLI haalbaar is; zowel artsen als begeleiders 
konden PALLI invullen (d.w.z. ze waren in staat om ‘ja’ of ‘nee’ te antwoorden voor de 
meeste items, laag aantal items met een hoog aantal ‘weet ik niet’). Construct validiteit 
was veelbelovend; een hogere PALLI score gerapporteerd door artsen en begeleiders was 
gerelateerd aan een grotere achteruitgang in gezondheid, een hogere symptoomlast, 
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een lagere kwaliteit van leven en grotere afhankelijkheid wat betreft ADL. We vonden 
minder en gemengd bewijs voor de predictieve validiteit. Een hogere PALLI score 
vergrootte het risico op overlijden binnen 12 maanden met 2-4% per positief gescoord 
item, maar dit was alleen statistisch significant voor scores van artsen. Verder vonden we 
dat de associatie van de PALLI score met de uitkomsten over tijd kleiner werd: voor artsen 
bleef alleen het vergrote risico op ernstige-volledige ADL afhankelijkheid significant na 
10-12 maanden, terwijl voor begeleiders alleen de positieve relatie met achteruitgang in 
gezondheid en symptoomlast significant bleef. Gebaseerd op de resultaten denken we 
dat PALLI haalbaar en valide is als hulpmiddel voor het screenen van een achteruitgang 
van gezondheid bij mensen met VB, indicatief voor een beperkte levensverwachting.
Hoofdstuk 8 is de algemene discussie van de belangrijkste resultaten en de 
methodologische overwegingen van de studies in dit proefschrift. Daarnaast omvat dit 
hoofdstuk aanbevelingen voor implementatie van PALLI en voor toekomstig onderzoek. 
We vinden dat PALLI een bruikbaar hulpmiddel is in de dagelijkse zorg voor mensen met 
VB voor het screenen van achteruitgang in gezondheid, indicatief voor een beperkte 
levensverwachting. Hiermee heeft PALLI de potentie voor het tijdig identificeren 
van mensen met VB die mogelijk behoefte hebben aan palliatieve zorg en voor het 
faciliteren van discussie over en het creëren van gezamenlijke visie op het bieden van 
palliatieve zorg. PALLI kan een waardevolle toevoeging zijn aan bestaande trainingen en 
opleidingen wanneer het ingezet wordt als middel om te herkennen wanneer iemand 
met VB behoefte heeft aan palliatieve zorg. Voor het effectief implementeren van PALLI 
binnen zorgorganisaties voor mensen met VB is duurzame aandacht op beleidsniveau 
voor palliatieve en levenseinde zorg en het ontwikkelen van een protocol voor inzet 
van PALLI nodig. Toekomstig onderzoek is nodig om onze resultaten te repliceren en te 
evalueren hoe PALLI het best geïmplementeerd kan worden.
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* Palliatieve zorg is een benadering die gericht is op kwaliteit van leven van mensen met een ernstige aandoening door het voorkomen en verlichten van 
lijden en door tijdige signalering en zorgvuldige beoordeling en behandeling van lichamelijke, psychosociale en spirituele problemen. Er kan al vroeg in een 
ziekteverloop nagedacht worden over palliatieve zorg, naast curatieve en levensverlengende behandelingen. Palliatieve zorg kan ook onderzoeken 
omvatten die nodig zijn om aandoeningen te begrijpen of te behandelen. 
 
De PALLI is financieel mogelijk gemaakt door:  
      Jan Jongmans Fonds, ds. Visscher fonds, stichting SFO 
 
© Stichting Katholieke Universiteit/Radboudumc. Gelieve voor eventueel gebruik van de PALLI in een andere vorm dan deze papieren versie contact op te nemen met de 
afdeling Valorisatie van het Radboudumc (secretariaat.val@radboudumc.nl). 
 
 
PALLI 
De PALLI is een vragenlijst die zorgverleners helpt om te bepalen of en in welke mate een cliënt met verstandelijke 
beperkingen achteruit is gegaan in gezondheid. Voor cliënten die achteruit zijn gegaan en met een beperkte 
levensverwachting kan palliatieve zorg* passend zijn: op comfort en kwaliteit van leven gerichte zorg en ondersteuning. 
 
De PALLI gaat over de gezondheid, het gedrag en het functioneren van uw cliënt ten opzichte van de afgelopen periode. De 
PALLI en uw kennis van de voorgeschiedenis van de cliënt kunnen u helpen om in gesprek met andere betrokkenen op tijd te 
bepalen of de zorg voor de cliënt een andere focus nodig heeft. Wij adviseren u de resultaten van de PALLI multidisciplinair 
te bespreken en gezamenlijk na te denken over palliatieve zorg.  
 
VOOR WELKE CLIËNTEN IS DE PALLI?  
De PALLI kan voor elke volwassen persoon met verstandelijke beperkingen ingevuld worden, ongeacht de mate en de 
aard van de beperkingen. Vanwege deze brede doelgroep kan het zijn dat niet alle vragen van toepassing zijn.  
 
WIE VULT DE PALLI IN?  
De PALLI is bedoeld voor zorgverleners die de cliënt goed kennen. Dit kunnen begeleiders zijn, maar ook artsen, 
gedragsdeskundigen en andere zorgverleners.  
 
WANNEER VULT U DE PALLI IN? 
- ‘Niet-pluis gevoel’: Voor zowel arts als begeleiding kan de PALLI helpen om een ‘niet-pluis gevoel’ concreet te 
maken en dit makkelijker te bespreken tijdens een consult. Dit ‘niet-pluis gevoel’ kan ook een vraag van familie zijn.  
- Overleg: De PALLI kan ingevuld worden voor een jaarlijkse zorgplanbespreking, maar bijvoorbeeld ook voor een 
multidisciplinair overleg bij vragen over het beleid rond ziekenhuisopnames of wel/niet reanimeren en bij de vraag 
‘welke palliatieve zorgbehoeften heeft deze cliënt?’. 
 
HOE VULT U DE PALLI IN? 
We willen u vragen in gedachten terug te gaan naar de afgelopen maanden en te bedenken of er veranderingen zijn 
geweest in de gezondheid, het gedrag en het functioneren van de cliënt. Als richtlijn hanteren wij 3-6 maanden, maar 
indien het beter van toepassing is kan een andere periode gebruikt worden.  
 
Bij elke vraag kunt u antwoorden met “JA” of “NEE”. Wanneer u twijfelt, willen we u toch vragen “JA” of “NEE” aan te 
vinken en uw twijfel op te schrijven bij opmerkingen. Wanneer u het antwoord echt niet weet en u er geen informatie over 
heeft, dan kunt u het vraagteken “?” aanvinken.  
 
Bij elke categorie is er ruimte voor ‘opmerkingen / anders namelijk …’. Hier kunt u uw antwoorden aanvullen. We willen 
benadrukken dat de PALLI een hulpmiddel is dat niet per definitie een compleet beeld geeft. 
 
U kunt de PALLI alleen of samen invullen, met of zonder het persoonlijke dossier. Er is geen goed of fout antwoord, het gaat 
om uw ervaring. Denkt u daarom niet te lang na voor u antwoord geeft. Dan duurt het invullen ongeveer 10-15 minuten.  
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Naam en functie invuller(s):    ………………………………………………………………………………... 
Datum invullen:     …… / …… / …… 
 
Naam cliënt:      ……………………………………………………………………………....... 
Geboortedatum cliënt:     …… / …… / …… 
 
Mate verstandelijke beperkingen:   ……………………………………………………………………................... 
Aard of oorzaak verstandelijke beperkingen:  ………………………………………………………………………………... 
 
Lichamelijk  
Hoe gaat het nu vergeleken met de afgelopen 3-6 maanden. 
1. Heeft de cliënt een slechtere lichamelijke conditie of wordt de cliënt sneller moe?   JA  NEE  ? 
2. Is de cliënt meer bedlegerig?  JA  NEE  ? 
3. Is de cliënt meer slaperig of suf?  JA  NEE  ? 
4. Is de cliënt minder mobiel? 
(Bijvoorbeeld: meer hulp nodig voor het bewegen; cliënt valt vaker) 
 JA  NEE  ? 
Opmerkingen / anders, namelijk … 
 
 
 
 
 
Functioneren 
Hoe gaat het nu vergeleken met de afgelopen 3-6 maanden. 
5. Neemt de cliënt minder initiatief of is de cliënt minder goed te stimuleren?  JA  NEE  ? 
6. Weigert de cliënt vaker om dingen te doen of te ondernemen?  
(Bijvoorbeeld: uit bed komen, bewegen, activiteiten, werk, dagbesteding) 
 JA  NEE  ? 
7. Kan de cliënt minder ADL handelingen zelf waardoor de begeleiding meer moet overnemen?  JA  NEE  ? 
8. Zijn er tekenen dat activiteiten of routines, het werk of dagbesteding niet meer zo goed lukken, 
waardoor begeleiding meer moet helpen?  JA  NEE  ? 
Opmerkingen / anders, namelijk … 
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Kenmerkend gedrag  
Hoe gaat het nu vergeleken met de afgelopen 3-6 maanden. 
9. Maakt de cliënt anders contact of meer / minder contact?  
(Bijvoorbeeld: reageert anders op contact met anderen of op de aanwezigheid van anderen, minder 
spraakzaam, of zoekt juist meer toenadering) 
 JA  NEE  ? 
10. Is de cliënt passiever of meer apathisch?  
(Bijvoorbeeld: volgzamer geworden, lusteloos, niet in staat zijn dingen te doen of te willen doen, heeft 
minder levenslust)  
 JA  NEE  ? 
11. Trekt de cliënt zich meer terug?  
(Bijvoorbeeld: meer behoefte aan rust, sneller overprikkeld) 
 JA  NEE  ? 
12. Vertoont de cliënt meer storend of onrustig gedrag?  
(Bijvoorbeeld: meer irriteerbaar, opstandig, agressief of boos) 
 JA  NEE  ? 
13. Is de cliënt  somberder of depressiever?  JA  NEE  ? 
14. Is de cliënt angstiger?  JA  NEE  ? 
Opmerkingen / anders, namelijk … 
 
 
 
 
Uitspraken 
Hoe gaat het nu vergeleken met de afgelopen 3-6 maanden. 
15. Heeft de cliënt iets gezegd dat kan wijzen op een verandering in gezondheid?  
(Bijvoorbeeld: “ik voel me …”, “ik wil niet meer …”, “ik ben bang …”)  JA  NEE  ? 
16. Hebben familieleden / naasten iets gezegd dat kan wijzen op een verandering in gezondheid?  
(Bijvoorbeeld: “zit niet lekker in zijn vel”, “iemand is zichzelf niet”, “er is iets aan de hand”, “eerst kon 
ie hiervan genieten, nu niet meer”) 
 JA  NEE  ? 
Opmerkingen / anders, namelijk … 
 
 
 
 
Klachten 
Hoe gaat het nu vergeleken met de afgelopen 3-6 maanden. 
17. Is het gewicht van de cliënt afgenomen of is de cliënt vermagerd?  JA  NEE  ? 
18. Is de voedselinname van de cliënt verminderd?  
(Bijvoorbeeld: minder eetlust, wil of kan minder eten, wil alleen bepaald voedsel) 
 JA  NEE  ? 
19. Is de vochtinname van de cliënt verminderd?  
(Bijvoorbeeld: wil of kan minder drinken, wil alleen bepaald drinken) 
 JA  NEE  ? 
20. Heeft de cliënt meer slikproblemen?  JA  NEE  ? 
21. Heeft de cliënt meer problemen met ontlasting?  
(Bijvoorbeeld: obstipatie, diarree) 
 JA  NEE  ? 
22. Heeft de cliënt meer last van misselijkheid of braken?  JA  NEE  ? 
Opmerkingen / anders, namelijk … 
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Klachten 
Hoe gaat het nu vergeleken met de afgelopen 3-6 maanden. 
23. Vertoont de cliënt meer (lichamelijke) tekenen van niet welbevinden? 
(Bijvoorbeeld: (nachtelijke) onrust, onrustige bewegingen, gezichtsuitdrukkingen, geluiden die de 
cliënt maakt, kenmerkende bewegingen van niet welbevinden) 
 JA  NEE  ? 
24. Heeft de cliënt meer pijn?  JA  NEE  ? 
25. Is de cliënt meer in de war?    JA  NEE  ? 
26. Gaat de cliënt cognitief achteruit?  
(Bijvoorbeeld: herinnert zich minder, kan zich minder oriënteren in tijd en plaats, verlies van praktische 
vaardigheden) 
 JA  NEE  ? 
27. Heeft cliënt meer slaapproblemen? 
(Bijvoorbeeld: problemen met in slaap komen, problemen met doorslapen, draait het dag / nachtritme om) 
 JA  NEE  ? 
Opmerkingen / anders, namelijk … 
 
 
 
 
 
Klachten 
Hoe gaat het nu vergeleken met de afgelopen 3-6 maanden. 
28. Heeft de cliënt last van ontregelde of toegenomen epilepsie?  JA  NEE  ? 
29. Heeft de cliënt last van toegenomen spasticiteit?  JA  NEE  ? 
30. Heeft de cliënt meer last van uitdroging?  
(Bijvoorbeeld: heeft  minder urineproductie) 
 JA  NEE  ? 
31. Is de cliënt meer kortademig? 
(Bijvoorbeeld: ademt meer hoorbaar, ademt sneller, meer moeite moeten doen om te ademen) 
 JA  NEE  ? 
Opmerkingen / anders, namelijk … 
 
 
 
 
 
Infecties of periodes van koorts 
Hoe gaat het nu vergeleken met de afgelopen 3-6 maanden. 
32. Heeft de cliënt last van terugkerende infecties of periodes van koorts? 
(Bijvoorbeeld: longontsteking, blaasontsteking, andere infecties of periodes van koorts) 
 JA  NEE  ? 
33. Is het effect van antibiotica minder bij iedere infectie of periode van koorts?  JA  NEE  ? 
34. Herstelt de cliënt minder of heeft de cliënt een langere herstelperiode nodig na iedere 
infectie of periode van koorts?  JA  NEE  ? 
Opmerkingen / anders, namelijk … 
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Kwetsbaarheid 
35. Is er sprake van meerdere gezondheidsproblemen die samen de cliënt kwetsbaar maken voor 
een (verdere) achteruitgang in gezondheid? 
(Gezondheidsproblemen kunnen betrekking hebben op lichamelijk, psychisch en sociaal welzijn) 
 JA  NEE  ? 
Opmerkingen / anders, namelijk … 
 
 
 
 
 
Aandoeningen 
36. Is er een diagnose of bestaat er een sterk vermoeden van de aanwezigheid van een ernstige 
(chronische) aandoening? 
(Bijvoorbeeld dementie, longaandoeningen, hart- en vaatziekten, diabetes, reuma of kanker etc.) 
 JA  NEE  ? 
37. Is er sprake van een ernstige (chronische) aandoening waarvan behandeling niet (meer) 
mogelijk of wenselijk is? 
(Bijvoorbeeld: er is geen behandeling of de behandeling slaat niet aan, de cliënt reageert slecht op de 
behandeling  door complicaties of bijwerkingen, of behandeling kan niet worden uitgevoerd of weegt niet 
op tegen de kwaliteit van leven) 
 JA  NEE  ? 
Opmerkingen / anders, namelijk … 
 
 
 
 
 
Prognose 
38. Is er sprake van een beperkte levensverwachting met een naderend einde? 
(Wat is uw inschatting op basis van een eventuele veranderingen in gezondheid of van een 
eventuele diagnose van een ernstige (chronische) aandoening?) 
 JA  NEE  ? 
39. Zou u verbaasd zijn als deze cliënt binnen één jaar zou overlijden? 
(Het gaat er hierbij niet om of u verwacht dat de cliënt gaat overlijden, maar of u verbaasd zou zijn als 
deze cliënt binnen een jaar zou overlijden) 
 JA  NEE  ? 
Opmerkingen / anders, namelijk … 
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* Palliative care is an approach that improves the quality of life of patients and their families facing the problem associated with life-threatening illness, 
through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems: 
physical, psychosocial and spiritual. Palliative care can be considered early in the course of illness, in conjunction with other therapies that are intended 
to prolong life, such as chemotherapy and radiation therapy, and includes those investigations needed to better understand and manage distressing 
clinical complications. 
 
The PALLI has been made financially possible by: 
      Jan Jongmans Fonds, ds. Visscher fonds, stichting SFO 
 
© The Catholic University Foundation (Stichting Katholieke Universiteit)/Radboudumc. Please contact the Valorisation department of the Radboudumc if you consider 
using a version of the PALLI other than this paper version (secretariaat.val@radboudumc.nl). 
 
 
 
The PALLI questionnaire can help care providers to assess whether and to what extent the health of a person with intellectual disabilities 
(ID) has deteriorated. For people whose health has deteriorated and life expectancy is limited palliative care* can be appropriate: care 
and support aimed at increasing comfort and quality of life. 
 
The PALLI is concerned with health, behaviour and functioning of the person with ID compared with the previous period.  
The PALLI, combined with your knowledge of the case history, can help you in timely deciding whether the care of the person should be 
refocussed in consultation with other parties involved. Our advice is to discuss the results of the PALLI in a multidisciplinary meeting 
and consider palliative care together with all people involved.  
 
WHO IS THE PALLI FOR? 
The PALLI can be completed for every adult with ID, regardless of the level and nature of disability. Due to this broad target group, 
some of the questions may not be relevant. 
 
WHO COMPLETES THE PALLI? 
The PALLI should be completed by care providers who are familiar with the person with ID. These may be daily care professionals, 
but physicians or other care providers may also complete the PALLI. 
 
WHEN DO YOU COMPLETE THE PALLI? 
- ‘Gut feeling’: For care providers, the PALLI can help in making concrete a gut feeling about a change in health and thereby 
facilitate discussion around this.  
- Consultation: the PALLI can be completed before a person’s regular (e.g. annual) personal review or care planning meeting, 
when specific plans around (for example) discharge to hospital or resuscitation need to be decided, or when specific questions 
arise around the palliative care needs for the person.   
 
HOW DO YOU COMPLETE THE PALLI? 
We would like you to cast your mind back to the previous months and consider whether there have been changes in health, behaviour 
or functioning of the person with ID. The guideline we apply is 3-6 months; you can use another period if that seems more appropriate.  
 
Every question can be answered with ‘YES’ or ‘NO’. Please choose ‘YES’ or ‘NO’ even if you are in doubt. You can describe your 
reservations in the space for additional remarks. If you really do not know the answer and do not have information about it, please tick 
the question mark ‘?’. 
 
In every category there is ‘other (please specify)’. Here you can complement your answer. We emphasise that the PALLI is a tool and 
that it does not necessarily give a complete picture.  
 
You can complete the PALLI alone or together with others, with or without consulting the personal or medical file. There is no right or 
wrong answer; this is about your experience. Therefore, please do not think too long before answering. Completion time is approximately 
10-15 minutes. 
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Name(s) and position(s) of the person(s) who complete the PALLI: ……………………………………………………………. 
    ……………………………………………………………. 
Date of completion:    …… / …… / …… 
 
Name person with ID:    ……………………………………………………………………................... 
Date of birth of person:    …… / …… / …… 
 
Level of ID (if known):    ………………………………………………………………………………... 
Nature or cause ID (if known):    ………………………………………………………………………………... 
 
Physical   
How are things going at the moment, when compared with the previous 3-6 months?  
1. Does the person have a worse physical condition or is the person tired more quickly?    YES  NO  ? 
2. Does the person spend more time in bed?   YES  NO  ? 
3. Is the person more sleepy or drowsy?    YES  NO  ? 
4. Is the person less able to move?    
(For example: more need for help with moving, more falls)    
 YES  NO  ? 
Other (please specify)…  
 
 
 
 
 
Activities 
How are things going at the moment, when compared with the previous 3-6 months?    
5. Does the person take less initiative or is it more difficult to motivate him/her?   YES  NO  ? 
6. Does the person more frequently decline to do or undertake things?   
(For example: getting out of bed, moving, daily activities, work, other activities) 
 YES  NO  ? 
7. Is the person less able to perform activities in daily living (ADL) himself/herself, as a result of 
which daily caregivers need to do more? 
 YES  NO  ? 
8. Are there any signs that the person does not manage daily activities or routines, work or other 
activities as well as before, as a result of which daily caregivers need to assist more?    YES  NO  ? 
Other (please specify)…  
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Characteristic behaviour  
How are things going at the moment, when compared with the previous 3-6 months?  
9. Does the person make more or less contact or does he/she make contact in a different way?   
(For example: responds differently to (the presence of) others, less talkative/communicative, trying to 
approach someone more often) 
 YES  NO  ? 
10. Is the person more passive or apathetic?  
(For example: has become more docile, listless, less able or inclined to do things, reduced zest for life)    
 YES  NO  ? 
11. Is the person more withdrawn?   
(For example: more need for peace and quiet, more easily overstrung) 
 YES  NO  ? 
12. Does the person display more challenging or restless behaviour?  
(For example: more irritable, obstinate, aggressive or angry)  
 YES  NO  ? 
13. Is the person more low in mood or depressed?    YES  NO  ? 
14. Is the person more anxious?    YES  NO  ? 
Other (please specify)…  
 
 
 
 
Statements  
This concerns things that have been said during the previous 3-6 months. 
15. Did the person say anything that indicated a change in health?  
(For example: “I feel…”, “I don’t want… anymore”,  “I’m frightened…”) 
 YES  NO  ? 
16. Did family members/loved ones say anything that indicated a change in health?  
(For example: “not feeling well”, “he is not himself”, “there’s something going on”, “he used to enjoy 
this, now he doesn’t anymore”)   
 YES  NO  ? 
Other (please specify)…  
 
 
 
 
Signs and symptoms  
How are things going at the moment, when compared with the previous 3-6 months? 
17. Has the person lost weight or is he/she becoming thinner?   YES  NO  ? 
18. Has the person’s food intake decreased?  
(For example: less appetite, cannot or doesn’t want to eat as much, preference for a certain kind of food)  
 YES  NO  ? 
19. Has the person’s fluid intake decreased?  
(For example: cannot or doesn’t want to drink as much, preference for certain drinks)  
 YES  NO  ? 
20. Does the person have more problems swallowing?  YES  NO  ? 
21. Does the person have more problems with bowel movements?  
(For example: constipation, diarrhoea) 
 YES  NO  ? 
22. Does the person have more problems with nausea or vomiting?   YES  NO  ? 
Other (please specify)…  
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Signs and symptoms  
How are things going at the moment, when compared with the previous 3-6 months? 
23. Does the person show more (observable) signs of unwellness?  
(For example: (nocturnal) agitation, restless movements, facial expressions, noises made by the 
person, characteristic movements of discomfort) 
 YES  NO  ? 
24. Does the person have more pain?    YES  NO  ? 
25. Is the person more confused?      YES  NO  ? 
26. Has the person’s cognition deteriorated?   
(For example: remembers less, less orientated in time and place, loss of practical skills)   
 YES  NO  ? 
27. Does the person have more sleep problems?   
(For example: problems falling asleep, problems staying asleep, changes in day/night rhythm)  
 YES  NO  ? 
Other (please specify)…  
 
 
 
 
 
Signs and symptoms  
How are things going at the moment, when compared with the previous 3-6 months? 
28. Does the person have worse, or less well controlled, epilepsy?  YES  NO  ? 
29. Does the person have worse spasticity?  YES  NO  ? 
30. Is the person more dehydrated?  
(For example: less urine production)  
 YES  NO  ? 
31. Does the person experience more shortness of breath? 
(For example: clearly audible breathing, faster breathing, difficulty breathing)   
 YES  NO  ? 
Other (please specify)…  
 
 
 
 
 
Infections or episodes of fever  
How are things going at the moment, when compared with the previous 3-6 months? 
32. Does the person have recurrent infections or episodes of fever?   
(For example: pneumonia, cystitis, other infections or episodes of fever)   
 YES  NO  ? 
33. Does the effect of antibiotics decrease with each infection or episode of fever?   YES  NO  ? 
34. Does the person recover less well or have a longer recovery period after each infection 
or episode of fever?    YES  NO  ? 
Other (please specify)…  
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Frailty 
35. Are there several health problems that together increase the person’s vulnerability to a 
(further) decline in health?   
(Health problems relate to psychical, psychological and social wellbeing)   
 YES  NO  ? 
Other (please specify)…  
 
 
 
 
 
Disorders/illness 
36. Is there a diagnosis or a strong suspicion of the existence of a serious (chronic) illness? 
(For example: dementia, lung diseases, cardiovascular diseases, diabetes, rheumatism or cancer etc.)   
 YES  NO  ? 
37. Is there a serious (chronic) illness that cannot be treated or for which treatment is not 
indicated (anymore)?   
(For example: there is no treatment or the treatment has no effect, the person doesn’t respond to the 
treatment due to complications or side effects, treatment can’t be carried out, or the treatment burden 
outweighs possible benefits for length or quality of life)   
 YES  NO  ? 
Other (please specify)…  
 
 
 
 
 
Prognosis   
38. Is there a shortened life expectancy and is the person approaching the end of life?   
(What is your assessment, perhaps based on changes in health or diagnosis of a serious 
(chronic) illness?)   
 YES  NO  ? 
39. Would you be surprised if this person were to die in the next 12 months?  
(This is not about whether you expect the person to die, but whether you’d be surprised if this person were 
to die within a year)   
 YES  NO  ? 
Other (please specify)…  
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